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Peptides are an attractive platform to make new and novel constructs for therapeutic 
applications due to their biocompatibility, biodegradability and biofunctionality. Peptides that 
self-assemble may have enhanced in vivo stability and may be able to self-deliver. Furthermore, 
peptides can be modified to enhance their in vivo stability through lipidation, PEGylation and 
other modifications. This thesis aims to explore the self-assembly and bioactivity of small 
oligopeptides, telechelic tyrosine functionalised PEGylated peptides and peptide hormones 
with potential therapeutic applications.   
With the rise in cases of antimicrobial resistance, there is a great amount of interest in the 
development of alternate medicines to combat these issues. Short cationic peptides are 
beginning to show great potential in this area, due to their ‘multi-hit’ strategy and relatively 
cheap cost of synthesis. The self-assembly and lipid interactions of a group of surfactant-like 
peptides (SLPs) and peptide bola-amphiphiles containing arginine and alanine are examined.  
It is apparent that the size of the hydrophobic block causes increased aggregation propensity 
and increased structural ordering. The cytocompatibility of the SLPs and bola-amphiphiles is 
measured, revealing that cytotoxicity is not linked to molecular weight. The SLPs are more 
cytocompatibile than the bola-amphiphiles. These peptides show activity at cytocompatibile 
concentrations against P.aeruginosa, a bacterial species on the World Health Organisations list 
of species that require new treatments.  
  Further to this, the self-assembly and bioactivity of two short symmetrical AMPs, consisting 
of arginine and phenylalanine was examined. These peptides were found to have weak self-
assembly behaviour, but strong interactions with many different Pseudomonas bacteria, with 
particularly strong interactions with P.aeruginosa. The peptides alter the structure of liposomes 
based on the composition of the P.aeruginosa membrane, with the most active peptide, R4F4, 
completely disrupting vesicle formation. The peptide R4F4 disrupts biofilm formation and 
interacts with cyclic diguanylate (c-di-GMP), a regulator of biofilm formation and dispersion 
in the species.  
 Materials functionalised with tyrosine may be of interest for enzyme responsive materials. The   
self-assembly of tyrosine functionalised telechelic PEO-star conjugates at native pH and pH 12 
was examined These conjugates were found to self-assemble into a mixture of spherical 
globules and fibres.  The self-assembly of the lower molecular weight conjugate was disrupted 
iii 
 
by pH adjustment. The larger conjugate formed mixed long straight fibres and smaller globules 
when adjusted to pH 12. These conjugates did not form hydrogels and were proved to be 
cytocompatible at sufficiently high concentration. Self-assembled hormones may have 
prolonged half-lives and increased stability in vivo. Peptide hormone oxytocin has found to be 
heat unstable, affecting its performance in developing nations. Probing conditions for self-
assembly may improve the stability. Thus, the assembly of the peptide hormone oxytocin and 
analogues was examined. The self-assembly of oxytocin was inconclusive when examined by 
biophysical techniques. Analogue carbetocin was found to not aggregate at native pH. Oxytocin 
was found to form a self-standing β-sheet gel at 2 wt% and pH 12, whereas carbetocin appeared 
slightly crystalline under these conditions. A lipidated variant of oxytocin was found to be 
insoluble and to assemble into irregular aggregates in ethanol. Overall, this thesis examines 
through biophysical techniques and bioassays, different peptides with a range of potential 
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This chapter has been in-part published in the review article titled “Self-assembly of bioactive 
peptides, peptide conjugates, and peptide mimetic materials” C.J.C.Edwards-Gayle and I.W.Hamley, 
2017, Org. Biomol. Chem., 2017,15, 5867-5876 
1.1 Peptides   
 
Peptides are small oligomeric molecules consisting of amino acids. In nature, there are 20 amino 
acids (Figure 1.1),1–3 encoded in the genetic code of eukaryotes and prokaryotic organisms.  In 
addition to this, there are thousands more amino acids which are created through post-
translational modifications and synthetically. Each amino acid consists of a α-carbon, amino 
group, carboxyl group, hydrogen, and variable group R, which dictates the properties of the 
amino acid. The exceptions to this are glycine (for which the R group is hydrogen, making it 
non-chiral), and proline, which is an imino acid.  
Peptide bonds are formed through a condensation reaction between an amine and a carboxyl 
group. For example, two amino acids may react together in this way to form a dipeptide (Figure 
1.2).4 Peptide bonds are sterically hindered, due to electron delocalisation. This results in cis-
trans isomerisation and resonance.  When multiple amino acids react in this way, polypeptides 
and proteins may be formed. It is commonly stated that a peptide is below 50 amino acids in 
length and a protein above, although there are some exceptions to this rule.5  
Peptides and proteins may form higher order structures. Primary structure describes the linear 
amino acid sequence. Secondary structure defines formation of more ordered structures for 
example α-helices and β-sheets (Figure 1.4), which are held together through hydrogen 
bonding. This is largely dictated by which amino acids are present in the sequence, as different 
amino acids have greater tendencies to form different conformations (Figure 1.3).6 This can 
enable a degree of intelligent design,  where amino acid residues can be selected in order to try 
to generate specific secondary structure, for example, selecting amino acids with high β-sheet 
propensity, with the aim to form β-sheet fibrils. Amino acids are also optically active, giving 
‘handedness’ to structures (Figure 1.2). Natural amino acids synthesised on the ribosome are L-
isomers which, in turn, makes right-handed α-helices the energetically favoured conformation.2 
D-amino acids occur synthetically, occasionally post translationally or in some bacteria. D-




amino acids would form left-handed α-helices. When these structures fold further, they are 
described as tertiary and when multiple domains of folded polypeptides come together, 
quaternary structures are formed. Although folding is not a fully understood phenomenon, it is 
thought to be mainly driven by the hydrophobic effect, with contribution also from attractive 
forces: hydrogen bonds, electrostatic interactions, Van der Waals forces as well as covalent 
disulphide cross bridges formed by cysteine residues. 
 
 
Figure 1.1. Amino acids classified based on their solubility.   
D Asp Aspartic acid Q Gln Glutamine M Met Methionine 
E Glu Glutamic acid C Cys Cysteine F Phe Phenylalanine 
K Lys Lysine G Gly Glycine Y Tyr Tyrosine 
R Arg Arginine P Pro Proline W Trp Tryptophan  
H His Histidine A Ala Alanine    
S Ser Serine V Val Valine    
T Thr Threonine L Leu Leucine    
N Asp Asparagine I Ile Isoleucine    




Peptides are an attractive platform due to their chemical diversity, biocompatibility, 
resemblance with proteins, feasibility to synthesise in large quantities and their use as building 
blocks for creating large assembled structures. 7 
 
 
Figure 1.2. a) Stereoisomers of amino acids, b) the formation of the peptide bond and c) 
structure of the peptide showing flexible bonds phi and psi, and sterically hindered 
amide/peptide bond, due to resonance.   
 
1.2 Peptide Self-assembly  
 
Self-assembly is defined as the ability of a molecule, without the guidance of external factors, 
to associate through non-covalent interactions to form highly ordered 3-dimensional structures. 
8–12 This occurs through a bottom-up approach. Most self-assembling molecules are 
amphiphilic, having both hydrophobic and hydrophilic components,9 although there are some 
exceptions to this.13,14  Lipids are perhaps the simplest molecule displaying amphiphilicity, with 




a hydrophilic head group, and a hydrophobic tail group. These molecules self-assemble with 
the degree of saturation in the lipid chain, among other variables, dictating the packing of the 
molecules. 
Peptides and proteins are more complex in their amphiphilicity. This is largely due to folding, 
giving rise to ‘faces’, each of which are exposed to different environments. For example a β-
sheet peptide may contain alternating hydrophilic and hydrophobic residues, resulting in the 
side chains being exposed on opposite sides of the sheet.15   
Self-assembly is commonly found in nature. A natural example of a self-assembled structure is 
the phospholipid bilayer, which is the basis of cell membranes, vesicles and organelle 
membranes in cells and bacteria.16 Another example is microtubules, which are cytoskeletal 
components of eukaryotic and some prokaryotic cells. Microtubules have many functions in 
eukaryotic cells, including cargo transport of vesicles, and are a main component of the mitotic 
spindle in cell division which contracts to pull apart chromosomes and assist in maintain cell 
shape. Additionally in prokaryotes, they make up the internal structure of cilia and flagella in 
bacteria enabling movement.17,18 Other examples include protein folding in enzymes, other 
protein molecular machine assemblies, DNA double helix formation and the formation of the 
virus protein capsid around a nucleic acid core.19  
 
Figure 1.3. Amino acid structure forming propensities calculated experimentally.20 





Figure 1.4. Common secondary structures formed by peptides and proteins.   





Figure 1.5. Possible self-assembled structures of peptide amphiphiles. Amphiphilic peptides 
may assemble into secondary structure through inter and intra molecular interactions (e.g 
electrostatic interactions and hydrogen bonding), and continue to aggregate into larger self-




Some of the most common self-assembled  structures (Figure 1.5) include micelles, vesicles 
and fibrillar structures (nanotubes, fibres).21 Micelles can be spherical, worm-like or disk-
shaped assemblies and form spontaneously above a critical micelle concentration and 
temperature.22,23 Vesicles are spherical lamellar structures which are hollow, surrounding an 




aqueous core. Fibres are cylindrical structures which can be either rigid or flexible. Nanotubes 
are lamellar structures which are tube-like in shape and hollow. In nanotubes, hydrophilic 
surfaces are exposed to the inner and outer aqueous environments, whilst hydrophobic residues 
pack together between hydrophilic interfaces.24  Peptides and proteins may assemble further 
from these tertiary structures, to form networks of packed self-assembled fibrils, which may 
result in the formation of hydrogels. 
Hydrogen bonding between the backbone of peptide chains is an important factor in peptide 
self-assembly, as it drives longitudinal packing of peptide monomers into β-sheets. Inter β-sheet 
interactions among side chains of peptide molecules regulate the lateral packing of the β-sheet 
at a slow rate compared to the fast growth in the hydrogen-bonding direction. Packing of β-
sheets, which are naturally twisted due to chirality, favours reduced twisting. Lateral 
interactions overcome the energy penalty due to untwisting.15 Thus, the final assembled 
morphologies are the result of these confinements, interactions and/or their interplay.15    
Self-assembly can be characterised by a number of physical techniques. Fluorescence can be 
used to detect aggregation concentrations, with probes specialised to structure types. Circular 
Dichroism (CD),25–28 Fourier-transform infra-red spectroscopy (FTIR)29–32 and X-ray fibre 
diffraction (XRD)32,33 are used to characterise secondary structure formation. Scattering 
techniques (e.g SAXS32,34,35) and several microscopy techniques are used to characterise self-
assembled structures.32  
 
1.3 Drivers of folding and self-assembly  
 
Peptide/protein folding and self-assembly  is driven by non-covalent forces to form ordered 
structures ranging from the nanometer to micron size.36 These non-covalent interactions include 
Van der Waals forces, hydrophobic interactions, electrostatic interactions, hydrogen bonding 
and π-π stacking (aromatic) interactions.9,11 These interactions are enough to stabilise these 
robust structures, and in turn, allows the structure to be influenced by a number of factors 
including temperature, pH, concentration and pressure. These factors may be exploited in the 
creation of new materials, providing a degree of tunability, for example pH responsive 
materials.  
Hydrogen bonding is a non-covalent bond which forms when hydrogen is bonded to an 
electronegative donor, which interacts with an electronegative acceptor.37–39 The acceptor needs 




to have a non-bonding electron pair. In peptides, the donors and acceptors are usually oxygen 
(O) atoms or nitrogen (N) retrospectively, particularly NH2 groups and OH groups, although 
C=O groups also can act as acceptors. Hydrophilic amino acid residues can form hydrogen 
bonds with water molecules, but hydrophobic residues cannot, which is a large driver of 
hydrophobic collapse. Hydrogen bonds are the strongest noncovalent, with an estimated energy 
of 12-30 kJ mol-1. Hydrogen bonds are highly directional, with the strongest bonds being found 
when all molecules are in a straight line (180 oC bond angles). For example, anti-parallel β-
sheets (Figure 1.4) are more stable than parallel β-sheets as the hydrogen bonding pattern is 
more optimal.  
Electrostatic interactions include ionic and permanent dipole interactions.40 Ionic bonds, the 
strongest electrostatic interaction (20 kJ mol-1), are attractions between positive and negative 
groups of ions. Only the charged amino acids are able to form electrostatic interactions 
(D,E,G,L,K,H). Ion-polar and polar-polar electrostatic interactions also occur through a similar 
principle, with negative dipoles interacting with positive dipoles.   
Van der Waals forces is a term used to describe a collective group of weak interactions between 
atoms which are positioned closely.41 Atoms may be electrically neutral, however as the 
electron cloud is dynamic, electrons are constantly moving. This can cause areas of the atom to 
become more electron rich than other parts, leading to temporary weak positive and negative 
dipoles. A negative charge on an atom will cause repulsion of the electron cloud of the 
neighbouring atom, thus creating a temporary positive dipole in the neighbouring atom. Van 
der Waals forces can operate between any two atoms and is distant dependent. Van der Waals 
are important in the hydrophobic effect, which causes peptides to form  structures, as it is the 
primary interaction between hydrophobic groups in the core of structures.  
Aromatic amino acid groups, Tyr, Trp and Phe, may form π-π stacking interactions,42 which is 
an important non-covalent interaction that plays a role in self-assembly and amyloid fibril 
formation.42 These interactions are the result of electrostatic attraction between π electron 
clouds, and the different arrangements can be seen in Figure 1.6. 
 





Figure 1.6. Non-covalent interactions which drive self-assembly.  
 
1.4 Biophysical Methods to Study Self-Assembly  
 
1.4.1 Fluorescence spectroscopy   
 
Critical aggregation concentrations are mainly determined using fluorescence spectroscopy. 
Fluorescence spectroscopy works through the excitation of electrons to the singlet state. Once 
excited, the electron relaxes back down to the ground state (Figure 1.7). As it relaxes, the 
electron releases a wavelength of light, that  usually has a longer wavelength than the 
wavelength used to excite. This is known as the Stokes shift. Fluorescence instruments 
contain a light source, a sample holder and a detector. A beam of light is passed through the 
sample, at a specific wavelength, and the light emitted (emission spectrum) or absorbed 
(excitation spectrum) is measured by the detector.   
 
 






Figure 1.7. Illustration of the Jablonski diagram to show fluorescence states.  
 
Compounds that fluoresce are known as fluorophores, and usually contain aromatic groups. 
Aggregation concentrations of peptides can be measured using intrinsic tyrosine, tryptophan 
and phenylalanine fluorescence, or fluorescent probes such as 8-Anilinonaphthalene-1-sulfonic 
acid (ANS),43 pyrene44,45 and thioflavin T.46–48 The amino acid residues and probes (aside from 
ThT) have generally increased intensity when bound to hydrophobic environments, whereas 
Thioflavin T has increased fluorescence when bound to β-sheet amyloid fibres.47 
Several factors affect the fluorescence spectrum. Fluorescence is directly proportional to 
absorbance, shown by the Beer-Lambert law:  
A = εcl 
Where A is absorbance, ε is the molar extinction coefficient (M-1 cm-1) , L is the pathlength 
(cm) and c is the concentration (M). Thus, concentration of the sample, pathlength of the 
cuvette, self-absorption of the sample can all affect the fluorescence of a sample.  
 




1.4.2 Circular Dichroism (CD) 
 
Circular dichroism is a technique used to examine the secondary structure of chiral molecules, 
through plane polarised light.25,26,49 Plane polarised light can be seen as being made up of two 
equal circularly polarised components, with one rotating clockwise (right-handed) and one anti-
clockwise (left-handed). Circular Dichroism measures the difference in absorption of these two 
components. If a compound is not chiral, or exists as a racemic mixture, then no signal is 
obtained as there is no absorption or equal left and right absorption which cancel out. Chiral 
molecules, for example peptides and proteins, have unequal absorption of left and right-handed 
circularly polarised light, which produces a non-zero CD signal. The change in absorption is 
written as:  
 
∆𝐴 =  𝐴𝐿 − 𝐴𝑅 
Where ∆A is change in absorbance, AL is left-handed circularly polarised light, and AR is right-
handed circularly polarised light.  
The CD spectrum in the far UV can be used to measure secondary structure, and to estimate the 
percentage of each secondary structure present. Each secondary structure has distinct peaks in 
the far UV region (Figure 1.8). 25,26,49 Circular Dichroism data is presented predominantly in 
this thesis as molar ellipticity which is calculated through the following equation:  





Where [θ] = molar ellipticity in deg cm2 dmol-1 , θ = ellipticity in mdeg (mo),  L = path length 
in cm, and C = concentration in Moles (M)  





Figure 1.8. Schematic of typical circular dichroism profiles for different secondary 
structures. 
 
1.4.3 Fourier Transform Infrared Spectroscopy (FTIR) 
 
Fourier Transform InfraRed spectroscopy can also be used to characterise the secondary 
structure of peptides and proteins. Infrared radiation excites vibrational transitions in molecules, 
and the ability of the molecule to absorb infrared depends on the polarity, strength and 
positioning of the vibrating molecule, thus molecules are influenced by intra and inter-
molecular interactions. 30,31,50,51 
In an FTIR instrument, an infrared source produces a broad spectrum of infrared light 
wavelengths which are split into two paths using a half-silvered mirror.  This light is then 
reflected back onto a beam splitter by two mirrors, one of which is moveable, where it is 
recombined and focused onto the sample. The intensity of light striking the detector is measured 
as a function of mirror position. This is then Fourier-transformed to produce the final plot of 
intensity vs wavenumber.  




For peptides and proteins, two of the most important regions in the FTIR spectrum are the 
Amide I region, which ranges from 1600 cm-1 to 1700 cm-1, and Amide II region, which ranges 
from 1510 cm-1 to 1580 cm-1. Secondary structure assignments can be seen in Table 1.1. 
 









   
 
1.4.4 X-ray fibre diffraction (XRD) 
 
X-ray Fibre diffraction (referred to as XRD) is a type of X-ray diffraction which is used to 
determine repeat distances in periodically repeating and partly ordered but non-crystalline 
structures.  XRD is commonly used to examine the structure of amyloid like fibres for this 
reason. An ideal fibre pattern of an oriented fibre exhibits 4-quadrant symmetry, with the 
perpendicular direction being called the equator of the fibre, and the meridian being the axis of 
the fibre.  
The technique is analogous to wide angle X-ray scattering (WAXS), which is similar to small 
angle X-ray scattering (SAXS, discussed in section 1.4.7), but the detector sample distance is 
closer. This means wider angles are measured in the diffraction pattern. Regularly spaced atoms 
in a crystalline structure can be measured by determining the d-spacing using Bragg’s law. Here 
in this thesis, it is used to investigate the structure of peptide and peptide conjugates which have 
the ability to form dried stalks.  
 
 




1.4.5 Electron Microscopy   
 
The four types of electron microscopy used in this thesis are transition electron microscopy 
(TEM), scanning electron microscopy (SEM), Cryo-TEM and Cryo-SEM. 52 
 Transmission electron microscopy is a high-resolution technique, where a beam of electrons is 
transmitted through the sample with different density. Electrons have a much shorter 
wavelength than visible light, enabling up to 1000 times higher resolution from TEM. This 
enables nanostructures to be examined with this technique. Samples must be below 100 µm in 
thickness, which increases the complexity of sample preparation for biological samples. 
Biological samples including peptides, often require negative staining to increase the electron 
density difference (contrast) of the sample to reveal the structure, for example a heavy metal 
salt such as uranyl acetate. 52  
Whilst TEM can give a detailed information on nanostructures, scanning electron microscopy 
(SEM) can give useful information about the surface topography of a structure (for example a 
hydrogel or a bacterial cell). Scanning electron microscopy produces images by scanning the 
surface of the sample with a focused electron beam. SEM has a lower resolution than TEM.  
For both microscopy techniques, the electron beam is emitted from a negatively charged 
electron gun, which most commonly either tungsten filament cathode or a lanthanum 
hexaboride (LaB6) source. The electrons are accelerated by a series of anodes under vacuum at 
high voltage. For TEM voltage ranges from 60-200 keV, and for SEM this voltage ranges from 
0.2-40 KeV.  
Both instruments have a series of lenses to focus the beam, which are composed of copper coil 
wires. The main types of lenses are the condenser lens, which is used as the primary way to 
focus the beam on the sample, the objective lens, which focuses and magnifies the lens, and the 
projector lens used to focus the image further and project it onto an imaging device. Apertures 
can be used in EM to decrease the beam intensity, filter out electrons which are scattered to 
high angles. High angle electron scattering can lead to diffraction, chromatic or spherical 
aberrations. In SEM and TEM there are two apertures, the condenser aperture which controls 
beam size on the sample, and the objective aperture, which selects which electrons contribute 
to the image, thus affecting the overall contrast. 52  
As both instruments are under vacuum, samples need to be dry in order to be imaged. For self-
assembled samples, and amphiphilic molecules that require hydration to be in the correct 




orientation, this can be a limiting factor. Some molecules will form different morphologies in 
the dried form, for example some peptides may transition upon drying to a β-sheet structure, 
leading to fibril formation. Biological samples also need to be dehydrated through a ethanol 
gradient and then dried. Thus, cryo-TEM and cryo-SEM which involves the swift freezing of 
samples, allowing them to be imaged in the solution state can have a large advantage over SEM 
and TEM.  
   
1.4.6 Small angle X-ray Scattering (SAXS)  
 
Small angle X-ray scattering (SAXS) is a powerful method to study the structural properties of 
materials at the nanoscale.  It is a non-destructive, accurate method that requires little sample 
preparation. Originally developed in the 1930s to study metal alloys,53 it has been shown to be 
useful for many other purposes including polymers, colloids and biological macromolecules. 
There have been two milestones that have increased the popularity of the technique. The first 
was in the 1970s, with the appearance of intense synchrotron sources. The second, in the 1990s, 
was associated with computational advances and methods allowing for high throughput 
SAXS.35 Recent progress in instrumentation and analysis methods has led to an increasing 
number of applications of this technique for biomacromolecule studies in solution state, 
allowing for example self-assembly to be studied in solution or in hydrogels.35  
 SAXS measurements on solutions are typically performed when molecules are randomly 
orientated in solution resulting in no diffraction peaks being observed, and all orientation 
information is lost. It is still possible to obtain information on magnitudes of the interatomic 
distances, such that the overall structural parameters, even low-resolution shapes of particles 
can be obtained. This enables SAXS to be used to determine the overall shape of proteins or 
self-assembled structures in solution. This is a useful and important tool, as many 
crystallographic high resolution studies, structures of peptides and proteins do not accurately 
represent conformation in solution, as the energetically favourable conformation for 
crystallisation is often different from how the peptide would behave in solution. New SAXS 
approaches include time resolution, assessment of oligomeric states of macromolecules and 
proteins, chemical equilibria and reaction kinetics.34  
 




1.4.6.1 Solution-SAXS  
 
Solution SAXS is a powerful technique to study self-assembly in solution. Scattering is  
isotropic, and photons are collected on a 2D detector. To overcome this, the image is radially 
averaged to obtain scattering intensities, as a function of the momentum of transfer or 






Where λ is equal to the wavelength of the incident beam, θ is half the angle of incidence (angle 
between incident beam and scattered radiation). A typical scattering curve will have intensity 
plotted against q in nm-1 or Å dependent on instrumentation (figure 11b). The q-range is 
determined by experimental set-up.  
During an experiment, scattering of the dissolved particles and that from the pure solvent are 
separately collected. The scattering of the pure solvent is subtracted from that of dissolved 
particle. The difference in signal is proportional to the concentration of the solution, and to the 
difference in electron density between particle Pp and solvent Ps. For biological molecules, 
including peptides, the density of the particle is can be only slightly higher than that of the 
corresponding aqueous buffer, meaning that the useful subtracted signal may be small. This 
means that background noise can be a problem with the technique, therefore equipment needs 
to be optimised to reduce background scattering as much as is possible. 35  
 For a monodisperse system, consisting of non-interacting identical particles, the scattering 
intensity from a single particle averaged over all orientations is proportional to the background-
corrected intensity I(q), as such that:  
𝐼(𝑞) = 𝐼(𝑞)𝛺 = 𝐴(𝑞)𝐴
∗(𝑞)𝛺 
Where the scattering amplitude, A(q) is a Fourier transformation of excess scattering length 
density, and Ω is the solid angle in the reciprocal space of the scattering. 





Figure 1.9 A typical SAXS experiment. When a monochromatic beam hits the sample, photons 
are scattered. The scattered photons are collected by a 2D detector, and the data is radially 
averaged in order to obtain a scattering curve.  
1.4.6.2 Computation of overall parameters  
 
Guinier analysis, developed in the 1930s, is still the most straightforward way to determine the 
radius of gyration (Rg) and forward scattering I(q).
54 The radius of gyration is a model 
independent size parameter, that can eventually be used to calculate the particle dimensions if 
a model is found. The Guinier approximation for a monodisperse system is:  







This approximation is valid for the range q.Rg < 1.3.
35 In practice Rg and I(0) are determined 
through a Guinier plot, a plot of ln[I(s)] against q2. The slope is equal to Rg, and the intersection 
with the ordinate is the forward scattering intensity. A linear Guinier plot is a good indicator of 
sample quality and monodispersity.35 However, complementary techniques, for example 
dynamic light scattering, should be used to confirm this.55 Non-linear Guinier plots can be due 
to a number of reasons for example polydispersity, improper background subtraction and 
interparticle interactions. As the Guinier region is influenced by interactions, non-specific 
aggregation this can result in a sharp increase at low angles and overestimation of both Rg and 
I(0). Although this effect is not ideal, it does have some uses, for example finding crystallisation 
conditions of a peptide/protein. 




Polydisperse samples can still be measured using techniques such as size-exclusion SAXS 
(SEC-SAXS), which separates fractions within a sample before running them into the beamline. 
It can also be used to detect different aggregation states. For example, if a self-assembling 
peptide has partial assembly to fibres and partial assembly to spherical micelles it is possible to 
separate the two assemblies through a size exclusion column, and load both onto the beam as 
they are eluted separately.   
The Guinier approximation provides a way to access I(0). Overall the Guinier method provides 
size information, data quality, interactions and oligomeric state. Today, it can be calculated 
automatically by computer programmes.35  
 
1.4.6.3 Modelling SAXS structure  
 
Every particle has an associated  form factor (an interference pattern describing every wave that 
is scattered by every atom inside the particle) that is characteristic to its structure. Overall size 
is determined primarily by the slope at low q, the final slope at high q bears the surface 
information (Porod’s region). Shape and internal distribution information are determined 
through the oscillating part of the middle section of the form factor. Rough classifications into 
globular, cylindrical and lamella shape can be done by investigating the power law form factor 
at small angles. On a double logarithmic scale, an initial slope of q0 indicate globular objects, 
q-1 indicates cylindrical shape, and q-2 equates to lamellar objects.34 When q values exceed this, 
the objects are too large for the resolution limit and only the Porod region (region observed that 
gives information about structure surface, toward q max) is observed.34 
     One method of investigating overall shape is to do a Fourier-transform, and the resulting 
curve p(r) is the “pair-distribution distance function”. This produces a histogram of distances 
found inside the particle. This gives an initial idea of the shape.35  
 From here it is possible to perform model calculations to determine relative positioning and 
orientations. They involve repeated calculations of pair-distribution distance functions, and 
comparisons with experimental curves.  Ab initio modelling, such as a dummy bead modelling 
algorithm can be used to build models for particles of different shapes based on beads. Rigid-
body modelling requires all atomic points (although this can be overcome by combination with 
ab initio techniques).34 There are many computer programmes available that can perform 
modelling functions.  




For self-assembled structures, it is possible to model them using form-factor fitting. This is the 
modelling method used predominantly in this thesis. This is based on using the SAXS profile 
to select and fit the data to different shaped models through adjusting various parameters. 
Programmes such as SASfit can be used to model structures using this method. Through this it 
has been possible to model spheres, core-shell and cylindrical micelle structures, bilayers, fibres 















Where Q = forward scattering, ∆η = the difference in the scattering length density between the 



















Where Q = forward scattering, ∆η = the difference in the scattering length density between the shell 
and the matrix, and R1 is the overall radius, R2 is the radius of the core, μ is the scattering contrast 
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Where R is the radius of the core, t is the thickness of the shell, L is the length of the cylinder, Q is the 
forward scattering, ηcore is the scattering length density of the core, ηshell is the scattering length density 
of the shell, ηcolv is the scattering length density of the solvent. For long cylindrical shell, the 
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Where Jn(x) are the regular cylindrical Bessel function of order n. R is the radius and L is the length. 
The approximation for a long cylinder is valid when L > 2R 
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The quality of the fit is assessed through examining the residuum (deviation between the data 













Where N is the number of data points, m is the number of fit parameters, Iexp(qi) is the 
experimental data, Ith(qi) is the fitting function. A good fit is achieved when χ
2 is close to 1.  
 
1.5 Peptide Amphiphiles (PA’s) and Amphiphilic Peptides  
 
The classical model of a peptide amphiphile (PA) was defined by Stupp (Figure 1.10). 57 This 
model has multiple sections. Firstly, a hydrophobic tail group, usually an alkyl group, which 
leads to hydrophobic interactions. Secondly, a peptide sequence that can form intermolecular 
hydrogen bonds, which determines the interfacial curvature of self-assembly. Next, a section 
of charged amino acids to promote solubility and finally a functional peptide epitope that has 
bioactivity.57 Although the classical model of peptide amphiphiles are defined as such, other 




peptides which are amphiphilic, with both charged and uncharged parts and without lipid tails, 
have also been shown to have remarkable self-assembly abilities.  
 The amphiphilicity of these molecules drives self-assembly, which draws the 
functional/hydrophilic part of peptide group to the surface of the structure. Self-assembly 
occurs above a critical aggregation concentration (cac). The cac can be measured using 
fluorescence methods, light scattering or proton NMR solubility.9  
 
 
Figure 1.10. Typical structure of a peptide amphiphile showing the four domains that are 
typically required for self-assembly, though variations of this structure have been shown to self-
assemble.57     
 
Self-assembly of peptide amphiphiles and amphiphilic peptides has been widely-studied due to 
their potential to assemble into a large range of novel nanostructures which are of interest 
commercially and biomedically. These structures can be monolayer based (for example 
micelles), or bilayer based (for example vesicles).58  The self-assembled structure of a peptide 
can largely be controlled by amino acid sequence, length of sequence and lipidation. Thus, they 
are a malleable tool in order to make novel biomaterials.  Some of their potential uses include 
drug delivery, tissue engineering and antimicrobial agents.9 
 
1.6 Surfactant-like Peptides (SLP’s) 
 
Surfactant-like peptides (SLPs) are peptides containing sequences of both hydrophobic and 
hydrophilic amino acids (Figure 1.11.), which self-assemble in a similar way to PAs. Popular 
examples of this include A6R,
59 A6D and V6D.
60 Alanine-containing SLPs have found to self-
assemble into more stable structures due to stronger hydrophobic interactions, in contrast to 
other hydrophobic amino acid residues.   




SLPs tend to feature 1-2 charged amino acids that form a hydrophilic head group, and 4 or more 
consecutively hydrophobic amino acids.61 Early studies of self-assembly of this group showed 
that in water, they undergo self-assembly to from bilayer nanovesicles and nanotubes, with an 
average diameter of 30-50nm ).62  Nanotubes are thought to form from bilayers of peptide 
molecules, which resemble sheets. These sheets then roll up to form tubes, which have a defined 
diameter, and continue to grow from the edges.  More recently, SLPs have been prepared that 
form micelles through packing of hydrophobic tails or nanofibers. Two variants of A6K were 
shown to have differences in assembly due to deprotection of the C-termini or the pH of the 
solution.  A6K with the sequence Ac-AAAAAAAK-CONH2 were observed to form nanofibers 
at low pH and pH 6, and amorphous aggregates at high pH. When the protecting NH2 group at 
the C-termini was removed, leaving the sequence Ac-AAAAAAAK-COOH (named A6K±),  it 
was shown to form short nanofibers at low pH, longer fibres at pH 5, and nanospheres at high 
pH.44 This was studied using atomic force microscopy, dynamic light scattering and transition 
electron microscopy (TEM). The difference at high pH was thought to be due to the ability of 
the carboxyl group in the second variant to disassociate. The uncapped version of A6K has also 
been shown to form single layer nanotubes at high concentrations using cryo-TEM and SAXS 




Figure 1.11. Structure of a SLP, where the hydrophobic tail group and hydrophilic head group 
can vary in size, where R1 is a hydrophobic group and R2 is a charged group. 
 
SLPs have promising potential to be used in the study of membrane proteins because, like lipids, 
they can form layered structures. Membrane protein purification is a complex process due to 
the size and interactions membrane proteins have with the lipid bilayer. Surfactant-like peptides 
could be used to bind the hydrophobic section of the membrane protein and sequester it from 
water, thus preventing denaturation. For example, surfactant-like peptides have been shown to 




enhance the stability of bovine rhodopsin, a G-protein coupled receptor.62 They also have 
promising antimicrobial applications.59  
 
1.7 Peptide Bola-amphiphiles  
 
A bola-amphiphile is a molecule described as having two hydrophilic head groups joined 
together through a hydrophobic core group.65 This type of peptide are naturally found in 
membranes of some extremophile archaebacteria, which have monolayer assemblies as 
membranes as opposed to the standard bilayer structures of normal lipid membranes (Figure 
1.12). This improves their stability in harsh conditions.66 Aside from this, peptide bola-
amphiphiles can consist of amino acids alone and be rather short in sequence, or have other 




Figure 1.12. Generic structure of a peptide bola-amphiphile, where the hydrophobic core and 
hydrophilic head group can vary in size, where R1 is a hydrophobic group and R2 is a charged 
group. 
 
The self-assembly of a group of short bola-amphiphiles, with sequence KAnK (where n ranges 
between 3 and 8) has been investigated.67 KA3K was found to not self-assemble, however when 
increasing the length of the alanine chain length between 4 and 8, self-assembly into nanofibers 
was observed. Interestingly, despite these peptides binding to ThT and having birefringence 
which is characteristic of amyloid fibres, the secondary structure determined through circular 
dichroism (CD) was disordered. Moreover, peptides with different hydrophilic capping groups 
were examined, those with arginine (RA6R), glutamic acid (EA6R) and threonine (TA6T) 
forming spherical structures, compared to serine (SA6R), lysine (KA6K) and aspartic acid 




(DA6D) which form nanofibers.
67 This group also examined the effect of replacing alanine in 
the hydrophobic core with other amino acids, and found that as long as the core remained 
hydrophobic nanofibers formed, however, the substitution of hydrophilic residues resulted in a 
loss of nanofiber formation.67 
 Recently, Guan and co-workers studied dendritic peptide bola-amphiphiles, which were shown 
to be able to transport siRNA (silencing RNA)  into primary adipocytes and hepatocytes without 
disturbing the normal metabolic interactions of the cells.68 siRNA transportation into the cell is 
important for tissue engineering, and in diseases where stopping the transcription of certain 
mRNA (thus affecting protein composition) is important. The dendritic peptides consist of a 
fluorocarbon core, which increases the stability of the dendrimer in the cytoplasm, assists 
cellular uptake and increases self-assembling propensity. Attached to this are two L-lysine 
residues, connected through a disulphide linker. This disulphide linker provides stimuli 
responsive release of siRNA. The dendrimers were functionalised with tryptophan and histidine 
to increase binding and buffering respectively.68 
The construction of a group of bola-amphiphile like peptides which mimic collagen was also 
examined.69 These sequences contain two hydrophilic head groups consisting of L-aspartic acid, 
linked together through repetitive triple helical core groups, which are similar to the architecture 
of collagen. These peptides, D2(GPO)7D2 and D2(PPG)12D2 were found to assemble into 
nanospheres, which were stable across a broad range of pH conditions.69 
Two short bola-amphiphiles containing eight amino acids were found to have remarkable self-
assembling properties. Peptide RFL4FR was found to self-assemble into cytocompatibile β-
sheet nanosheets,70 which over time fold into nanotubes.70 Peptide EEL4FE was found to form 
nanosheets, transitioning from β-sheet to disordered secondary structure upon nanotube 
formation.71  
Therefore, peptide and peptide-functionalised bola-amphiphiles may have a range of 
applications including studying model systems, membrane modelling of extremophile bacteria, 








1.8 Lipopeptides  
 
Self-assembling amphiphilic lipopeptides are a class of molecules defined as having a one or 
more lipid chains attached to a peptide head group.  The self-assembly of this class is thought 
to depend upon the hydrophile/lipophile balance (HLB).12 They offer advantages compared to 
peptides, as they offer increased amphiphilicity and are compatible with the phospholipid 
bilayer (which makes up cell membranes), enabling them to deliver actives into cells via 
endocytosis. Additionally, self-assembly of lipopeptides facilitates the presentation of peptide 
functionalities at high density at the surface of nanostructures (micelles, vesicles and fibrils) 
and increase the in vivo stability.11,12    
Many naturally expressed bioactive lipopeptides contain one lipid chain (C14-C18) with a cyclic 
head group. Cyclisation is thought to have evolved to reduce proteolysis, thus enhancing in vivo 
stability. However, these conformational peptide constraints may be relevant to bioactivity. In 
bacteria, many naturally occurring amphiphilic lipopeptides are produced as part of a host 
defence response against other organisms.72 This has many interesting uses clinically. An 
example is daptomycin, produced by gram positive bacteria, Streptomyces roseoporous, which 
is used to treat MRSA and self-assembles into micelle structures.73,74  
Synthetic amphiphilic lipopeptides tend to be based on a bio-derived sequence, often containing 
a linear peptide head group with 1-3 (usually palmitoyl) lipid chains attached. An example is 
Toll-like receptor agonists (TLRs). TLRs are transmembrane proteins which are part of the 
innate immune response, making them an important therapeutic target. Agonists of TLRs were 
designed based on the Pam3Cys peptide (where Pam denotes a C16 chain). This synthetic peptide 
has been shown to stimulate cytotoxic T lymphocyte (CTL) responses against cells infected 
with influenza virus.75 Another related lipopeptide to this is Pam3CysSer2 which has been 
shown to stimulate antibodies against foot and mouth disease.76 Pam1CKS4 and Pam2CSK4 have 
been shown to self-assemble into spherical micelles in contrast to Pam3CSK4 which forms 
bilayer based structures.77  
 
1.9 PEGylation and other modifications  
 
Attachment of polymer chains to peptides can increase in vivo stability through the reduction 
of proteolysis / promoting album binding. One such way is to PEGylate peptides.78 PEGylation 




is covalently attaching polyethylene glycol (PEG) or polyethylene oxide (PEO) to a peptide 
chain. This can increase the molecular weight, increasing resistance to enzymatic degradation. 
PEG is an attractive polymer for attachment as it is FDA approved, meaning it has huge 
potential in the area of developing drug delivery technologies and extending drug half-lives.79,80   
PEGylation has resulted in a mixture of positive and negative results. For example, the 
PEGylation of gut peptide PYY3-36, which is involved in several stomach processes including 
feeling full after eating, was examined. It was shown that PEGylation extended the circulation 
half-life of the peptide in a mouse model, but eliminated its activity.81 To overcome this issue, 
attaching PEG through a hydrolysable linker was found to restore activity.81 Recently, Hamley 
and co-workers examined the effects PEGylation of PYY3-36 had on self-assembly by attaching 
short oligoPEG chains in several regions across the peptide.82 PEGylation was found to inhibit 
peptide aggregation, shown through fluorescence studies, although α-helical secondary 
structure was observed.82   Thus PEGylation can increase stability, decrease activity dependent 
on method of attachments, and increase solubility/ prevent or increase self-assembly dependent 
on the length of the PEG chain.  
Hamley and co-workers reported the gel-sol transition of PEO conjugates with hydrophobic 
dipeptides, including dityrosine and diphenylalanine.83 One conjugate with a di-tyrosine cap 
and a C-terminal Fmoc protecting group was found to undergo a gel-sol transition period near 
body temperature, driven by loss of β-sheet structure associated with extended fibril 
formation.83 The self-assembly of three conjugates, Tyr5-PEO2K-Tyr5, Tyr5-PEO6K-Tyr5 and  
Tyr3-PAla-Tyr3 (PAla = poly(L-alanine),  was examined.
84 Tyr5-PEO2K-Tyr5 and Tyr3-Pala-
Tyr3 were shown to have poor solubility in water until adjusted to pH 12, whereas Tyr5-PEO6K-
Tyr5 showed good solubility. All three polymer conjugates were shown to assemble into β-sheet 
fibrillar structures probed by cryo-TEM. Interestingly, hydrogel formation was not observed 
for any samples, in contrast to the previous work, up to 20 wt%.84  
Other modifications aside from PEGylation that can increase stability can include the 
substitution of L-amino acids to D-amino acids. Mammalian enzymes do not recognise D-amino 
acids, therefore this can delay their enzymatic breakdown.85,86 Moreover, the addition of 
carbohydrates (glycosylation),87 conjugation to protein serum albumin88 or changing the 
position of the R-functional group to the nitrogen  as in peptoids, are other techniques to 
improve peptide stability.89 
 




1.10 Hydrogels  
 
Hydrogels can often form as the result of a higher order of self-assembly beyond the structures 
described above. A hydrogel is defined as a water swollen, cross-linked polymeric network. It 
is produced by simple reactions between one or more monomers, retaining water but not 
dissolving. Some hydrogels are able to absorb large amounts of water and they may also be 
designed to have mechanical properties similar to natural tissue. Hydrogel formation can be 
very dependent upon temperature, pH, concentration of polymer/peptide or salts.90  
 Hydrogels can be made of natural or synthetic materials, and can be prepared through use of 
homopolymers, copolymers or multi-polymer networks. Homopolymeric hydrogels contain 
one polymer, copolymer networks contain two or more polymers interacting with each other to 
form the fibrillar network, and co-networks contain two independent fibril forming monomers. 
They can be non-crystalline, semi-crystalline or crystalline.90 Formation can occur through 
covalent interactions between monomers, or through electrostatic interactions,  hydrogen 
bonding, Van der Waals and/or ionic interactions.  
Peptides and peptide conjugates have the ability to form hydrogels. Hydrogelation is a 
hierarchical process, which occurs with continuing self-assembly.91  For example, for fibre-
based hydrogels, self-assembly might occur from β-sheet peptides to nanofibers. These fibres 
may then elongate in three dimensions, leading to increased fibre length and entanglement, 
ultimately leading to fibrillar network formation. These complex networks of peptides may then 
entrap water, thus providing a self-supporting hydrogel. Peptides and peptide conjugates with 
other secondary structures, for example α-helical, have also been shown to be able to form 
hydrogels.92  





Figure 1.13.  Simplified schematic of hydrogel formation  
 
Hydrogels designed for biomedical applications must be cytocompatible. Synthetic hydrogels 
are more likely to induce immune inflammatory response, which could have potential cytotoxic 
and thus detrimental effects. Natural hydrogel polymers, for example peptide, or peptide 
functionalised polymer hydrogels,83,93–98 are more likely to be biocompatible. A number of 
other physical parameters, for example degradation and performance (e.g. cell adhesion) must 
also be considered. The mechanism by which the hydrogel forms is important. Gels formed by 
ionic cross-linking may be prematurely degraded in vivo due to salts in body fluids, making 
covalent cross-linking preferred. Some examples of other naturally occurring polymers include 
fibrin, collagen and gelatin and hyaluronate. The most popular FDA-approved synthetic 
polymers are poly(acrylic acid) derivatives  and poly(ethylene oxide) (PEO).99  
Hydrogels have also been shown to have applications in cell culturing. Peptide hydrogels for 
cell culturing must mimic the extracellular matrix and incorporate peptide adhesion motifs. 
Peptide RGD,  is one of the most widely used peptide sequences for this purpose. A Fmoc-RGD 
peptide was shown to form β-sheet secondary structure, and to self-assemble into amyloid 




fibrils. The hydrogel formed by Fmoc-RGD was shown to be capable of sustaining cells and 
supporting fibroblasts compared to a control scrambled sequence.100 Other applications for 
peptide and peptide conjugate hydrogels include biosensors,101 regenerative medicine and tissue 
engineering,102–112  and slow release drug delivery systems.80,113–117 The applications described 
below are those most relevant to this thesis.  
 
1.11 Therapeutic applications  
 
Peptide amphiphiles have many applications. Some applications, including 
biomineralization,118–120 membrane stability enhancement121–124 and antibody production125,126 
are not covered here but are described in detail elsewhere.8,127 The applications presented below 
are those most relevant to this thesis.  
 
1.11.1 Tissue scaffolds  
 
Tissue scaffolds are engineered materials that mimic the extra-cellular matrix (ECM), and are 
designed to allow cell attachment/migration, enable diffusion of desired molecules, exert 
mechanical and biological influences to modify the behaviour of the cell phase, or to deliver 
and retain cells and biochemical factors. Peptide amphiphiles (PAs) have been shown to have 
potential applications in this field.  
One of the most commonly studied cell adhesion motif is the integrin recognition motif RGDS 
from fibronectin. Terrill’s group attached RGD units either through amino or carboxyl units to 
dialkyl lipid chains. They also prepared a conjugate which contained loops connected by linkers 
to dialkyl chains on both sides.128 It was found that lipid chain attachment to the RDG peptide 
affected the spreading of melanoma (tumour associated with skin cancer). Amino conjugated 
PA was found to show no spreading, whilst the looped PA was found to show concentration-
dependent spreading, and indiscriminate spreading was observed for the carboxyl coupled PA. 
Further studies based on liposomes revealed that spontaneous metastasis could be inhibited by 
RGD-based PAs.129 
PAs have also been shown to have promise in regenerative medicine. PA nanofibril gels 
containing peptides incorporating a cell adhesion motif, IKVAV have been observed to 




encapsulate cells and rapidly differentiate them into neurones.130 This same PA has been shown 
to be effective in a mouse model for treating spinal cord injury, the self-assembling nanofibers 
inhibiting glial scar formation and promotion of axon elongation. Other PAs have been shown 
to be effective in cartilage regeneration using bone marrow-derived stem and progenitor 
cells.131 
Cosmetic lipopeptide amphiphile Matrixyl (C16-KTTKS), shown to stimulate collagen and 
fibronectin production in fibroblasts, undergoes self-assembly in aqueous solution.127 At neutral 
pH, it has been shown to have β-sheet secondary structure and form bilayer-based nanotapes63 
which are stable between the pH range of 3-7 at room temperature. However, pH 
reduction/increase132 or increased temperature133  favours random coil secondary structure, and 
spherical micelle self-assembly. 
 
1.11.2 Delivery and cell internalization  
 
Transportation of hydrophobic drugs and other active molecules into cells is an important and 
ongoing biomedical challenge. PA-based nanocarrier systems have shown potential and are 
usually designed based upon natural sequences. An example is a PA comprising of a tandem 
dimer, containing binding sites for LDL (low-density lipoprotein) receptor and cell-surface 
heparin sulphate proteoglycans. Internalisation of the PA into brain capillary endothelial cells 
was imaged using fluorescent techniques, showing potential drug transport applications.134 
Another example of a delivery system is a PA containing cell adhesive MMP-2  (matrix 
metalloprotease-2) sensitive peptide domain, which was shown to form fibrillar hydrogels. This 
PA can deliver anti-cancer agent cisplatin through enzymatic degradation.135 
Cationic PAs have also been shown to be useful in gene therapy. The PAs H5R10 and H10R10 
were conjugated to cholesterol.136 They were shown to assemble into cationic micelles, which 
lead to increased localization charge and increased DNA binding. H10R10 was shown to 
stimulate higher gene expression, probed through use of a reporter gene in HEK293 and Hep62 
cells.136 Moreover, A12H5K10  and A12H5K15 were also investigated.
137 Through the same 
reporter assay, these PAs were shown to have improved gene expression compared to non-
amphiphilic control peptide, and a more favourable cytotoxicity profile compared to 
polyethyleneimine (PEI), a commonly used synthetic DNA-condensing polymer. Simultaneous 
delivery of genes (either p53 tumour suppressor or luciferase reporter gene) and doxorubicin 




was examined using Ac-(AF)6H5K15-NH2.
138  This PA self-assembled into micelles with the 
ability to encapsulated condensed DNA and doxorubicin, with delivery efficiency and in vitro 
expression examined in HePG2 cells. 
It has also been possible to use PAs to study endocytosis. One such PA, based on p53 tumour 
suppressor, comprised of this pro-apoptotic peptide attached to C16 lipid chain. Internalization 
was investigated using fluorescent methods. This PA was shown to self-assemble into rod-
shaped micelles. FRET (fluorescence resonance energy transfer) showed internalization of 
monomers into SJSA-1 human osteosarcoma cells as opposed to micelles, and uptake was 
enhanced by lipidation.139 
 
1.11.3 Peptide Hormones 
 
Hormones are tightly regulated chemical messengers produced by the endocrine system, to 
regulate growth, development, tissue function, metabolism, sleep, reproduction, mood and 
sexual function.11,140 In the endocrine system there are two major types of hormone, steroid 
hormones which are water-insoluble hormones, and peptide hormones which are water soluble 
hormones. Steroid hormones generally interact through permeating cells with intracellular 
targets, e.g. DNA. Peptide hormones generally act on the surface of target cells, binding to 
specific receptors on membrane surfaces which trigger downstream signalling cascades.  
Imbalance of peptide hormones can cause disease, for example type II diabetes, which is caused 
by cells becoming insensitive to peptide hormone insulin, due to repeatedly high levels in the 
blood stream.141 Peptide hormones may also be used therapeutically. One example is insulin, 
which is used to treat type I diabetes, caused by the pancreas not making enough to control 
blood sugar levels.142 Another example is oxytocin, which is both produced naturally by the 
pituitary gland, playing a role in social bonding, and is used as a therapeutic during childbirth 
to induce labour and prevent excessive blood loss.143,144 Oxytocin is heat sensitive, limiting it’s 
therapeutic use. Thus an analogue of oxytocin, Carbetocin, was developed as an alternative 
therapeutic for areas where correct storage cannot be guaranteed.145  
There is increased interest in peptide hormones that may be able to self-assemble to increase 
efficacy and stability in vivo. One example is oxyntomodulin, a 29 amino acid long peptide 
hormone, expressed naturally as an appetite suppressant. Oxyntomodulin was found to have 
increased activity in rats, when injected in a nanofibril conformation. The self-assembly is 




reversible, causing slower release of the active in vivo.146 Peptide YY (PYY3-36) is a 
gastrointestinal peptide hormone that has been shown to reduce calorific intake in mice when 
higher levels are present. PYY, which has an α-helical secondary structure, has a short half-life 
in vivo, therefore there is interest in chemical modifications to increase stability,147 such as 
PEGylation mentioned in Section 1.7. 
 
1.11.4 Antimicrobial Peptides  
 
The increased prevalence of multi antibiotic-resistant pathogens has been listed by the World 
Health Organisation (WHO) as one of the biggest threats to modern day healthcare, food 
security and development.148 Antimicrobial resistance is the reduced effectiveness of a 
previously active substance against a microbe, where the microbe has evolved this resistance 
through changes in one/a combination of factors including, but not limited to, gene expression, 
membrane composition and enzyme expression. This process occurs naturally, although is 
accelerated by the over usage of antibiotics in medicine and agriculture, and the lack of 
development of new actives by pharmaceutical companies.149 Table 1.2. lists the bacteria that 
are prioritised by the most important targets for new therapies, as listed by the WHO.148  
Antimicrobial peptides (AMPs) are attracting attention as an alternative to conventional 
antibiotics, and can target a range of microbes including viruses, fungus, bacteria and parasites. 
They have several attractive qualities.149–152 Firstly, they are highly effective against gram-
negative bacteria, which are harder to target due to their double membrane cell wall.153 
Secondly, AMPs commonly interact non-specifically with microbes, leading to a ‘multiple-hit’ 
strategy, enabling to kill microbes through more than one antimicrobial mechanism at the same 
time, increasing the likelihood of targeting multi-drug resistant bacteria.154,155 Another 
advantage of this non-specificity is that is harder for the microbe to develop resistance, as the 
AMP does not target one specific protein/pathway. Finally, the rapid action of AMPs (with 








Table 1.2. Priority list devised by the World Health Organisation (WHO) of resistant bacteria 
species. 148   






Acinetocater baumanni -ve Carbapenem 
Pseudomonas aeruginosa -ve Carbapenem 
Enterobacteriacae (including 





Enterococcus Faecium +ve Vancomycin 
Staphylococcus aureus +ve Methicillin, Vancomycin 
Helicobacter pylori -ve Clarithromycin 
Camplyobacter Spp. -ve Fluoroquinolone 
Salmonellae -ve Fluoroquinolone 





 Streptococcus pneumoniae +ve Penicillin 
Haemophilus influenzae -ve Ampicillin 
 
Shigella -ve Fluoroquinolone 
 
1.11.4.1 Structure and classification.  
 
Antimicrobial peptides, (AMPs) are generally oligopeptides, ranging in lengths from 5 amino 
acids to 100 amino acids. 149–152 long. Most AMPs are cationic, due to the abundance of lysine 
and arginine residues,157–160  allowing AMPs to interact with the anionic microbe membrane.  
AMPs also contain ~40% hydrophobic residues, making them amphiphilic.152 This enables 
AMPs to interact with both the phospholipid head group (hydrophilic part) and the lipid tail 
group (hydrophobic part). Due to the cationic charge of the majority of AMPs, they are often 
referred to as cationic antimicrobial peptides, or, in the case of natural AMPs, cationic host-
defence peptides. There are also naturally occuring of AMPs with low positive charge, neutral 
charge and anionic charge, for example dermcidin secreted from sweat glands in humans.161,162 
Some other important amino acids frequently found in both naturally occurring and synthetic 
AMPs are proline,163 tryptophan,149,152,164 cysteine,165 glycine,166,167 and histidine.168  




Due to the high diversity of AMPs, they are generally categorised into four groups based on 
their secondary structure. These are: β-sheet forming, α-helical forming, extended or loop 
structures.169,170  The most studied class of these is α-helical forming antimicrobials, which 
include magainin,171 indolin, ,172 and LL-37.173,174 β-sheet forming AMPs usually consist of two 
β-sheet strand structures stabilised by S-S bridges.  
Some AMPs are cyclic, and do not fit into these four classes. Some examples include surfactin, 
iturins and lichenysin, which have antifungal properties175. Surfactin, produced by B.subtilis, 
has the ability to reduce the surface tension of water to 27 mN m-1 at concentrations as low as 
20 µM. This peptide self-assembles into spherical micelles in bulk aqueous solution, and adopts 
a more globular conformation at the interface (for example air/water).12,176 Several cyclic 
peptides have been approved by the FDA, including Oritavancin and Dalbavancin, which are 
used to treat skin infections.  
 
1.11.4.2. Mechanism of action   
 
AMPs which are α-helical or β-sheet forming generally target the anionic lipopolysaccharide 
layer of the cell membrane on microorganisms, which is ubiquitous. Eukaryotic membranes 
(found in animals and plants), which are rich in cholesterol and low in negative charge may not 
be targeted by AMPs. Methods by which antimicrobial peptides interact with membranes are 
listed in Table 1.3. As well as membrane interactions, some extended structures have been 
observed to be bactericidal by moving across membranes and interacting with DNA sequences 












Table 1.3. Mechanisms of action by AMPs.154  
Interaction Model Mechanism Ref 
Detergent-like / 
Carpet Model 
Peptide coats a small area of the membrane, leading to bilayer 





Peptides insert themselves into one side of the bilayer, causing gaps 
in the lipid bilayer molecules, causing thinning 
180,181 
Aggregate  Peptides stick parallel to the membrane surface, then reorientation 
occurs causing peptide spheres to form inside the membrane 
182 
Toroidal Pore  Peptides are orientated with the hydrophobic region associated with 
the centre part of the lipid bilayer, and hydrophilic regions facing the 
pore. 
183,184 
Barrel-Stave  Staves form parallel to the membrane, which the further assemble 





Figure 1.14. Mechanism of membrane interactions of AMPs. 




1.11.4.3 Clinical antimicrobial peptides 
 
To date, very few AMPs are available clinically. One of the most known AMP is Daptomycin. 
Daptomycin was approved as an antibiotic by the FDA in the mid-1980s. Several other AMPs 
are in use in other areas of the world, with many more in clinical trials, (listed in Table 1.2). 
Daptomycin self-assembles into micelles that assist delivery to the bacterial cell membrane, 
which was previously thought to be Ca2+ dependent.188 However, recently Hamley and co-
workers proved daptomycin could self-assemble into micelles spontaneously in aqueous 
solutions, with and without Ca2+.74   
The mechanism by which Daptomycin causes bacterial cell death is unclear.188 Daptomycin 
inserts into the lipid bilayer, a process which is largely dependent on the presence of lipid PG 
(discussed in section 1.12.1). After this, there are two possible mechanisms of action. The first 
is linked to membrane depolarisation due to Daptomycin forming pore structures in the 
membrane, resulting in ion leakage and loss of membrane potential. The second proposed 
model involves Daptomycin aggregating at the membrane surface, causing bending and pore 
formation.188 
 
Figure 1.15. Daptomycin. This peptide has an anionic charge and disrupts the membrane of 
gram-positive bacteria.  
 
There are a large number of AMP’s under clinical investigation (Table 1.4.). Interesting actives 
include several pre-clinical trial AMPs, such as Novamycin (RRRRRRRRRRRRRR)189 
Novarifyn (RRRFRFFFRFRRR)190 and D2A21 (FAKKFAKKFKKFAKKFAKFAFAF).191  
These are rich in arginine, alanine and phenylalanine, which are residues used in this thesis to 
construct potential short AMP’s. 




Table 1.4. AMPs in clinical trials or preclinical trials156 
Name Structure 
Net 
charge Target Mechanism Administration Ref 
In use 
Nisin A Polycyclic CP + E.coli, S.aureus 




Gramicidin S Cyclic, cationic, β-sheet + E.coli, S.aureus Membrane disruption Topical 193 
Polymixin Polycationic, lipopeptide + 
K.pneumonia, 
A.baumannii 
Membrane disruption Oral / Intravenous 
194 
Daptomycin* Anionic, cyclic, lipopeptide - MRSA, VRE Membrane disruption Intravenous 195 
 
Clinical trial Stage III 
Pexiganan α-helical, cationic, amphiphilic + Diabetic foot ulcers 






- C.difficile Membrane disruption Oral 197 
 
Ramoplanin 
Macrocyclic Lipopeptide + G(+) (VRE, C.difficile) Cell wall synthesis Oral 198 
 
D2A21 
α-helical, cationic, amphiphilic + Burn wound infections Membrane disruption Topical 191 
SGX942 Cationic + Oral mucositis Immunomodulation Oral rinse 199 
PXL01 Cationic + Postsurgical adhesions Immunomodulation Topical 200 
POL7080 Cationic, macrocyclic + 
p.aerguinosa 
k.pneumonaie 
LptD binding Intravenous 201 
 
 
Clinical trial stage II 
EA-230 Short peptide - 
Sepsis and Renal Failure 
protection 
Immunomodulation Intravenous 202 
Delmitide Cationic + 
Inflammatory bowel 
disease 
Immunomodulation Topical 155 










Immunomodulation Intravenous 203 
C16G2 α-helical, cationic, amphiphilic + Tooth decay by S.mutans Membrane disruption Mouth wash 204 
DPK-060 Radom coil, cationic + Acute external otitis 
Membrane disruption / 
Immunomodulation 
Ear drops 205 
PAC113 α-helical, cationic, amphiphilic + Oral candidiasis 
Membrane disruption / 
Immunomodulation 
Mouth rinse 191 
LTX-109 Cationic, amphiphilic + 
G(+) MRSA skin 
infections, impetigo 
Membrane disruption Nasal Topical 206 
 
Clinical trial stage I 
hLF1-11 α-helical, cationic, amphiphilic + 
MRSA, K.pneumonaie, 
L.monocytogenes 
Membrane disruption / 
Immunomodulation 
Intravenous 207 
Wap-8294A2 Macrocyclic, thioesther + 
G(+) bacteria (VRE, 
MRSA) 
Membrane disruption Topical 208 
Friulimicin B Macrocyclic, lipopeptide - Pneumonia, MRSA Membrane disruption Intravenous 209 
 
Pre-clinical  
Novamycin Cationic + Fungal infections Membrane disruption Topical 189 
Novarifyn Cationic, amphiphilic + 
Broad-spectrum G(+) 
and G(-) 
Membrane disruption Topical 190 
D2A21 α-helical, cationic, amphiphilic  + 
Skin infections, 
P.aeruginosa 
Membrane disruption - 191 
HB1345 Cationic, lipopeptide + Skin infections, acne Immunomodulation Topical 210 
       
 




1.11.4.4 Challenges of AMPs 
 
The main challenge AMPs face is in vivo stability. Naturally occurring and synthetic AMPs can 
be readily degraded by proteolytic enzymes. One way to overcome this is to use chemical 
modifications,  for example lipidation,211 insertion of D-amino acids into cleavage sites, macro-
cyclisation of the C and N termini, and/or the insertion of noncanonical amino acids or peptide-
mimetic materials. Another method to overcome this to transport the peptide in a delivery 
system, which can lead to targeted release.12,85,156  
Self-assembly may also increase efficacy by increasing the local concentration of the AMP. 
One example is LL-37, which forms dimers on gram-negative bacteria membranes, leading to 
the formation of toroidal holes.173,174,212 Moreover the cell penetrating peptide TAT 
(YGRKKRRQRRR) peptide from HIV retrovirus, 213,214 had increased antimicrobial strength 
and membrane translocation when conjugated to polyarginine and cholesterol. This drove self-
assembly into micelles, and has shown to be effective in rabbit and mouse models against 
S.aureus.215 
AMPs are also easily affected by different conditions including physiological salt conditions 
and pH, which can cause loss of electrostatic interactions between the cell membrane and 
peptide to occur. Additionally, AMPs can indirectly bind to serum proteins (e.g. albumin) thus 
losing efficacy. Some AMPs have also been reported to interact with mammalian cells as well 
as bacterial cells, inducing toxicity.150,151,156,165 
Manufacturing AMP’s through solid phase synthesis is expensive.156 One method to overcome 
this is to use short peptides. Small synthetic peptides (peptides below 10 aa) could be a good 
alternative to reduce the cost of synthesis. Synthetic short peptides containing arginine and 
tryptophan have been shown to be sufficient in killing bacteria, when using sequences [RW]n-
NH2 where n = 1-5.
216 Overall the optimum length was found to be 3 repeating units as though 
higher units displayed higher activity, the toxicity to red blood cells was also increased. 
Moreover, lysine-based di- and tri- PAs showed that antimicrobial activity on Gram-positive 
and Gram-negative bacteria occurred through leakage, caused by cell membrane disruption.175 
Other methods of peptide synthesis including bioengineering and fermentation.  
 
 




1.12 Lipid Bilayers  
 
In the design of peptides which can be used therapeutically, it is important to consider their 
interactions with lipid bilayers. Lipid bilayers surround nearly all cell types, providing basic 
structural support. Bilayers act as a barrier both against outside molecules, and to stop various 
molecules (e.g. proteins, ions, organelles) from diffusing out. Compositions of membranes 
differ depending on species and the kingdom from which the organism originates. Thus, 
consideration of peptide interaction with the lipid bilayer is essential in the consideration of 
peptides for therapeutic use. Interaction with lipid bilayers can be examined in three main ways; 
1) biophysical membrane models 2) in vitro models and 3) in vivo models.  
 
1.12.1 Components of Lipid Bilayers  
 
Membranes mainly consist of 3 major types of lipid (Figure 1.16)217–220 The main components 
of lipid bilayers in animal and bacteria cells are phospholipids. Phospholipids are amphipathic 
molecules containing glycerol linked to a phosphate head group and two hydrocarbon chains. 
The most abundant structures of different phosphate headgroups can be seen in figure 1.16.  
The second class of lipids are sphingosines, which have a core of 1-amino-2-hydroxyethane, 
with substitutions. Sphingosines contain a choline derivative sphingomyelin (SP) which is 
similar to phosphatidyl choline (PC) in terms of headgroup and no charge. Alternatively, 
sphingosine head groups may also have complex sugars, broadly classed as glycolipids, which 
are present in some human cell types. Sphingosines also have hydrocarbon fatty acid chains.  
The final lipid class found in membranes are sterols. Sterols are structurally very different from 
the other groups of membrane lipids. The bacterial equivalent of sterols are hopanoids (Figure 
1.13). 218,221 
Two of the three major groups, of lipids contain acyl groups. These acyl groups generally range 
from C12– C30 and give a huge amount of variation to the lipid classes found in biomembranes. 
It is very rare that the two fatty acids attached to the functional head groups are identical. The 
length of the fatty acids and the amount of saturation ultimately determines the fluidity of the 
bilayer.218  
All these classes of membrane lipid are amphiphilic, which leads to spontaneous self-assembly 
into bilayers in aqueous environments, with the lipid tails facing inward, and the polar head 




groups facing the solution. This then assembles further into either vesicles/liposomes or micelle 
like structure to ‘seal-off’ the hydrophobic region from the aqueous environment.  
 
 
Figure 1.16. the phosphoryl head group, and sphingosine head group, where R blue groups 
have one of the righthand side head groups attached, and the green R groups generally have 
acyl chains attached. In the red are the sterols and hopanoids groups.  
 
Generally, biological membranes are asymmetric due to the composition of lipids, as well as 
proteins and sugars.222,223 The degree of asymmetry can range depending on cell type, from 
complete symmetry (PC in blood platelet membranes) to unilateral (e.g. PS in rat 
erythrocytes).221 Some of these asymmetric variations can be documented in liposome 
preparations, for example PC/PE mixtures showing PC has preference for the outer face and 
PE for the inner face of the vesicle.223 The asymmetry strongly depends on deviation from 
complete homogeneity of lateral mixing membrane components. Biological membranes are 
found in lamellar phase symmetry, however other structures have been observed in artificial 
membranes through heating (Figure 1.17).193,224,225 
 





Figure 1.17. Different types of structures of lipid micelles or membranes. a) cubic phase in 
aqueous (aq) solvent and b) cubic phase in organic solvent, c) lamellar phase in aqueous 
solvent, the form generally of most cell bilayers, d) hexagonal phase symmetry in aq solvent e) 
hexagonal phase in organic solvent and f) different temperature phases within the lamellar 
phase,  Lβ= lamellar solid crystalline phase, Pβ = the transition phase and Lα= the liquid 
crystalline phase. 
 
Although membranes are ubiquitous to all cells, there are composition differences between 
groups of cells (Table 1.5). The most abundant phospholipids in animal cells are PC, PS and 
PE, with cholesterol. Generally bacteria contain no sphingolipids and trace amounts of 
steroids. The major components of bacterial membranes are cardiolipin, PE and PG (with no 










Table 1.5. Lipid headgroup ratios in different membranes found in bacteria and humans. 218,221  
.  
 CL PG PE PC PS Sphingomyelin Cholesterol 
Gram Negative Bacteria  
E.coli 5 15 80 - Trace - - 
E.cloacae 3 21 74 - - - - 
K.pneumoniae 6 5 82 - - - - 
P.aeruginosa 11 21 60 - - - -- 
Gram positive  
S.aureus 42 58 - - - - - 
S.pneumoniae 50 50 - - - - - 
B.cereus 17 40 43 - - - - 
Human Cell types  
Liver plasma cell - - 7 24 4 19 17 
Red blood cell - - 18 17 7 `8 23 
Myelin - - `5 10 9 8 22 
Mitochondrion 12 - 28 44 2 0 3 
ER - - 17 40 5 5 6 
CL is cardiolipin, PG is phosphatidyglycerol, PE is phosphatidylethanolamine, PC is 
phosphatidylcholine, PS is phosphatidylserine 
 
1.12.2 Physical States of Membranes 
 
Temperature changes in bilayers result in mesomorphic states. Below the transitional 
temperature Tm, membranes exist in the solid crystalline Lβ phase.
226–228 In the Lβ phase, there 
is very little lateral movement of the acyl chains in the phospholipids, and the acyl chains will 
mainly be in trans confirmation. Above the transition temperature, the membrane will mainly 
exist in the liquid crystalline Lα phase. This permits free rotation of the acyl chains around the 
normal axis plane, which leads to the formation of rotamers of acyl chains. Overall the effect 
of this is increased volume of the bilayer and decreased membrane viscosity in the Lα phase. 
This is because in the Lβ phase, the acyl chain is more condensed, 0.2-0.23 nm
2 per chain, 




whereas in the Lα phase the alkyl chains have more rotational freedom, and will take up around 
0.3-0.4 nm2 per chain.16,218,229 In the transition Lα to Lβ phase and vice versa, there is a pre-
transition phase, Pβ phase, which is characterised by a ripple distortion of the bilayer plane.  
 The Lβ and Lα phases are not well separated phases. Actually, there are defects in the lattice 
parameters of both Lβ and Lα phases, the number of which increases upon heating. These defects 
give rise to domain formation of areas of the bilayer that will transition faster and areas that 
will transition slower. Thus, if the transition is approached on heating, islands of fluid lipid are 
observed, floating on a ‘sea’ of crystalline solid phase, and if the transition is approached from 
cooling, islands of solid float on a ‘sea’ of liquid. 226–228  The interfacial sites between these 
islands are the areas with higher amounts of permeability to molecules.  
Sterols and hopanoids also affect the transition temperature. 221,226–228  Sterols have rigid four-
ringed cores which in the Lα phase prevents adjacent acyl chains from freely rotating, thus 
increasing rigidity. In the Lβ phase, sterols remain in situ, preventing surrounding phospholipids 
from forming crystal lattice structures. Thus, increase in sterols or hopanoid content in the 
membrane gradually abolishes the transition from Lα to Lβ and vice versa, without shifting the 
melting temperature, Tm. For membranes consisting of PC mixed with cholesterol, the Tm 
observed by DSC was not present at 22% cholesterol and above.230  
The temperatures at which lipids transition is largely dependent on many factors, including the 
length, saturation, positioning of C=C bonds, branching and positioning of the acyl chain to the 
polar head group, charge of the overall phospholipid, and which head group the phospholipid 
has. PE has the highest melting temperature, followed by PS, and then PC and PG which are 
equivalent.  In nature, tight regulation on the fluidity of the membrane is essential for survival. 
Several types of extremophile bacteria alter their alkyl lipid chain lengths based on their 
immediate environment in order to maintain membrane fluidity.229 
 
1.12.2 Biophysical methods to study membrane interactions  
 
Membrane models can be made in vitro using commercially available lipids. Both the selection 
of lipids, and ratios of phospholipids/sphingolipid/sterols can be varied to make simplified 
models of specific cell types or organisms. The majority of membrane lipids used to make 
models are phospholipids as they are the most abundant lipid in membranes. Phospholipids can 
form a range of structures including disks, bilayers, monolayers and vesicles (which can be 




multi-lamellar or unilamellar), depending on preparation. Moreover, they generally have well 
characterised phase diagrams, 231 and can form in a variety of different buffers, making them a 
convenient tool in understanding mechanisms and interactions.    
Models can be examined using a number of techniques including differential scanning 
calorimetry,232–234 small-angle X-ray scattering, fluorescence (to examine leakage),235 dynamic 
light scattering236 and microscopy techniques. 59,232,233,237–240 
 
1.12.3 In-vitro methods  
 
1.12.3.1 Bacteria  
 
Although membrane models can be well characterised, giving an idea about potential 
interactions, bacteria are much more complex than biophysical models. As well as having 
membranes, bacteria also have cell walls and periplasm. These combined structures are called 
the bacterial envelope.  Bacteria can be categorised as Gram-negative or Gram-positive, 
depending on whether they bind the Gram stain, which ultimately shows large differences in 
the envelope structure. 241–243 
Gram-positive bacteria have a thick layer of peptidoglycan in their envelope. Peptidoglycan is 
a mesh like polymer composed of sugars and amino acids, which gives the bacterial cell wall 
rigidity. These layers also contain teichoic acids, which often carry oligosaccharide chains and 
D-alanine residues. 242 
Gram-negative envelopes are much more complex, thus they are harder to find actives against. 
The Gram-negative cell wall is mainly composed of outer membrane. The outer membrane is 
made up of an outer part, made up of lipid A, core and liposaccharides and porins. 241,243  The 
inner leaf is made up of phospholipids. In between the outer membrane and the cell membrane, 
there is the periplasmic space. The periplasmic space is defined as being a gel-like space, 
consisting of numerous proteins and a loosely ordered peptidoglycan layer. The outer 
membrane is connected to the peptidoglycan layer through lipoproteins.  The complexity of the 
bacteria envelop increases the difficulty of AMPs-induced the membrane disruption. 241,243 





Figure 1.18. Schematic of Gram positive and negative membranes, where WTA is wall 
teichoic acids, LTA is lipoteichoic acids and where LPS is lipopolysaccharides. 
 
Some bacteria may form biofilm matrices. Biofilm matrices form when free floating bacteria 
attach to a surface by secreting EPN (extracellular polymeric network) which is made up of 
sugars, proteins and nucleic acids. This enables bacteria to stick together, and attracts more 
bacteria to the site eventually ending up as a large 3D network.244  Parts of this network may 
then break off and establish themselves elsewhere. Biofilm networks account for 80% of the 
infections in the human body, and can grow on implanted devices, for example P.aeruginosa 
can grow on catheters in a biofilm network.244 The ability of bacteria to form biofilm networks 
increases the difficulty for actives to access the bacterial population. All the bacteria listed in 
Table 1.2 are able to form biofilms.   





Figure 1.19. Scheme of biofilm formation.  
 
One of the major regulators of biofilm formation is secondary messenger molecular 3’,5’-cyclic 
diguanylic acid (c-di-GMP).245–247 A secondary messenger molecule is a molecule realised by 
a cell in response to a primary signal (or primary messenger molecule). Secondary messengers 
regulate physiological changes to the cell including proliferation, apoptosis, migration, survival 
and can trigger signalling cascades.  In bacteria, c-di-GMP is a key regulator of numerous 
functions including differentiation, cell cycle, biofilm formation and dispersion, virulence and 
motility. Specifically for biofilms, low levels of c-di-GMP are associated with planktonic 
existence and high levels are associated with biofilm formation.246 Recently proline-rich 
peptides were shown to be able to bind this secondary messenger, inhibiting the growth of 
P.aeruginosa. Thus c-di-GMP is an important target for AMPs.  
 
 
Figure 1.20. Secondary messenger c-di-GMP, an important regulator of biofilm formation.  
 




1.12.3.2 Human cells 
 
Human cells also have increased complexity compared to lipid models, due to the occurrence 
of many different proteins attached or associated with the membrane.  Moreover, different cell 
types have different lipid compositions (Table 1.4) All types of eukaryotic cell have glycolipids 
on their outer surface that have important functions in cell interactions, cell recognition, 
protection and provide electrical effects. The most complex glycolipid are the gangliosides, 
which contain oligosaccharides with net negative charge.221  
 In vitro cell culture is often used as a first line examination of either activity or toxicity 
screening when examining new materials.248 Peptides that are thought to target cancer may be 
tested in vitro cancer cell lines, or peptides for other uses may be tested in normal cell lines.  
Primary cells are extracted directly from a human/animal and are grown in media. These cells 
usually have a limited life-span but maintain more of the markers and characteristics seen in 
vivo.  Cell lines (or secondary cells) are immortalised cells, taken from a host and grown from 
a single cell. Cell lines are easier to culture and manipulate. Due to years of circulation, most 
cell lines differ genetically and phenotypically from their original host. It is important to screen 
cell lines which are appropriate for the application. For example, if the application is 
intravenous, it is important to test against blood cell lines as well as the target tissue. 248 
 
1.12.5 In-vivo studies  
 
In vivo studies are the final line of testing, which is stringently regulated. In vivo testing detects 
whether the active 1) goes to the correct place, without off-targets which result in 
toxicity/inflammation response, 2) can distinguish between target and non-target cells, for 
example an AMP would need to target bacterial cells, not host cells and 3) has good efficacy. 











1.13 Aims and Objectives  
 
This thesis aims to examine different peptides with potential therapeutic applications, using 
physical characterisation and in vitro studies using cell culture and bacteria. More specifically 
the aims are as follows:  
 
• To investigate the self-assembly, membrane interactions and bioactivity through human 
cell culture and bacterial studies of short peptide sequences containing arginine and 
alanine, with AnR or RAnR structures. To examine the effect of hydrophobic block 
length and positioning on bioactivity and self-assembly. These peptides are 
hypothesised to have antimicrobial activity; thus experiments focus on whether this 
activity occurs in the physiological range, and whether this activity is predominantly 
due to membrane disruption.  
 
• To investigate the self-assembly, membrane interactions and bioactivity of short 
symmetrical peptides rich in phenylalanine and arginine, using cell culture and bacterial 
studies, both in solution and in the biofilm matrix, and to examine their interactions with 
messenger molecule ci-d-GMP through biophysical techniques. These peptides are 
hypothesised to have antimicrobial activity, higher activity than the AnR or RAnR due 
to the cationic charge of these peptides being increased. Experiments focus on whether 
this activity occurs in the physiological range, and whether this activity is predominantly 
due to membrane disruption.  
 
• To investigate the self-assembly and cytocompatibility of tyrosine-capped telechelic 
PEO-star conjugates of different sizes, for use as enzyme responsive delivery material, 
and hydrogels which may be used as tissue scaffolds. 
 
• To investigate the self-assembling properties of neuropeptide hormone Oxytocin and 
heat stable derivative Carbetocin using biophysical characterisation techniques.   
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Self-assembly and bioactivity of peptide bola-amphiphiles and surfactant-
like peptides containing Alanine and Arginine 
This work has, in part, been published by the author as several research articles titled: 1. Self-Assembly, 
Antimicrobial Activity, and Membrane Interactions of Arginine-Capped Peptide Bola-Amphiphiles 
Charlotte Edwards-Gayle, Valeria Castelletto, Ian W. Hamley, Glyn Barrett, Francesca Greco, Daniel 
Hermida Merino, Robert P. Rambo, Jani Seitsonen, Janne Ruokolainen. ACS Appl. Bio Mater. 2019, 
25, 2208-2218. 2. Peptide-Stabilized Emulsions and Gels from an Arginine-Rich Surfactant-Like 
Peptide with Antimicrobial Activity. Valeria Castelletto, Charlotte J. C. Edwards-Gayle, Ian W. Hamley, 
Glyn Barrett, Jani Seitsonen, Janne Ruokolainen ACS Appl. Mater. Interfaces. 2019,11(10), 9893-9903 
3. Restructuring of Lipid Membranes by an Arginine-Capped Peptide Bolaamphiphile Valeria 
Castelletto, Ruth Barnes, Kimon andreas Karatzas, Charlotte Edwards-Gayle, Francesca Greco, Ian W 
Hamley, Robert Rambo, Jani Seitsonen, Janne Ruokolainen. Langmuir. 2018, 35(5),1302-1311 4. 
Arginine-Containing Surfactant-Like Peptides: Interaction with Lipid Membranes and Antimicrobial 
Activity. Valeria Castelletto, Ruth Barnes, Kimon andreas Karatzas, Charlotte Edwards-Gayle, 
Francesca Greco, Ian W Hamley, Robert Rambo, Jani Seitsonen, Janne Ruokolainen. 
Biomacromolecules. 2018, 19(7), 2782-2794. 
 
2.1 Introduction  
 
Antibiotic resistance has led to a number of conventional medicines to become less effective. 
This leaves an urgent need to discover naturally occurring actives or to design novel 
therapeutics to combat this issue. One class of therapeutics that have been found to be effective 
are antimicrobial peptides. Antimicrobial peptides are attractive as they can be easily 
biofunctionalized and  made biocompatible.1–3   Many organisms, for example fungi, have 
naturally evolved host defence antimicrobial peptides, which can be used as an actives 
themselves or form the basis of designed synthetic materials. Antimicrobial peptides with the 
ability to self-assemble may be active without the need for carrier molecules.  
A class of peptide with strong self-assembly properties are surfactant-like peptides (SLPs), 
initially developed by Zhang et al.4–7 These peptides are short, consisting of a one or two 
charged residue head group, with a longer hydrophobic sequence as a tail group. Peptides with 
various cationic and anionic headgroups, and different hydrophobic amino acid tail groups 
(including alanine, glycine and valine repeat units) have been studied. Previously our group has 





11. Self-assembly was observed for these peptides, above a critical aggregation 
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concentration (cac), into variety of structures including nanosheets, helical ribbons, fibrils, 
vesicles, nanotubes and nanotapes, with a range of applications.  
SLPs with cationic head groups have been shown to have potential antimicrobial activity. SLPs 
A3K, A6K and A9K were shown to assemble into increasingly ordered structures with increased 
length of the alanine hydrophobic motif.12 Interestingly, the antimicrobial activity of these 
peptides also increased with the length of the hydrophobic motif. The peptide A3K had no 
antimicrobial activity whereas A6K and A9K showed activity against E.coli and S.aureus, which 
are Gram-negative and Gram-positive respectively.12 
Peptide bola-amphiphiles are a class of surfactant-like peptides. These peptides incorporate a 
charged residue at either end of the molecule. The self-assembly behaviour of these SLPs has 
been investigated. The self-assembly of I2K2I2 and KI4K has been compared and it was reported 
that the former does not aggregate, whereas the latter aggregates into β-sheet nanotubes.13,14 In 
another example, the self-assembly ability of arginine based bola-amphiphile RFL4FR was 
investigated and found to form nanosheets through lateral association of the backbone and dried 
films were compatible with human corneal stromal fibroblast cells.15   
This chapter focuses on the self-assembly and bioactivity of a group of alanine-arginine SLPs 
and peptide bola-amphiphiles (Scheme 2.1 and 2.2). The self-assembly and lipid interactions 
of A6R, CapA6R, A9R and RA3R has been studied by Dr Valeria Castelletto (University of 
Reading).  
 A6R assembles into thin sheets.
16  Peptide capA6R (CONH-AAAAAAR-NH2) assembled into 
fibres and had a lower cac value than A6R due to increased hydrophobicity.
17 Interactions with 
zwitterionic membrane models (POPC/DOPC) [POPC: 1,2-dioleoyl-sn-glycero-3-
phosphocholine, DOPC: 2-oleoyl-1-palmitoyl-sn-glycero-3-phosphocholine] and mixtures 
(POPG/POPE) [POPG: 2-oleoyl-1-palmitoyl-sn-glycero-3-phospho-rac-(1-glycerol) sodium 
salt, POPE: 2-oleoyl-1-palmitoyl-sn-glycero-3-phosphoethanolamine] containing the anionic 
POPG lipid were studied by SAXS and circular dichroism spectroscopy.17 CapA6R was found 
to incorporate into the anionic membrane in a β-sheet conformation, in contrast to the uncapped 
peptide A6R (NH2-AAAAAAR-OH). CapA6R was found to have a strong selective 
antimicrobial activity against Listeria monocytogenes, compared to A6R which shows non-
selective activity against E.coli, S.aureus and L.monocytogenes. A9R was found to assemble 
into β-sheet fibrils and induce bilayer correlations for the POPE/POPG vesicles, but not insert 
into the POPC mammalian membrane model.  
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The self-assembly, antimicrobial activity and membrane interaction of a short bola-amphiphile, 
RA3R, was examined.
18 RA3R formed a polyproline II (collagen-like) secondary structure but 
did not assemble in water, probably due the solubility imparted by the R residues. RA3R was 
found to induce strong correlation between anionic lipid bilayers through electrostatic 
interactions with POPG. The peptide demonstrated strong activity against the Gram-positive 
foodborne pathogen L. monocytogenes. 
 Here, the self-assembly of three bola-amphiphiles, RA6R, RA9R, RA12R and one SLP A12R2, 
is examined. The interactions of these peptides with lipid vesicle membrane models consisting 
of DPPG and DPPE at different ratios in water are measured. DPPG (1,2-dipalmitoyl-sn-
glycero-3-phosphoglycerol), is anionic and DPPE (1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine) is zwitterionic. Phosphatidylglycerol (PG) and 
phosphatidylethanolamine (PE) lipids are commonly found in bacterial cell walls, and have 
been used previously as model systems.12,19–21  The lipids DPPG/DPPE were selected for the 
present study as they have accessible melting temperatures (in contrast to POPG used in 
previous studies which has Tm = -2 oC).  After this, the cytocompatibility of all the peptides in 
Scheme 2.1 and 2.2 is examined using MTT assays. Finally, the antimicrobial activity of the 
peptide bola-amphiphiles, RA6R, RA9R, RA12R, and SLP’s A9R and A12R2 are assessed against 
one gram positive strain, S.aureus, and gram-negative strains E.coli, P.aeruginosa and 
P.syringae. 




Scheme 2.1. Structure of peptide bola-amphiphiles discussed in this chapter  




Scheme 2.2. Structure of surfactant like peptides (SLP’s) discussed in this chapter.  
 
Scheme 2.3. Structure of Lipids used to model bacterial membranes  
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A fluorescence assays using 8-Anilinonaphthalene-1-sulfonic acid (ANS), was performed to 
determine the critical aggregation concentration (cac) for RA6R in water Figure 2.1. The 
fluorescence intensity of ANS increases when bound to a hydrophobic environment, which 
occurs through peptide aggregating.22 ANS assays provided no evidence of peptide aggregation 
up to 1 wt% RA6R, since there were no discontinuities in the fluorescence spectra for either 
fluorescence probe (Figure 2.1). In fact, CD, FTIR, XRD and SAXS experiments, performed 
to study the secondary structure of RA6R in water, indicate the formation of oligomeric 
aggregates.  
The CD spectra for (0.5-1) wt% RA6R are characterised by a broad positive maximum at ~220 
nm and a deep negative band around 190 nm (Figure 2.1b) and can be assigned to a polyproline 
II (PPII) conformation.18,23–27 The FTIR spectrum for a 1 wt% sample (Figure 2.1c) shows 
bands at 1672 cm-1, 1608 cm-1  and 1587 cm-1, the former of which can be assigned to TFA 
counter-ions in solution,28,29 while the latter two can be assigned to arginine side chain 
vibrations.30,31 A small peak at 1675 cm-1  is observed for 2 wt% RA6R, which is characteristic 
of short peptides with a poly-proline II structure, in agreement with the CD spectrum (Figure 
2.1b).32,33 The XRD profile (Figure 2.1d) shows a peak at  4.6 Å corresponding to a disordered 
side-to-side packing of the RA6R molecules.
34  
SAXS data for RA6R (Figure 2.1e) shows the features of peptide monomers. The SAXS curves 
were fitted to a generalised Gaussian coil model, corresponding to coil-like molecules in 
solution with different degrees of solvation. The parameters fitted using the generalised 
Gaussian coil model where the radius of gyration of the peptide Rg and the Flory exponent, . 
Fittings of the SAXS data (Table 2.1) provided Rg= 7.0 Å for all concentrations and a = 0.64, 
0.24, 0.20 for 1 wt%, 5 wt% and 15 wt% RA6R respectively. This set of parameters implies that 
RA6R is in a swollen conformation at 1 wt% and a relatively folded conformation at 5 wt% and 
16 wt%. Cryo-TEM images of RA6R solutions show the formation of clustered monomers 
(Figure 2.1f).   




Figure 2.1. Conformational and structural characterization of RA6R in solution a) ANS 
binding, b) CD and c) FTIR spectra, d) XRD profile, e) SAXS profiles, with fits in red (see table 
2.1) and f) cryo-TEM. 
Table 2.1. Parameters extracted from the fitting of the SAXS curve in Figure 2.1e  
Where N denotes scaling parameter, v is the Flory exponent, I(0) is the forward scattering intensity, Rg 
is the radius of gyration and BG is the background.  
 1 wt% RA6R 5 wt% RA6R 16 wt%  RA6R 
Rg / (Å) 7.0 7.0 7.0 
 0.6 0.2 0.2 
I(0) 0.02 0.04 0.02 
N 0.12 0.50 0.57 
BG 9.09 x 10-6 7.20 x 10-6 0.5 





The self-assembly of RA9R in water was examined. Results from Thioflavin T (ThT) assay 
(Figure 2.2a) shows that  RA9R aggregates in amyloid fibres
35 above a cac = (0.18 ± 0.03) wt%. 
CD shows that the structure of the fibres is predominantly PP-II like (Figure 2.2b). This is an 
unexpected finding since fibril structures are generally associated with β-sheet structures. The 
secondary structure remains predominantly PPII like upon heating (Figure 2.2c), but changes 
into a β-sheet conformation, characterised by the minimum near 216 nm, upon drying the 
sample (Figure 2.2d). The FTIR spectrum for 1 wt% RA9R (Figure 2.2e) shows peaks at 1672 
cm-1, 1647 cm-1,1608 cm-1 and 1587 cm-1 which are respectively assigned to modes associated 
with TFA counter ions,28,29 disordered structure or arginine vibrations30,31 as stated above. Upon 
increasing concentration to 5 wt%, additional peaks appear at 1675 cm-1  which can be assigned 
to PP-II structure and 1667 cm-1 which indicates a β-turn secondary structure.31,36 
       The XRD profile of RA9R (Figure 2.2f) shows a 5.32 Å reflection which can be assigned 
to the packing of polyalanine β-sheets,17 with inter-strand and intra-strand spacings  of 4.32 Å, 
3.72 Å, 2.83 Å, 2.39 Å and 2.26 Å. Interestingly, we observed that RA9R has the ability to form 
a weak gel at a concentration of 5 wt%, which could be driven by the change in secondary 
structure from PP-II to β-sheet. 
      SAXS data, measured for 1 wt% RA9R, was modelled using the form factor of a long 
cylindrical shell (Figure 2.2g; fitting parameters listed in Table 2.2). The parameters of the 
model are the core radius R (with polydispersity R), the shell thickness Dr and the scattering 
length density of the core, shell and solvent Dcore, Dshell and Dsolv.  The extracted parameters R 
± R = (15±10) Å and Dr = 3 Å, indicate that the cylinder core radius is smaller than the length 
of the oligoalanine A9 sequence= 28.8 Å (spacing per residue in a parallel β-sheet is 3.2 Å), 
while the external shell has a thickness very similar to one arginine unit. This result shows that 
there is an overlapping of the alanine chains within the core of the fibers, with the arginine 
residue exposed at the surface of the fibres. Cryo-TEM confirms the presence of fibres with an 
average diameter of 7.6 nm thick (Figure 2.2h).  RA9R forms a self-standing gel at 10 wt% and 
15 wt%.  
 
 




Figure 2.2. RA9R self-assembly in water: a) concentration dependence of ThT fluorescence 
intensity at λem= 520 nm,  b)c) and d) CD data, e) FTIR spectra; f) XRD data,  g) SAXS profiles 
h) cryo-TEM image for samples above the cac. The concentration of the solutions is indicated 
in the plot. The red line in e) correspond to the fitting of the SAXS data as described in the text. 
1wt% solution.   
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Table 2.2. Parameters extracted from the fitting of the SAXS curve in Figure 2.2g: core radius 
R, shell thickness Dr and scattering length density of the core, shell and solvent ηcore, ηshell and 









ANS was used to determine the critical aggregation concentration of RA12R (Figure 2.3a). 
Results from ANS show a critical aggregation concentration of 0.007 wt%. This is lower than 
reported for RA6R and RA9R, however a different probe was used. ThT, which binds to amyloid 
fibrils, 22,37  was also used to determine the cac (data not shown), however, there was no clear 
increase in fluorescence intensity. 
 To examine the secondary structure, CD and FTIR was used (Figure 2.3c,d). The circular 
dichroism spectrum at 1 wt% is characterised by a minimum at 218 nm, corresponding to a β-
sheet secondary structure.26 CD spectra of 5 wt% and 10 wt% RA12R gel show reduced molar 
ellipticity.  FTIR was used to further probe the secondary structure. FTIR showed peaks in the 
amide-I region at 1619 cm-1, 1624 cm-1 which confirm the β-sheet secondary structure.31,36,38,39 
The 1673 cm-1 peak can be assigned to TFA counterions,28,29  and 1586 cm-1 as stated previously 
is assigned to arginine vibrations.30,31  
SAXS data, measured for 1 and 2 wt% RA12R, was modelled using the form factor of a long 
cylindrical shell.40 (Figure 2.3e. Fitting parameters listed in Table 2.3) . The extracted 
parameters R ± R = (23 ± 11) Å for 1 wt%, which is similar for the 2 wt%, and Dr = 15 Å and 
17.3 Å.  The high polydispersity is confirmed by cryo-TEM which shows a small population of 
micelles. This implies the cylinder core radius is smaller than the length of the oligoalanine A12 
sequence= 38.4 Å, while the external shell has a thickness very similar to 7 arginine units. This 
result shows that there is an overlapping of the alanine chains within the core of the fibres, with 
 1 wt% RA9R 
R ±  R (Å) 15 ± 10 
Dr (Å) 3 
ηcore (a.u.) 4x10-9 
ηshell (a.u.) 1.5x10-6 
ηsolv (a.u.) 1.1x10-7 
BG 2.3x10-3 
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the arginine residue exposed at the surface of the fibres. RA12R forms a standing gel between 
at 10 wt%, the SAXS data for which is included in figure 2.3e. This is slightly higher than the 
concentration at which RA9R forms a stand-alone gel.   
 
Figure 2.3. Self-assembly of RA12R. a) b) critical aggregation concentration using ANS, c) 
circular dichroism d) FTIR, e) SAXS data of RA12R at different concentrations with fits in Red 
and f) cryo-TEM image 
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Table 2.3. Parameters extracted from the fitting of the SAXS curves in Figure 2.3e: core radius 
R, shell thickness Dr and scattering length density of the core, shell and solvent ηcore, ηshell and 




A12R2 was studied previously.
41 It was re-examined here for comparison with the other SLP’s 
and instead of A12R which is not soluble in water as it is too hydrophobic. To determine the 
cac, ANS and ThT were used (Figure 2.4a,b). Results from ANS show a critical aggregation 
concentration of 0.007 wt%. ThT which binds to amyloid fibrils, was also used to determine 
the cac, however, there was no clear increase in fluorescence intensity.22,35,37 This is similar to 
RA12R. 
 To examine the secondary structure, CD and FTIR was used (Figure 2.4c,d). The circular 
dichroism spectrum at 1 wt% is characterised by a minimum at 221 nm, corresponding to a β-
sheet secondary structure.26,42 FTIR was used to further probe the secondary structure. FTIR 
showed peaks in the amide-I region at 1624 cm-1 which confirm the β-sheet secondary 
structure.31,36,38 The 1673 cm-1 peak can be assigned to TFA counterions,28,29 and 1586 cm-1 as 
stated previously is assigned to arginine vibrations.30,31 The 1698 cm-1 shoulder can be assigned 
to anti-parallel β-sheet.38  
SAXS data, measured for 1 and 2 wt% A12R2 (Figure 2.4e), was modelled using the form factor 
of a long cylindrical shell40 (Figure 2.4e. Fitting parameters listed in Table 2.4. The extracted 
parameters for 1wt% R ± R = (23 ±15) Å, with the same radius for 2wt% but with less 
polydispersity. The polydispersity is confirmed by cryo-TEM which shows a mixture of fibres 
and spherical micelles. The shell radius, Dr = 25.5 Å, indicate that the cylinder core radius is 
smaller than the length of the oligoalanine A12 sequence= 38.4 Å, while the external shell has 
 1 wt% RA12R 2 wt% RA12R 
R ±  R (Å) 23 ± 11 23 ± 11 
Dr (Å) 14.5 17.3 
ηcore (a.u.) 3.00 x 10-6 3.38 x 10-6 
ηshell (a.u.) -6.33 x 10-7 -5.13 x 10-7 
ηsolv (a.u.) 0 0 
BG 9.31 x 10-4 1.65 x 10-3 
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a thickness very similar to  8 arginine units. For 2 wt% this decreases significantly to 5 alanine 
amino acids, which could be due to increased ordering, as Cryo-TEM (Figure 2.4f) at 1 wt% 
shows clustered fibres as well as individual fibres, which explains somewhat the high 
polydispersity in the SAXS fits. This result shows that there is an overlapping of the alanine 
chains within the core of the fibers, with the arginine residue exposed at the surface of the fibres. 
A12R2 forms a standing gel at 5 wt% which is lower than the concentration at which RA12R 
forms a gel.  
 
Figure 2.4. Self-assembly of A12R2 a) b) critical aggregation concentration using ANS, c) 
circular dichroism d) FTIR e) SAXS data of A12R2 at different concentrations with fits in Red 
and f) cryo-TEM of 1 wt% A12R2  
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Table 2.4. Parameters extracted from the fitting of the SAXS curve in Figure 2.4e: core radius 
R, shell thickness Dr and scattering length density of the core, shell and solvent ηcore, ηshell and 
ηcore and background BG. 
 
2.2.1.5 Comparison of Self-Assembly  
 
A6R was previously shown to assembly into ultrathin nanosheets at relatively dilute solutions, 
and ordered nanotubes at high concentration, with a critical aggregation concentration of 1.4 
wt%.16 Adding cap to the C-terminus promotes the assembly of long fibres, lowering the cac to 
0.4 wt%. A9R was reported to have a cac of 0.05 wt% and assemble into β-sheet amyloid 
fibres.17 A12R2 as reported above assembles into β-sheet amyloid fibres, with a cac of 0.007 
wt%. The tend for the cac to decrease with the length of the An chain length is consistent with 
increased hydrophobicity.  
A similar effect is observed for the bola amphiphiles. RA3R and RA6R do not self-assemble 
into regular structures in water. It is likely that the flexibility of the PP II helical structure 
together with the solubility of the arginine residues does not favour RA3R and RA6R assembly. 
Increasing the length of the hydrophobic central block decreases the solubility of the molecule 
and allows for the self-assembly of RA9R and RA12R into β-sheet fibrils.  RA9R forms long 
amyloid fibres, and interestingly RA12R forms shorter comparative fibres (as can be seen by the 
SAXS and Cryo-TEM.)  
Generally, the aggregation concentration is lower for the SLP’s than for their corresponding 
bola amphiphile, which is probably linked to the bola amphiphiles (except for RA12R and A12R2 
which have the same cac) being more soluble due to the additional arginine residue. Across 
both groups, the alanine chain length increases, the increased amphilicity causes lower 
 1 wt% A12R2 2 wt% A12R2 
R ±  R (Å) 22.6 ± 15 22.6 ± 12 
Dr (Å) 25.7 15.5 
ηcore (a.u.) 3.55 x 10-6 2.53 x 10-6 
ηshell (a.u.) -6.52 x 10-7 -5.50 x 10-7 
ηsolv (a.u.) 0 0 
BG 1.61 x 10-3 8.05 x 10-4 
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aggregation concentrations, more ordered structures, and generally lower concentrations for 
which hydrogelation is observed.    
 
Scheme 2.4. Schematic representation of the self-assembly of the surfactant-like peptides 
(SLPs) s at 1 wt% 
 




Scheme 2.5. Schematic representation of the self-assembly of the bola-amphiphiles at 1 wt% 
 
2.2.2 Cytocompatibility of RAnR’s and AnR’s  
 
 
To assess the cytocompatibility of the peptides, an MTT assay using human skin fibroblast cells 
was performed on all of the RAnR and AnR peptides (Figure 2.5). The IC50 values can be seen 
in Table 2.5. This was examined to assess whether increased alanine chain, and the architecture 
of the bola-amphiphile or the SLP affects the toxicity. Previously it has been reported that 
increased size of antimicrobial peptides (AMP’s),43 as well as increased catonic charge and 
increased hydrophobic motifs can increase toxicity.  
For the bola-amphiphiles, there is no clear relationship between the length of the peptide and 
the cytotoxicity. In order of compatibility, the most compatible is RA6R, followed by RA12R 
and RA3R, with the least compatible being RA9R. The peptide RA6R is much more strongly 
tolerated by the cells than the other peptides in the group. The least compatible peptide, RA9R, 
is significantly less compatible, particularly when looking at the molar concentrations, which 
reveals it is around 5 times less compatible than the second most toxic peptide RA3R.  
Although we can establish there is not a strong link between the self-assembled structure of 
these peptides, and toxicity, it does imply that toxicity may arise through different mechanisms. 
RA3R was reported to interact with lipid membranes in the form of unassociated molecules due 
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to interactions between the arginine residues and anionic or lipid head groups.20 The mechanism 
of toxicity for RA6R could be similar to this. The cytotoxicity of RA9R and RA12R is higher 
than that of RA6R at a given concentration, likely in some part due to the self-assembly of the 
fibrils, in which the arginine motif is presented at high density on the fibril surface.  
One theory for increased toxicity between the group may be due to the sizes of the peptides. 
Although passive diffusion across cell membranes is generally thought to occur for small polar 
molecules (e.g. CO2 and O2), there are reports of some peptides passively diffusing across 
membranes, for example, cyclosporin A.44  RA3R is relatively small and is a monomer, enabling 
it to potentially be more permeable to the human cell membrane than RA6R, which also forms 
some clustered aggregates which may also be too large to cross. Thus, RA3R may diffuse into 
the membrane more easily than RA6R. The increased molecular weight and perhaps self-
assembly into larger aggregates displayed by RA9R and the RA12R may prevent the from being 
able to diffuse across the membrane. However, the self-assembled overall structure, which 
presents cationic charge at high density may be more disruptive to the membrane, thus the 
increased toxicity. This could imply there is an optimum length of alanine chain, where there 
is less toxicity when there is less permeability at longer peptide lengths, but not too amphiphilic 
where it presents positive charge at high density. Further cytotoxicity data of bola-amphiphiles 
with alanine lengths of 4, 5, 7 and 8 would be needed to examine this further.  
The majority of the SLP’s did not have an IC50 concentration within in the studied range (above 
0.5 wt%). A12R2 did have an IC50 within this range, which could either be to do with increased 
size of the hydrophobic motif, the increased amphilicity or the additional arginine residue.  
The cytotoxicity of both RA6R and A6R, are within the same error of each other across the 
concentration range (Figure 2.6a). RA9R is significantly more toxic that A9R (Figure 2.6b). 
A12R2 is more toxic than RA12R (Figure 2.6C). 





Figure 2.5.  Cytocompatibility of peptides using MTT assay, a) peptide bolaamphiphiles and 
b) SLPs with sigmoidal fits as a guide to the eye.   
 





RA3R 0.077 ± 0.03 1.4 
RA6R >0.5 >6.61 
RA9R 0.026 ± 0.008 0.27 
RA12R 0.18 ± 0.1 1.56 
A6R >0.5 >8.32 
CapA6R >0.5 >7.79 
A9R >0.5 >6.14 
A12R2 0.05 ± 0.02 0.48 




Figure 2.6. MTT assays of bolaamphiphiles compared to the same alanine-chain length 
surfactant-like peptides. Sigmoidal fits are used as a guide to the eye.  
 
2.2.3 Antimicrobial Activity of RANR’s and AnR’s  
 
To investigate the potential antimicrobial activity of the peptides, a range of common Gram- 
negative and Gram-positive bacteria were selected for initial screens, using straightforward 
bacterial kill (counts of colony-forming units, CFUs) assays. The Gram-positive microbe 
selected was S.aureus, which is commonly found as part of the human microbiota, and is an 
opportunist pathogen which can cause a range of infections including food poisoning, skin 
infections and respiratory tract infections. The Gram-negative strains selected included E.coli, 
which is a widely studied bacteria which often causes food borne infection, and P. aeruginosa, 
which is an opportunist pathogen causing serious infections in cystic fibrosis. We also examined 
P.syringae, a Gram-negative plant pathogen 
 
Antimicrobial assays were conducted against these species to assess the survival of E.coli, 
S.aureus, P.syringae and P.aeruginosa in the presence of either control (water), RA3R, RA6R, 
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RA9R, RA12R, A9R or A12R2. The concentration used and corresponding viability are reported 
in Table 2.6.  
 
2.2.3.1 Antimicrobial activity of the bolaamphiphiles.  
 
RA6R at lower concentration showed a small reduction in bacterial colony counts for E.coli and  
P. aeruginosa after 24 hours (Figure 2.7). For RA6R acting against both E. coli, P.aeruginosa 
and P.syringae the main reduction in the number of CFUs occurs in the first 2 hours after 
treatment with the peptide. At 0.1 wt% RA6R there is a more significant effect against P. 
aeruginosa (Figure 2.7c), denoted by a 5 log reduction in CFU after 24 hrs. There is a small 
increase in the effect of 0.1 wt% RA6R on E. coli or S. aureus (Figure 2.7a,b). Interestingly, 
RA6R is also strongly active against P.syringae with a log 4.5 reduction in CFU after 24 hrs 
(Figure 2.7d), suggesting that RA6R is more active against pseudomonas bacterium.  
There was no reduction in the bacterial colony count of P.aeruginosa or E.coli below the IC50 
concentration of RA9R (Figure 2.f,g). There is a small reduction of 1.4 log for S.aureus (Figure 
2.7e). When increasing the concentration to 0.05 wt%, there was a 0.6 log CFU reduction for 
E.coli after 24 hours. For S.aureus there was a similar reduction of 1.4 log CFU after 2 hours 
and 1.3 log CFU after 24 hours (Figure 2.7e). For P.aeruginosa  and P.syringae there is no 
effect (Figure 7g,h). When increasing the concentration to 0.1 wt% peptide, there is a small, 
statistically insignificant reduction of 1.3 log of E. coli numbers when exposed to RA9R. 
Interestingly, the reduction in colony forming units (CFU) after 24 hrs are 2.6, 3.3 and 4.0 
orders of magnitude for S. aureus, P. aeruginosa and P. syringae respectively. From this we 
can conclude RA9R has no effect in the cytocompatible range, but has a small effect of E.coli, 
a slightly larger effect on S.aureus, P.aeruginosa and P.syringae above this range. As S.aureus 
is gram positive and P.aeruginosa and P.syringae are Gram-negative, this shows a broader 
range effect.  
Antimicrobial activities of RA3R was previously measured at 0.25 wt%.
18 This concentration 
has low human cell viability, but showed a large effect against food pathogen L.Monocytogenes. 
In order to compare the peptide length with activity, RA3R and RA12R were screened at 0.1 
wt% (Figure 2.8).  RA12R has more activity against all species than RA3R. Interestingly, when 
the length of the alanine chain is plotted, against the reduction in colony forming units, there 
seems to not be any correlation between length of the peptide chain with activity (Figure 2.8d). 
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Table 2.6. Reported and measured antimicrobial activity of the SLP’s and bola-amphiphiles 
after 24 hours.  
 
Peptide Conc 
/ wt% Viability 
Reduction / Log CFU mL-1 




(±4.2) 2.6 N/A 3.5 5.6 
0.1 
47.1 
(±4.6) 0.68 3.69 1.18 N/A 
A6R 0.516,17 
51.5 
(±1.8) ~6 N/A ~4 ~6 
CapA6R 0.2517 
72.0 




(±3.4) 0 1.36 0.68 N/A 
0.1 
72.2 
(±1.8) 0.64 4.98 1.01 N/A 
A9R 0.05 
72.3 




(±6.3) 1.4 0.011 0 N/A 
0.05 
48.2 
(±12) 1.4 0.096 0.62 N/A 
0.1 
25.3 
(±2.9) 2.64 3.32 1.29 N/A 
A12R2 0.1 
49.5 
(±9.9 0.41 4.0 1.7 N/A 
RA12R 0.1 
55.7 








Figure 2.7. Antimicrobial screen of RA6R with a ) S.aureus, b) E.coli, c) P.aeruginosa d) 
P.syringae and  RA9R with e) S.aureus, f) E.coli, g) P.aeruginosa and h) P.syringae 




Figure 2.8. Antimicrobial screen of A12R2 and RA12R with a ) S.aureus, b) E.coli, and c) 
P.aeruginosa  and d) Antimicrobial activity vs length for alanine chain length of the bola-
amphiphiles compared at 0.1 wt% after 24 hours.  
 
2.2.3.2 Surfactant like peptides  
 
The antimicrobial activity of A6R and CapA6R was discussed previously elsewhere.
16,17 In 
summary, all of these peptides showed strong activity against L.monocytogenes a food borne 
pathogen (Table 2.6). A6R had a much larger effect against S.aureus than CapA6R, although 
this may be due to the concentration difference used in the study.   
 
Peptide A9R (Figure 2.9) assayed at 0.05 wt% had a statistically significant decrease in the 
numbers of E.coli and P.aeruginosa after 24 hours. The latter particularly, with a reduction of 
4 log CFU mL-1.  As A9R reduced the number of the two Gram-negative bacteria, if may be 
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that it is selective for Gram negative bacteria, although a larger group of gram-negative bacteria 
species would be needed to examine this further. A9R does have significantly higher activity 
against P.aeruginosa than bola-amphiphile RA9R, being more active by 4 log units at the 
corresponding concentration of 0.05 wt%, and by 0.8 log units when the concentration of RA9R 
is doubled (Figure 2.7g, 2.9c, Table 2.6). RA9R does display some activity at against S.aureus, 
(Figure 2.7e) but A9R demonstrates a negligible activity at the corresponding 
concentration(Figure 2.9b).  
 
A12R2, similar to the other peptides displays activity against P.aeruginosa (Figure 2.9f , and log 
4.0 reduction in cFU mL-1). Despite being measured at a higher concentration than A9R, it still 
displays less activity against P.aeruginosa. Similarly to RA12R, (Table 2.6) there is activity 
against E.coli (Figure 2.9d, log 1.7 reduction) but little activity against S.aureus (Figure 2.9e, 
0.4 log reduction).  
 
Overall, both the SLP’s and bola-amphiphiles display some antimicrobial activity. It can be 
seen that RA9R displays little antimicrobial activity under these conditions. Interestingly RA6R 
and A9R display strong activity against P. aeruginosa at a concentration where the 
cytocompatibility (to fibroblasts) is acceptable. The concentrations used for A6R and CapA6R 
measured in previous studies16,17 are significantly higher than those in the present study, 
meaning further testing would be required in order to compare the effectiveness of these 
peptides with the rest of the group.  




Figure 2.9. Antimicrobial screening of A9R a) E.coli b) S.aureus and c) P.aeruginosa and A12R2 
with d) E.coli e) S.aureus and f) P.aeruginosa 
 
2.2.3 Interactions with liposomes. 
 
In order to understand further the way in which these cationic peptides interact with bacterial 
membrane models, RA6R, RA9R, RA12R and A12R2 were examined with combinations of 
simple membrane models.  
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Previously Dr Castelletto examined the interactions of A6R, capA6R, RA3R and A9R with 
DOPC/POPC zwitterionic membranes and POPG/POPE anionic lipid vesicles. Mammalian 
cells contain PC and PG lipids, whereas bacterial cells contain PG and PE (Table 2.7). 
Therefore, these lipids were used as a simplified system to model peptide interactions.  RA3R 
was shown to decorrelate the bilayers of DOPC/POPC vesicles, and change the structure of 
POPG/POPE vesicles depending on composition of the latter.18 A6R was reported to have a 
thinning effect on DOPC/POPC vesicles through interacting at the surface, and a minimal effect 
on anionic vesicles POPG/POPE.17 A9R has a similar mechanism for interacting with the 
zwitterionic vesicles, however, inserts into the POPG/POPE bilayers, causing increased bilayer 
distances and correlation.45 CapA6R was reported to cause structuring of the POPG/POPE 
bilayers due to incorporation of the peptide with the lipid membrane in a β-sheet conformation, 
and tubulation of the zwitteironic vesicles at certain compositions.17  
For this study, three ratios of DPPG/DPPE, 1:3 DPPG/DPPE (which is similar to P.aeruginosa), 
1:1 which has a similar ratio to B.cereus, 3:1 DPPG/DPPE and DPPG only which are more 
similar to S.aureus membranes which contain no PE lipid. The rationale for the change of model 
system from previously the POPG/POPE system to DPPG/DPPE system was due to transition 
temperatures. POPG and POPE have Tm values of -18 
oC and 25 oC, whereas DPPG/DPPE have 
Tms of 41 
oC and 63 oC respectively.46 These Tm values are more accessible for measurement 
(for example nanoDSC, which has a minimum temperature of 0 oC), and these lipids have well 
defined phase diagrams.  
 
 Table 2.7. Content of different species bacteria membranes.47 
Species % PG % PE 
Gram Negative 
Escherichia coli 15 80 
Pseudomonas aeruginosa 21 60 
Gram Positive 
Staphylococcus aureus 58 0 
Bacillus cereus 40 43 
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2.2.3.1 Circular Dichroism  
 
 Figure 2.10. CD spectra for (a) RA6R and (b) RA9R peptides on their own or mixed with  lipids 
at the concentrations indicated.  
 
CD was used to examine whether interactions of the peptide with DPPG/DPPE membranes 
influenced the peptide secondary structure. Figure 2.10 shows the CD spectra of the RA6R and 
RA9R with 0.08 wt% peptide concentration compared to those in the presence of DPPG/DPPE 
lipid mixtures. RA6R appears to remain as a PP II helix in the presence of lipids. The decreased 
molar ellipticity implies slight loss of structure. The molar ellipticity decreases with higher 
ratios of DPPG:DPPE, and a disordered structure is observed for the solution of RA6R with 
DPPG, which is characterised by a 190 nm minimum and the loss of the 220 nm broad peak. 
This is perhaps due to the strong binding between the ionic head group of the DPPG and the 
peptide inhibiting secondary structure formation.  
Remarkably, the PP-II helix secondary structure measured for pure RA9R in solution, changes 
into a β-sheet structure in the presence of lipid (Figure 2.10b). This shows that the DPPG/DPPE 
lipid membrane orders the peptide into a β-sheet secondary structure at a concentration of RA9R 
below its cac (Figure 2.10b). A similar effect has previously been reported by us for capA6R.
17 
The population of RA9R-induced β-sheets increases with increasing DPPG (Figure 2.10b), 
showing that RA9R binds more strongly to DPPG than to DPPE.  
 




Figure 2.11. CD spectra for (a) RA12R and (b) A12R2 peptides on their own and mixed with  
lipids at the concentrations indicated.  
 
For both A12R2 (Figure 2.11a) and RA12R (Figure 2.11b), the concentration of 0.08 wt% is 
above the aggregation concentration for which the peptides form fibres. CD with lipid mixtures 
(Figure 2.11) shows that β-sheet formation is already observed at these low concentrations. For 
both peptides, addition of the lipid mixtures causes reduced molar ellipticity, decreasing the 
order of the structure. RA12R has decreased molar ellipticity when interacting with liposome 
mixtures, which decreases more when there is increased PE content, and blue shifted β-sheet 
structure when compared to DOPC/POPC mammalian membrane model (Figure 2.11b).  
Interestingly, A12R2 becomes disordered when mixed with high PE ratios, is disordered when 
mixed with DOPC/POPC human membrane models. This is interesting as A12R2 has more 
activity against bacteria with high PE cell wall content (Table 2.7, E.coli and P.aeruginosa) 
which could in turn be linked to the change in conformation of the peptide at the surface. 
  
2.2.3.2 SAXS and Cryo-TEM  
 
SAXS was also used to examine the interactions of lipids with the peptides. SAXS data for 
lipids and peptides shown in Figure 2.12 was collected at 20 oC, which is in the gel Lβ phase 
for all lipid mixtures.21 For the pure lipids, a broad peak positioned at approximately q = 0.15 
Å-1 corresponds to unilamellar vesicles. SAXS data from temperature ramps in the range 20 – 
50 oC for the peptides mixed with DPPG at two concentrations (Figure 2.13) shows particularly 
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enhanced lipid bilayer correlations on heating at the higher peptide concentration studies (0.25 
wt%). 
 
Figure 2.12. SAXS profiles for mixtures of lipids (total 0.5 wt%) and 0.08 wt% peptide.  
 
Upon addition of RA9R, the SAXS data in Figure 2.12 shows that some correlation between 
bilayers is induced, as indicated by the presence of small Bragg peaks. In contrast, RA6R only 
causes a shift to lower q of the form factor minimum, i.e. there is a slight increase in the bilayer 
spacing. This implies that RA9R causes membrane correlations due to the formation of β-sheet 
structure as concluded from CD results above. However, RA6R does not change membrane 
correlations, but it does restructure the membranes, possibly due to interaction between the 
arginine residues and the charged DPPG head groups. In the DPPG/RA9R, mixture the peptide 
induces two Bragg peaks with d-spacing values of 83.1 Å and 44.8 Å (d= 2π/q0; q0: coordinate 
for the peak maxima), consistent with a lamellar structure. Cryo-TEM images of peptides in the 
presence of the lipid mixtures are shown in Figure 2.14. These images show the presence of 
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some fibrils of RA9R coexisting with vesicles, however the SAXS signal is dominated by the 
contribution from the vesicles, as shown by the data in Figure 2.12.  
 
 
Figure 2.13.  Temperature-ramp SAXS data for a) 0.5 wt% DPPG, 0.08 wt% RA6R b) 0.5 wt% 








Figure 2.14. Cryo-TEM images of a) 0.5 wt% DPPG/DPPE 1:3, b) 0.5 wt% DPPG/DPPE + 
0.08 wt% RA6R and c) 0.5 wt% DPPG/DPPE + 0.08 wt% RA9R  , d) 0.08 wt% RA6R + 0.5 wt% 
DPPG/DPPE 1:1 e) 0.08 wt% RA9R + 0.5 wt% DPPG/DPPE 1:1 f) 0.08 wt% RA6R + 0.5 wt% 
DPPG/DPPE 3:1 g) 0.08 wt% RA9R + 0.5 wt% DPPG/DPPE 3:1 
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Comparing the SAXS data of RA12R and A12R2 with different mixtures of liposomes, across 
the liposome ratios there is some correlation between the bilayers, similar to RA6R and RA9R, 
indicated by the presence of small Bragg peaks. For DPPG alone, A12R2 causes a shift in the 
central peak q = 0.1 Å-1 peak to 0.123 Å-1, whereas for RA12R there is a Bragg peak with d 
spacing value 86.9 Å. For  DPPG/DPPE 3:1 mixture, Bragg peaks at d spacing values 88.38 Å 
for both A12R2 and RA12R are seen. There is a second Bragg peak at 57.1 Å for A12R2 and 47.0 
Å for RA12R respectively. In the 1:1 DPPG/DPPE, RA12R mixture, there are 2 d-spacing values 
of 85.8 Å and 47.1 Å for RA12R, which is a 1.82 ratio, similar to the 3:1 ratio. Mixtures of 
A12R2 with the 1:1 DPPG/DPPE also have similar d-spacing values to the 3:1 DPPG/DPPE, 
with d-spacings of 85.8 Å and 50.7 Å respectively. These peaks can be explained by coexisting 
lamellar phases.  
For DPPG/DPPE 1:3 mixtures with both peptides, there is a complete loss of form factor 
features, which is different for the peptide alone assembled fibres. This shows that the peptides 
disrupt liposome formation. This is consistent with the circular dichroism data which suggests 
a loss of secondary structure of the peptide.  
 
Figure 2.15. SAXS profiles of 0.08 wt% RA12R and 0.08 wt% A12R2 with different liposome 
ratios at 0.5 wt% peptide concentration.  
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2.2.3.1  DSC  
 
Next, differential scanning calorimetry (DSC) was used to examined the interactions of RA6R 
and RA9R with a model bacterial lipid membranes, represented by DPPG/DPPE vesicles. 
DPPG is an anionic lipid, whereas DPPE is zwitterionic and both are commonly found in 
bacterial membranes.12,21 We selected DPPG and DPPE because the melting temperatures (Tm), 
are accessible by conventional instruments being 41 oC (DPPG) and 63 oC (DPPE).21  We 
examined 0.5 wt% DPPG/DPPE vesicles with ratios 3:1, 1:1 or 1:3, loaded only with 0.08 wt% 
peptide. While 0.08 wt% peptide is in the range of concentrations used for the antimicrobial 
assays discussed previously, higher concentrations of peptide led to DPPG/DPPE peptide 
sample precipitation and therefore were excluded from this study. DSC has previously been 
used to investigate lipid de-mixing in binary lipid membranes, driven by the membrane 
interaction with charged peptides.12,21 The results  of this study are displayed in Figure 2.16, 
with Tm and ΔH values being reported in Table 2.8.  
DSC thermograms for the lipids alone (Figure 2.16) present well-defined peaks in the second 
heating ramps, as observed previously21,48 (with the exception of the data DPPG which shows 
a broad transition for reasons discussed below). To compare the influence of RA6R and RA9R 
on the thermotropic phase behaviour of the DPPG/DPPE mixtures, the thermodynamic 
parameters, namely the main transition temperature (Tm) and the transition enthalpy ΔH were 
calculated as an indication of the transition cooperativity. For DPPE, the Tm stays within 0.1 
oC 
of the lipid transition alone indicating little peptide binding, however there is a decrease in ΔH 
by 23.2 kJ mol-1 and 27.8 kJ mol-1 upon addition of RA6R and RA9R respectively. This indicates 
that there may be some interaction between the peptides and DPPE which promotes a lowering 
of the energy needed for DPPE to undergo the phase transition from the Lβ to the Lα phase. 
DPPG alone shows a pre-transition to the Pβ ripple phase at about 35 
oC and a main chain 
melting temperature (to fluid state, Lα phase) of 40.5 
⁰C in good agreement with previous 
measurements for DPPG.19,49 In the presence of RA6R, there is a shift in the melting temperature 
Tm to 47 
oC as expected from peptide binding to anionic lipid.19 RA9R also causes transition a 
slight increase in the main Tm.  A similar lowering of energy is observed for DPPG where ΔH  
is reduced by 8.9 kJ mol-1 and 14.93 kJ mol-1 for RA6R and RA9R respectively. Interestingly 
there is an increase in main transition temperature by 11.9 oC for RA6R and 14.0 
oC for RA9R. 
This increase in main transition temperature is likely caused by the charged arginine residues 
strongly binding to the anionic DPPG group causing an increase in the main transition 
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temperature. Moreover, the peaks for DPPG with added peptide are asymmetric in shape, with 
RA9R having a small second peak at 50.1 
oC which could be due to DPPG transitioning in steps 
into the Lβ phase based on how much peptide is bound.   
The DPPG/DPPE 3:1 mixture shows an increase in main chain transition temperature by 5.5 oC 
and 10.8 oC respectively for RA6R and RA9R, which places Tm for RA6R at a similar value to 
that observed in the mixture with DPPG alone, suggesting some de-mixing could be occurring. 
RA9R has a higher main transition temperature than that of DPPG alone. There is an increase 
in ΔH for the transition temperature, when mixed with both RA6R (9.27 kJ mol
-1) and RA9R 
(2.88 kJ mol-1) showing that the peptide is stabilising the Lβ phase. At a ratio of 1:1 
DPPG/DPPE, there are no large changes in main transition temperature (~1oC), however RA6R 
shows a small secondary peak at 60 oC showing evidence of DPPE-rich regions, which shows 
de-mixing may be occurring. Finally, in the mixture with 1:3 ratio of DPPG/DPPE, RA9R has 
an asymmetric peak with a Tm of 61.5 
oC which is comparable to that when only DPPE is 
present, suggesting de-mixing. RA6R has a decreased transition temperature from 60.8
 oC to 
56.2 oC (4.6 oC reduction) suggesting formation of DPPE depleted domains compared to the 
control lipid mixture.  
Overall, the DSC shows that the both peptides stabilise the Lβ phase of DPPG, seen through 
increased transition temperature. This could be due to the peptides being cationic, therefore 
binding to anionic DPPG. When the peptides are mixed with DPPE, the temperature of 
transition remains the same, however the peptides reduce enthalpy requirement for transition to 
Lα phase, thus the peptides destabilise the Lβ phase. Thermograms of the mixtures with peptide 













Figure 2.16. DSC scans showing second heating of DPPG/DPPE lipid mixtures with or without 
peptide. Scans for peptides mixed with lipids are plotted as dashed lines, and data for the lipid 
mixtures (without peptide) by the solid lines. The corresponding sample compositions are 
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Table 2.8. The maximum transition temperature, Tm and enthalpy ΔH of phase changes 
determined from the data plotted in Figure 3. 
Mixture Tm (oC) ΔH (kJ mol-1) 
DPPE 63.9 37.1 
DPPE +RA6R 63.9 13.9 
DPPE + RA9R 64.0 9.3 
   
0.5 wt% DPPG/DPPE 3:1 47.1 29.4 
0.5 wt% DPPG/DPPE 3:1 + 0.08 
RA6R 
53.6 38.6 
0.5 wt% DPPG/DPPE 3:1 + 0.08 
RA9R 
57.7 32.2 
   
0.5 wt% DPPG/DPPE 1:1 56.9 30.8 
0.5 wt% DPPG/DPPE 1:1 + 0.08 
RA6R 
56.8 34.6 
0.5 wt% DPPG/DPPE 1:1 + 0.08 
RA9R 
57.8 36.9 
   
0.5 wt% DPPG/DPPE 1:3 60.8 37.5 
0.5 wt% DPPG/DPPE 1:3 + 0.08 
RA6R 
56.2 43.0 
0.5 wt% DPPG/DPPE 1:3 + 0.08 
RA9R 
61.5 37.5 
   
DPPG 40.5 32.4 
DPPG + RA6R 52.4 23.5 
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2.3 Conclusions  
 
The self-assembly of peptide bola-amphiphiles and SLPs containing arginine and alanine have 
been examined.  Peptide RA6R does not form self-assembled nanostructures, similar to RA3R, 
and in contrast to RA9R and RA12R which form fibrils above a critical aggregation 
concentration. Interestingly, RA9R binds amyloid specific dye ThT, although CD and FTIR 
spectroscopy show no evidence of β-sheet conformation. RA12R does not bind ThT although 
there is evidence of β-sheet structures in CD and FTIR. A12R2 has a similar aggregation 
propensity to RA12R and similar self-assembly into clustered fibres. Hydrogelation occurs at 
lower concentrations as the length of the alanine chain is increased across the series of bola-
amphiphiles, however SLP A12R2 gels at a lower concentration than corresponding bola-
amphiphile RA12R.  
The cytotoxicity data reveals that generally (with the exception of A12R2 and RA12R) that the 
SLPs are less toxic that their corresponding bola-amphiphile, which is perhaps due to the lower 
cationic charge. Increase in toxicity for the bola-amphiphiles is not directly linked to increased 
molecular weight but perhaps is linked to a mixture of membrane permeability and the 
presentation of cationic charge at high density from the larger self-assembled bola-amphiphiles 
which can cause membrane disruption.  
The initial antimicrobial screening study (and corresponding assay showing low cytotoxicity at 
the corresponding peptide concentration) shows that A9R and RA6R are promising antibacterial 
agents active against P. aeruginosa, strains of which (including those that have evolved 
antimicrobial resistance) can cause serious infections. The strong activity of these two peptides 
is within the cytocompatible range. There is no correlation between the size of the alanine 
hydrophobic block and antimicrobial activity. Peptides A12R2, RA12R and RA3R also have 
activity against P.aeruginosa but near the concentrations for which they are toxic.  
Lastly, concerning the interaction of the peptides with model DPPG/DPPE lipid membranes. 
DSC shows evidence for peptide-induced lipid de-mixing, especially in the DPPG rich 
mixtures, consistent with electrostatic interactions between this anionic lipid and the cationic 
arginine units in the peptides. Circular dichroism spectra indicate no change of peptide 
conformation for RA6R in the presence of lipids (PPII conformation retained) whereas 
unexpectedly RA9R undergoes a transition to a β-sheet conformation in the presence of the 
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lipids. Peptides A12R2 and RA12R show potential reordering of the bacterial bilayer models, 
with A12R2 becoming disordered on associating with membranes with high PE content.   
These arginine-rich peptide bola-amphiphiles show activity towards lipid membranes, which is 






Peptides RA3R, RA6R, RA9R, RA12R, A6R, CapA6R, A9R and A12R2 were supplied by 
Biomatik (Cambridge, Ontario, Canada). The purity values were as follows: RA3R 96.85%, 
RA6R 98.86 %, RA9R was 96.56%, RA12R was 97.15%, A6R was 96.64 %, CapA6R was 
95.87%, A9R was 98.73% and A12R2 was 97.51%, determined by HPLC using an Inertsil ODS-
SP column with an actetonitrile/water gradient with 0.1% TFA.  
The molar mass of each peptide determined by ESI-MS was : RA3R was 543.63 gmol
-1, RA6R 
was 757.45 gmol-1 RA9R was 970.65 gmol
-1, RA12R was 1183.32 gmol
-1,  A6R was 600.68 
gmol-1 and CapA6R was 641.73 gmol
-1, A9R was 814.90 g mol
–1 and A12R2 was 1183 gmol
–1.  
  Solutions containing pure peptide in water were made by dissolving weighed amounts of 
peptide in water and leaving to equilibrate for 3 hrs. Lipids DPPG and DPPE were obtained 
from Sigma-Aldrich. Details of multi-lamellar lipid vesicles preparation are given below. 
 
2.4.2. Fluorescence Assays 
 
The presence of any critical aggregation concentration (cac) was assayed using fluorescence 
probes, measuring spectra for a series of peptide concentrations. Fluorescence spectra were 
recorded with a Varian Cary Eclipse fluorescence spectrometer with samples in 4 mm inner 
width quartz cuvettes. ThT was used to determine the cac of RA9R, RA12R and A12R2, as it is 
sensitive to the formation of amyloid fibrils at the cac.35,37,50–52 ThT assays were performed 
using 5.0 x 10-3 wt% solution to solubilise the peptide. Spectra were recorded between 460-600 
(λex = 440 nm). ANS (8-anilinonaphthalene-1-sulfonic acid) was further used to examine 
whether there is a cac for RA6R, , RA12R and A12R2. ANS is a fluorescent probe used to 
Chapter 2: Self-Assembly and Bioactivity of Bola-Amphiphiles and SLPs 
104 
 
determine the formation of molecular hydrophobic environments in solution,22,53 and can be 
used to determine the cac independently of self-assembly into amyloid fibres. Peptides were 
dissolved in a 66.8 μM ANS solution, and spectra were recorded between 400-650 nm (λex= 
356 nm) 
 
2.4.3. Circular Dichroism (CD) Spectroscopy  
 
CD spectra were recorded using a Chirascan spectropolarimeter (Applied Photophysics, UK) 
in the wavelength range 180 – 260 nm. Samples containing 1 wt% RA6R, RA9R, , RA12R and 
A12R2 in pure H2O at were pipetted into 0.1 mm pathlength quartz cuvettes. Mixtures of 
liposomes in ratios with 0.08 wt% peptide were also loaded in the same way. Data with 
absorbance less than 2 at any point only are reported. Measurements were recorded with a 0.5 
nm bandwidth, 1 nm step and 1 s collection time per point. The CD signal for the background 
solution was subtracted from the CD signal of the sample, and molar ellipticity was calculated.  
 
2.4.4. Fourier Transform Infrared (FTIR) Spectroscopy 
 
Spectra were recorded using a Thermo Scientific Nicolet IS5 instrument equipped with a DTGS 
detector, with a PEARL liquid cell (sample contained between fixed CaF2 plates). Aliquots 
containing 80 µL of (1-5) wt% RA6R, RA9R, , RA12R and A12R2 in D2O were prepared and 
added to a PEARL liquid cell. Spectra were scanned 128 times over the range of 900 − 4000 
cm-1. The peptide signal was background corrected with the FTIR spectra of D2O.  
 
2.4.5. Cryogenic Transmission Electron Microscopy (cryo-TEM)  
 
Cryo-TEM was kindly performed by Jani Seitsonen, Aalto University, Finland. Vitrified 
specimens were prepared using an automated FEI Vitrobot device using Quantifoil 3.5/1 holey 
carbon copper grids with a hole size of 3.5 μm. Prior to use, grids were plasma cleaned using a 
Gatan Solarus 9500 plasma cleaner and then transferred into the environmental chamber of a 
FEI Vitrobot at room temperature and 100% humidity. After this, sample solutions were applied 
onto a grid, and were blotted twice for 5 s and then vitrified in a 1/1 mixture of liquid ethane 
and propane at a temperature of −180 °C. The grids with vitrified sample solution were 
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maintained at liquid nitrogen temperature and then cryo-transferred to the microscope. Imaging 
was carried out using a field emission cryo-electron microscope (JEOL JEM-3200FSC) 
operating at 200 kV. Images were taken in bright field mode and using zero loss energy filtering 
(Ω type) with a slit width of 20 eV. Micrographs were recorded using a Gatan Ultrascan 4000 
CCD camera. The specimen temperature was maintained at −187 °C during the imaging.  
 
2.4.6. Liposome preparation 
 
Liposome vesicles were prepared using the thin-layer hydration method. Weighed quantities of 
DPPG and DPPE were dissolved in chloroform, and thin lipid films were prepared by 
evaporating the chloroform under a stream of nitrogen. Lipid films were then placed under 
vacuum for 2 hrs to remove any remaining organic solvent. After this, lipids were re-suspended 
in water at 0.5 wt% lipid at 65oC heated above their lipid melting temperature, Tm, and vortexed 
for 5 minutes. Liposome mixtures were then left to equilibrate for 3 hrs before experiments.  
DPPG/DPPE vesicles were prepared using this method at different molar ratios of 1:3, 1:1, 3:1 
and 1:0 DPPG:DPPE. Peptide/lipid mixtures were made by adding enough peptide powder to 
re-suspend lipids and obtain a final concentration of either 0.08 wt% or 0.25 wt% peptide. 
Peptide/lipid samples were then heated above the Tm and vortexed for 5 minutes, and finally 
left to equilibrate for 3 hrs before experiments.  Dynamic light scatter (DLS) (data not shown) 
was measured to check the size of the liposomes using a Zetasizer instrument.  
 
2.4.7. Nano Differential Scanning Calorimetry (nano-DSC) 
 
Differential scanning calorimetry measurements were carried out using a nanoDSC, DSC TA-
Q200 instrument. 600 µl of lipid mixtures at 0.5 wt% with and without 0.08 wt% peptide were 
degassed for 10 minutes before being 600 µL pipetted into the DSC sample cell. 600 µL of 
water was pipetted into the reference cell. The temperature range measured was 20 oC to 80 oC 
for DPPG/DPPE mixtures and 20oC to 60oC for DPPG alone. The scan rate was 1 oC per minute 
at pressure of 3 bar. Background subtraction, main phase transition temperature, and the 
transition enthalpy ΔH, were calculated using nanoanalyse software.  
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2.4.8. Small-angle X-ray scattering (SAXS) 
 
Data from solutions was collected on the bioSAXS beamlines B21 (Diamond Light Source, 
UK) and ID02 (ESRF, Grenoble). At the former, liposome and peptide samples were loaded 
into PCR tubes in an automated sample changer, then 30 µL was delivered into a temperature-
controlled quartz capillary and 30 frames (1 s each) of SAXS data were acquired at 20 oC. The 
temperature was then increased, measurements being taken each 10 oC. The camera length was 
3.9 m, and the X-ray wavelength was λ= 1.02 Å. Data was collected using a Dectris PILATUS 
2M detector and processed using ScÅtter,54and is presented as a function of q = 4πsinθ/λ. At 
the ESRF (ID02), 200 µL of sample was manually loaded into a glass capillary with a 2 mm 
internal radius.  The beamline operated with a flux of 2.19 x 1012 photon s-1 (100 mA) and an 
12.46 keV energy. The sample-detector distance was 1474.2 mm. The 2D data was collected 
using a Rayonix MX170 detector, with a 2x2 binning, and processed using SAXSUtilities 
software. The SAXS data was fitted using model form factors using the software SASfit.40 
SAXS from hydrogels was collected on beamline BM26B (DUBBLE) at the ESRF. On 
BM26B, hydrogels were placed in DSC pans modified with mica windows to enable 
transmission of the X-ray beam. The sample to SAXS detector distance was 3.16 m using a 
wavelength of 1.033 Å. A Dectris PILATUS 1M detector was used to acquire the 2D SAXS 
scattering patterns. Standard corrections for sample absorption and background subtraction 
were performed. The data were normalized to the intensity of the incident beam (in order to 
correct for primary beam intensity fluctuations) and were corrected for absorption, background 
scattering. The diffraction spectra from silver behenate were used to calibrate the wavevector 
scale of the scattering curve. 
 
2.4.9 Cell Viability assays  
 
In vitro cell culture was conducted using 161Br (European Collection of Authenticated Cell 
Cultures, ECACC) cells, a human skin fibroblast cell line. Cells were maintained in a 
humidified atmosphere at 37 oC, 5% CO2, and cultured in EMEM (Eagle’s minimum essential 
medium), with 2 mM glutamine, enriched with 15% fetal bovine serum (FBS) and 1% non-
essential amino acids (NEAA).  
Potential cytotoxicity effects of RA3R, RA6R, RA9R, RA12R, A6R, CapA6R, A9R and A12R2 
were examined using an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
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assay. Cells were seeded into a 96-well plate at 4x104 cells/mL and allowed to adhere for 24 
hrs in 100 µL complete medium. This seeding density was selected through growth curve assays 
(Appendix Figure A1.)  After this, peptides were dissolved in complete medium, and 100 µL 
of either complete media and/or peptide solution was added, to give either control solution 
(complete medium only) or peptide solutions with concentrations in the range (0.05-5) mg/mL 
 Cells were incubated for 67 hours. Following this, 20 µL MTT (5 mg/mL, in PBS) was pipetted 
into each well plate and allowed to incubate for 5 hrs. After a further 5 hrs (corresponding to a 
total of 72 hrs treatment) the solution was removed from the wells and replaced with 100 µL 
DMSO per well, in order to dissolve the formazan crystals. Plates were incubated for 30 mins, 
and then analysed using the UV microplate reader (λ = 570 nm). Results are reported as a % 
cell viability compared to control (untreated) values, and fitted to a sigmoidal function as a 
guide to the eye. 
 
2.4.10 Antimicrobial Assays  
 
The antimicrobial assays were performed with four species of bacteria, Escherichia coli 
(K12),55 Staphylococcus aureus56, Pseudomonas aeruginosa57  and P.syringae. Stock cultures 
were stored in -80 oC in 7% (v/v) DMSO.  Prior to experiments all three strains were streaked 
out onto Lysogeny Broth (LB) agar and grown overnight at 37oC. 
 From these plates, one colony was then transferred into 5 mL LB, and grown at 37 oC under 
agitation at 150 rev/min, on an orbital shaker overnight and these cultures were used for ongoing 
experiments. Cultures were then transferred into a 15 ml Falcon tube and cells were harvested 
by centrifugation at 9000 rpm and 4oC for 10 minutes. The supernatant was discarded and the 
pellet was resuspended in 1.5 mL ice chilled PBS (phosphate buffered saline).  
 After this, 30 μL of this solution was transferred into 300 μL of 0.1, 0.5 or 1 mg/mL (or 
0.01,0.05 or 0.1 wt%) of RA3R, RA6R, RA9R, RA12R, A9R and A12R2 in sterile water, or control 
solutions of 300 μL of sterile water. Solutions were then vortexed for 5 seconds and 3 x 20μL 
aliquots were taken at times 0, 30, 60, 120 and 1440 mins. These samples were then serially 
diluted in PBS, and 10 μL of each dilution was plated onto LB agar and incubated at 37 oC 
overnight before colony counting. 
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Selective Antibacterial Activity and Lipid Membrane Interactions of 
Arginine-Rich Amphiphilic Peptides 
This chapter has been submitted by the author as a research article entitled “Selective antibacterial activity 
and lipid membrane interactions of arginine-rich amphiphilic peptides” C.J.C. Edwards-Gayle, G. Barrett, S. 
Roy,  ,  F. Greco, J. Seitsonen, J. Ruokolainen, R. P. Rambo, I.W. Hamley . 
 
3.1 Introduction  
 
The increase in prevalence of multi antibiotic-resistant pathogens is of great concern and has 
been listed by the World Health Organisation (WHO) as one of the biggest threats to modern 
day healthcare, food security and development. There is great interest in the development of 
new therapeutics in order to overcome this.  Peptides, especially those containing cationic 
residues and/or tryptophan, have been shown to have great potential in this regard.1,2 Many 
antimicrobial peptides have evolved naturally in species of plants and animals, providing a 
strong basis to produce biocompatible therapeutics.  
Antimicrobial peptides are thought to interact with the cell membranes of bacteria through 
different mechanisms.2 It has been proposed that some peptides induce pore formation where 
the pore is lined with peptide (the barrel-stave model), or with a mixture of peptide and lipid 
(the toroidal pore model).3 Another mechanism involves peptide deposition on the 
membrane surface (the carpet model) which is followed by a detergent-like action that leads 
to pore formation.3 Cationic peptides are able to associate with the membrane and cause an 
electrical potential difference across the membrane, inducing electroporation (the molecular 
electroporation model).4–6   
An important class of antimicrobial peptide are those containing L-arginine.2  L-arginine is 
commonly found as an active site residue in proteins,7 and is common in many cell-
penetrating peptides.  The antimicrobial activity of L-arginine is due the cationic charge of 
this amino acid which interacts with anionic or zwitterionic lipid membranes and can lead 
to pore formation.8,9  
Surfactant-like peptides (SLPs) are a group of peptides with promising applications as 
antimicrobials. Structurally, SLPs have a head group of a small sequence of charged residues 
and a longer hydrophobic tail which gives them good self-assembling properties.10–19  
Recently, the self-assembly of three SLPs, A3K, A6K and A9K, was examined and distinct 
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morphologies were observed for the three peptides.20  The antimicrobial properties were 
found to be dependent on the length of the hydrophobic chain, with A9K being most active 
against E. coli and S. aureus. Peptide A6K strongly disrupted the structure of anionic vesicle 
DPPG,20 used as a model system for bacterial cell membranes. Our group has studied the 
self-assembling properties and antimicrobial activities of several SLPs and bola amphiphiles 
containing one or two arginine groups, discussed in more detail in Chapter 2.  
Recently, Silva et al examined the self-assembly of peptides consisting of alternating RF 
motifs. The short oligopeptide [RF]4 was found to assemble into highly ordered amyloid-
like fibrils above a critical aggregation concentration.21  Further studies of [RF]n, where n is 
between 1 and 5, showed an increased structural order and cytotoxicity with increasing n.22 
In another example, Fojan et al. studied the self-assembly of RFFFR which was shown to 
self-assemble into fibres stabilised by π-stacking interactions, which further assembled into 
solid spheres. 23 
This chapter focuses on the self-assembly behaviour and antimicrobial activity of two SLPs 
(Scheme 3.1) with sequences RRRFFF (R3F3) and RRRRFFFF (R4F4). These peptides 
comprise a hydrophobic phenylalanine block and a block of cationic L-arginine residues. 
They were designed as novel arginine-rich SLPs containing aromatic hydrophobic blocks, 
incorporated to drive self-assembly via π-stacking interactions. The two peptides we 
investigate, R3F3 and R4F4, are architecturally different from these previously studied RF- 
containing peptides and surfactant-like peptides, as they contain symmetric charged and 
hydrophobic blocks. These can be considered oligomeric block co-polypeptides, although 
the blocks are much shorter than those studied by Deming et al,24,25 such as R60L20, which 
were prepared by ring-opening polymerization methods and showed cell penetrating 
properties. 
The self-assembly and conformation of R3F3 and R4F4 is examined, as well as interactions 
with bacterial membrane models DPPG and DPPE. DPPG (1,2-dipalmitoyl-sn-glycero-3-
phosphoglycerol) is anionic, whereas DPPE (1,2-dipalmyitoyl-sn-glycero-3-
phosphoethanolamine) is zwitterionic. Cationic peptides may have the ability to distinguish 
between human cell membranes, which mainly contain lipids based on phosphocholine (PC), 
as opposed to bacterial cell membranes, which contain significant quantities of PG 
(Phosphatidylglycerol) and PE (Phosphatidylethanolamines) lipids.26–29 Examining the 
interactions of the two peptides with these bacterial membrane models enables greater 
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understanding on the mechanisms by which these peptides interact with specific membrane 
constituents of bacteria. Typically, more PG lipids are found in Gram positive bacteria, 
whereas PE lipids are more abundant in Gram negative bacteria.30,31 Here, the interaction of 
the two designed peptides with model lipid (Scheme 3.1.) membranes are examined better 
understand antimicrobial activity.  Specifically, the interactions of the peptides with mixed 
liposomes comprising ratios PG:PE and 3:1, 1:1, 1:3 and 1:0, in line with a previous study, 
was examined.29 The combination of DPPG/DPPE was chosen due to the accessible melting 
temperature Tm values, which are well separated for the two lipids, being reported to be 41
oC 
and 63oC respectively.32  
 
Scheme 3.1. Structures of peptides RRRFFF (R3F3), RRRRFFFF (R4F4) and the two lipids 
used in model membranes, 1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol (DPPG) and 1,2-
dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE). 




Finally the antibacterial activity of these peptides against five strains of human pathogenic 
bacteria, E.coli, S. aureus, and P.aeruginosa and S.typhi was measured. Further to this, plant 
microbes from the pseudomonas family were screened with the peptides. Since minimal 
toxicity to human cells is an essential requirement of an effective peptide therapeutic, the 






The critical aggregation concentration (cac) for both R3F3 and R4F4 was determined using 8-
anilinonaphthalene-1-sulfonic acid (ANS) which is used because the fluorescence changes 
within a hydrophobic environment. The cac values for R3F3 (Figure 3.1a) and R4F4 (Figure 
3.2a) were found to be (0.32± 0.02) wt% and (0.22 ± 0.03) wt% respectively. There is a 
significant difference in cac values between the two peptides, with the cac being lower for 
R4F4 than for R3F3. This suggests that the cac depends not only on the balance of 
hydrophobic and charged residues but is also influenced by the number of charged residues. 
To further assess the critical aggregation concentration, thioflavin T (ThT) was used. ThT is 
a fluorescent probe used to detect amyloid fibril formation.33,34 Interestingly, only R3F3 was 
found to bind significantly to ThT indicating that it forms amyloid like fibres (Figure 3.1c). 
As shown in Figure 3.1a, the cac of R3F3 determined by ThT was found to be (0.27± 0.03) 
wt%, which is consistent within uncertainty with that detected by ANS.35 This suggests that 
hydrophobic collapse occurs at the same concentration as the formation of amyloid 
structures for R3F3.  
To examine the secondary structure of R3F3 and R4F4, circular dichroism (CD) and Fourier 
transform infrared spectroscopy (FTIR) were conducted at concentrations above the cac. 
The CD spectrum (Figure 3.1b and 3.2b) is dominated by electronic transitions associated 
with the phenylalanine side chain. The main feature for all spectra is the peak at 220 nm 
which is due to phenylalanine π-stacking electronic transitions.36 The molar ellipticity 
increases when R3F3 and R4F4 are adjusted to pH 7. This indicates an increase in content of 
chiral secondary structure. FTIR (figure 3.1c and 3.2c) was used to further probe secondary 
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structure. The data shows a peak at 1673 cm-1 which can be assigned to vibrations of the 
TFA counter-ions bound to the peptide.37,38 The peak at 1645 cm-1, characteristic of a 
disordered secondary structure, is present only at native pH for both peptides. All spectra 
show a peak at 1608 cm-1 which is characteristic of arginine side chains.27,39–42 The peak at 
1588 cm-1 can be assigned to the arginine side chain guanidinium group vibrating 
symmetrically. The 1456 cm-1 peak can be ascribed to -CH2 bond vibrations.
43 Considering 
the data from both CD and FTIR spectroscopy, we conclude that at native pH R3F3 and R4F4 
have a disordered secondary structure.  
Transmission Electron Microscopy was used to image the self-assembled structure of R3F3 
and R4F4 (Figure 3.1e,f and 3.2e,f). Self-assembled structures were observed for both 
peptides, with R3F3 forming a population of twisted nanotapes that are several microns long, 
with a width between 50 nm-120 nm. The presence of nanotapes agrees with the binding of 
fluorescent probe ThT. R4F4 was found to assemble into a population of large nanosheets of 
differing sizes with widths between 342 nm to 1.7 μM. These non-amyloid structures are not 
expected to bind ThT, consistent with the fluorescence binding assays.  
To further probe the self-assembled structures, SAXS measurements were performed 
(Figure 3.1d and 3.2d) in dilute solutions order to provide form factors. These are analysed 
to provide information on the shape and dimensions of self-assembled nanostructures. Data 
from peptide solutions at pH 7 show initial intensity decays with q-2 which indicates planar 
structures. The data was fitted to a bilayer Gaussian form factor model (previously used by 
our group to describe the density profile across a bilayer)44,45 and a generalised Gaussian coil 
form factor to account for any monomers remaining in the solution using the software 
SASfit.46 The parameters for these fits are presented in Table 3.1 and 3.2.  This model fits 
the data very well. An estimate of the length of the peptide (assuming an antiparallel β-sheet 
structure) is the number of residues multiplied by 3.4 Å. The approximate lengths of R3F3 
and R4F4 are 20 Å and 27 Å respectively. The bilayer thickness obtained from the SAXS fit 
corresponds approximately to these values implying that the nanosheets and twisted tapes 
are one molecule thick. This suggests an antiparallel arrangement leading to arginine-coated 
nanotapes/nanosheets (a nanosheet structure with this configuration was proposed for 
A6R).
17  From these measurements, it can be seen that the peptides primarily remain as 
monomers in solution at pH 2 and pH 7 with a population of bilayer structures, as seen by 
TEM and SAXS. Adjustment to pH 7 increases the population of these structures. 





Figure 3.1. Conformation and self-assembly of R3F3 a) cac fluorescence assay using ANS 
and ThT at native pH (pH 2) b) CD spectra at pH values indicated c) FTIR spectra at pH 
values indicated d) SAXS data with fitted form factors in red, and e)f) TEM images of 1 wt% 
R3F3 
 





 Figure 3.2. Conformation and self-assembly of R4F4 a) cac fluorescence assay using ANS 
at native pH (pH 2) b) CD spectra at pH values indicated c) FTIR spectra at pH values 
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Table 3.1. Parameters from SAXS fits for R4F4 and R3F3 at pH 7. Fits were performed 
using SASfit 
 
NA and NB are relative weights of the bilayer Gaussian and generalized Gaussian coil terms 
summed in the model form factor fits. For a Bilayer Gaussian form factor,47 t = bilayer 
thickness, Δt = associated polydispersity.   σout = Scattering density of outer Gaussians.  bout 
= width of outer Gaussians.  σcore = scattering density of inner Gaussian.  bcore = width of 
inner Gaussians, D = diameter of disc (fixed parameter) 
Generalized Gaussian coil model, the radius of gyration of the chain is defined as 𝑹𝒈
𝟐 =
𝒂𝒏𝟐𝒗/(𝟐v + 𝟏)(𝟐v + 𝟐) where a is the segment length, n is the chain length and v is the 


















 Bilayer Gaussian 
NA 1.31x10-3 1.69x10-4 1.13x10-2 2.07x10-3 5.46x10-3 1.34x10-2 
T /  Å 21.9 44.1 20.0 27.3 25.0 25.1 
Δt /  Å 10.3 13.3 13.7 10.7 13.5 13.7 
σout 3.54 7.36 6.61 3.48 3.47 4.88 
bout 2.41x10-6 2.60x10-6 1.87x10-6 2.56x10-6 2.32x10-6 1.94x10-6 
σcore 9.86 6.79 4.94 9.91 5.86 5.45 
bcore -2.12x10-6 -2.80x10-6 -3.68x10-6 -1.93x10-6 -2.36x10-6 -2.47x10-6 
D /  Å 1000 1000 1000 1000 1000 1000 
 Generalised Gaussian Coil 
NB 0.03 0.03 0.30 0.03 0.03 0.45 
Rg /  Å 5.09 5.72 6.77 7.66 7.78 6.11 
Ν 0.52 0.31 0.52 0.59 0.43 0.39 
I(0) 0.07 0.22 0.04 0.13 0.27 0.02 
 Background 
BG 2.26x10-4 1.63x10-4 1.89x10-3 3.12x10-4 1.11x10-3 4.12x10-4 
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Generalized Gaussian coil model, the radius of gyration of the chain is defined as 𝑹𝒈
𝟐 =
𝒂𝒏𝟐𝒗/(𝟐v + 𝟏)(𝟐v + 𝟐) where a is the segment length, n is the chain length and v is the 
Flory exponent. I0 = forward scattering 
 
3.2.2 Cytocompatibility  
 
Before investigating the potential antimicrobial activity of R3F3 and R4F4, it is good practice 
to assay cytocompatibility, to determine the concentration range of peptides over which 
viability of human cells is retained. Therefore, cytotoxicity assessments were performed 
using the MTT assay on 161BR human skin fibroblasts (Figure 3.3). The IC50 of R4F4 was 
calculated to be 2.15 mM (or 2.64 mg/ml or 0.264 wt%). Interestingly, this is in the error 
range of the cac value determined for R4F4 (Figure 3.2a) implying that the self-assembly into 
nanosheet structures correlates to the onset of increased toxicity. The IC50 of R4F4  is higher 
than previously studied [RF]4 peptide which has an IC50 value of less than 1 mM, meaning 
that R4F4  is less cytotoxic. Clearly, sequence has a significant effect on the cytotoxicity of 
these compositionally identical peptides. The IC50 of R3F3 was found to be 4.31 mM, the 
maximum concentration used in the concentration series and above the cac of this peptide. 
The finding that an increased number of residues leads to increased toxicity agrees with 
studies conducted with [RF] repeating peptides,22 although R4F4 is significantly less 
cytotoxic than its compositional homologue RFRFRFRF.  
 1 wt% R3F3 1 wt% R4F4 
Generalised Gaussian Coil 
NB 0.48 0.30 
Rg /  Å 6.99 9.35 
Ν 0.28 0.46 
I(0) 0.005 0.004 
Background 
BG 3.36x10-4 2.14x10-4 




 Figure 3.3. Cytotoxicity profiles from MTT assays. a) R3F3 and b) R4F4. IC50 values 
(vertical blue dashed lines) were calculated in Origin using sigmoidal fits to the viability 
data (dashed red lines shown). Where, n=3, error bars = standard deviation,   
 
 3.2.3 Initial Antimicrobial screening   
 
Having determined conditions where viability of human fibroblasts in the presence of these 
peptides is acceptable, we then studied their antimicrobial activity in planktonic form. 
Compounds that are active against bacteria have either inhibitory or bacteriocidal properties. 
Inhibitory compounds are less likely to cause bacterial resistance but are more vulnerable to 
the innate immune system and antibiotics. Bacteriocidal compounds are useful for fighting 
bacterial infections, but can increase the resistance of bacteria. Both activities are valuable 
for different purposes.48  To examine whether R3F3 and R4F4 are bacteriocidal, the two 
peptides were inoculated with several strains of bacteria for 24 hours.  Figure 3.4 shows the 
antimicrobial activity of these peptides against Gram positive S. aureus and three Gram-
negative bacteria, one strain of P. aeruginosa (PA01) and one of E. coli (K12), and S,typhi. 
A concentration of 0.05 wt% was selected based upon the viability of human skin fibroblasts 
at this concentration which was shown to be 77% and 81% for R3F3 and R4F4 respectively 
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(Figure 3.3). The data indicate that R3F3 has no effect on E.coli, S.typhi and S.aureus. The 
peptide R4F4 causes a small, but not statistically significant reduction of one order of 
magnitude in colony forming units/millilitre (CFU/mL) of E. coli (K12) after 24 h. This 
effect however, is not seen for the clinically relevant E. coli (0157) strain (Figure 3.4b). 
Neither peptide showed  activity against S.typhi or S. aureus, the latter in contrast to 
previously studied arginine-rich peptides,27,49 although this could be due to the lower 
concentrations used. Interestingly, both peptides showed a strong antimicrobial effect 
against P. aeruginosa (Figure 3.4e), with a 3.2 log reduction in CFU/mL upon addition of 
R3F3, and complete death of the strain after 2 hours on exposure to 0.05 wt% R4F4 (Figure 
3.4e). To investigate this further, a series of concentrations of R3F3 (Figure 3.4g) and R4F4 
(Figure 3.4f) were examined to locate any MIC. The data indicate that R3F3 does not have 
an MIC below 0.1 wt% and R4F4 has a MIC value between 0.045 wt% and 0.05 wt% for P. 
aeruginosa. 
To further understand the specificity of these peptides against Pseudomonas bacteria, the 
antibacterial activity of the peptides against four other species was examined (Figure 7). 
Since R4F4 is particularly active against Pseudomonas species, data were obtained for an 
additional three species. Data for P. putida, P. agarici and P. fluorescens are shown in Figure 
3.5 which shows that all bacteria displayed an initial die off when exposed to R4F4. However, 
interestingly P. fluorescens has some recovery in bacterial colony counts after 24 hours, 
which may be due to the bacteria being able to metabolise the peptide, however further 
studies would be needed to understand this effect. There is also a significant (log 2.6) 
reduction in CFU/mL of plant pathogen P. syringae when exposed to R3F3 and a complete 
bacterial death when exposed to R4F4, similar to the effects seen with P. aeruginosa after 2 
hours of exposure. The MIC concentration is ~0.001 wt% R4F4 for P. syringae, which is 
approximately 50x lower than that for P. aeruginosa. Our data suggests that R4F4 is 
selectively active against specific Pseudomonas species. 
 




Figure 3.4.  Activity of R3F3 and R4F4 against several strains of human bacterial pathogens. 
Where, n=3, error bars = standard deviation,  *= p<0.05, **=p<0.01 and ***= p<0.001. 




Figure 3.5. Survival assays of R4F4 and R3F3 against other species of Pseudomonas. Where, 
n=3, error bars = standard deviation,  *= p<0.05, **=p<0.01 and ***= p<0.001.  
 
3.2.4 Interaction with Lipid Vesicles  
 
To understand the antimicrobial activity of R3F3 and R4F4 discussed in the previous section, 
the interaction between the peptides and the model lipid membrane models composed of  
DPPG and DPPE mixtures was examined. The lipids DPPG and DPPE are commonly used 
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as a bacterial membrane models. 20,29 SAXS was used to probe structure changes resulting 
from interaction of peptides with lipid membranes. We examined the ratios 1:0, 1:3, 1:1 and 
3:1 of DPPG/DPPE. In accordance with the phase diagrams recorded previously,29,50 the 
samples with mixtures 1:0, 1:1 and 3:1 DPPG/DPPE are expected to be in the disordered 
liquid crystal phase at 20 oC, Lα whereas 1:3 DPPG/DPPE is expected to be in the Lα/ Lβ 
coexistence region at 20 oC (where Lβ is the ordered gel phase). PE alone is not studied as 
the shape of the lipid means it forms inverted micelles with hexagonal symmetry.27 The 1:3 
DPPG/DPPE has similar PE content to the amount found in the P.aeruginosa, whereas 
DPPG alone more resembles the S.aureus membrane which has no PE.  
 Figure 3.6 shows SAXS intensity profiles obtained with ratios 1:0, 1:3, 1:1 and 3:1 of 
DPPG/DPPE at 0.5 wt% with and without R3F3 and R4F4. For all ratios, the lipids alone 
displayed a broad scattering pattern with a peak centred at q ~ 0.1 Å-1, which is associated 
with unilamellar vesicles.26 Figure 3.6 also contains the SAXS data for samples containing 
the peptides. A concentration of 0.08 wt% peptide was used (data being shown for an 
additional concentration of 0.25 wt% for R4F4 with DPPG), since addition of 0.25 wt% 
peptide caused precipitation in many samples, as seen with previously studied peptides.26,27  
In the SAXS data for 1:0 DPPG:DPPE, 0.08 wt% R3F3, there is a small Bragg peak with a 
corresponding domain spacing d= 45.9 Å and a distortion of the broad peak shape. This 
indicates some correlation between bilayers, i.e. restructuring of a proportion of vesicles into 
multilamellar vesicles. Adding 0.08 wt% R4F4 to DPPG leads to a change in the shape of the 
SAXS profile (broadening of the form factor extrema), and when the concentration of R4F4 
is increased 0.25 wt%, two Bragg peaks with d= 43.4 Å and 14.6 Å are present. These peaks 
correspond to the first and third order reflections of a multi-lamellar structure. This shows 
restructuring of most liposomes into multilamellar vesicles in the presence of R4F4 indicating 
peptide-induced lipid restructuring. R3F3 was not examined at this concentration due to 
precipitation of the sample.   
For the lipid mixture 3:1 DPPG:DPPE, no Bragg peak was observed in the SAXS profiles 
in the presence of either peptide. Indeed, the form factor resembles that for the corresponding 
mixed liposome, with again only some broadening of form factor features (and a shift to 
higher q), particularly in the presence of R4F4. For R3F3 combined with 1:1 DPPG:DPPE, 
there is again a broadening in the features in the SAXS curve. However, for R4F4, two Bragg 
peaks are noted with corresponding spacings d = 96.0 Å and d = 68.2 Å which is 
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approximately a 1 : √2 ratio, suggesting cubic symmetry,51 although the presence of two 




Figure 3.6 SAXS profiles for different ratios of DPPG:DPPE in the presence of R3F3 or R4F4 
at the concentrations indicated. 
 
Considering the SAXS data for the samples containing the most DPPE (1:3 DPPG:DPPE), 
the liposome form factor is lost upon addition of either peptide, thus being replaced with 
form factor profiles with a similar shape to those for the peptides alone (Fig.3.1d, Fig.3.2d), 
especially for R4F4. Though there is a Bragg peak for R3F3 showing some multilamellar 
vesicles are still present. Cryo-TEM images of samples prepared with lipids at this ratio 
show that R3F3 causes a change in morphology of liposomes, seen by the appearance of 
rougher looking surfaces (Figure 3.7d,e). Cryo-TEM images of samples with this lipid 
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composition in the presence of R4F4 show that the peptide induces complete disruption of 
liposome formation, in agreement with conclusions from the SAXS data (Figure 3.7d,f). The 
Cryo-TEM image for vesicles of DPPG (Figure 3.7a), shows that vesicles are generally 
larger when exposed to R3F3 (Figure 3.7b) with some fibres (presumably peptide) also 
present. For mixtures of DPPG with R4F4 (Figure 3.7c) the vesicles are more swollen, and 
moreover are much more angular in shape and have a multilamellar structure.  This is 








Figure 3.7. Cryo-TEM images of vesicles with and without peptide. a) 0.5 wt% DPPG/DPPE 
1:3 b) 0.5 wt% DPPG/DPPE 1:3 + 0.08 wt% R3F3 c) 0.5 wt% DPPG/DPPE 1:3 + 0.08 wt% 
R4F4 d) 0.5 wt% DPPG e) 0.5 wt% DPPG + 0.08 wt% R3F3 f) 0.5 wt% DPPG + 0.08 wt% 
R4F4. Cryo-TEM captured by Janne Rukolanien, University of Aalto, Finland.  
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Circular dichroism spectroscopy is often also used to examine the interactions of lipid 
membranes with peptides.26,27,50 In some instances, peptide secondary structure is shown to 
be influenced in the presence of lipid membranes, inducing the formation of a more ordered 
secondary structure. This gives information about whether the peptide interacts with the lipid 
as a monomer or as a self-assembled structure. Figure 3.8 shows the circular dichroism 
spectra for the mixtures of the two peptides with different composition lipid mixtures. Due 
to the presence of a broad maximum around 220 nm in the spectra, it is concluded that the 
peptides interact with the lipids in a monomeric form.  
 
Figure 3.8 CD data for a) R3F3 and b) R4F4 with DPPG (concentrations indicated).  
 
Differential scanning calorimetry (DSC) is a valuable technique to detect phase transitions 
in lipid systems and has also been used to probe the interactions of peptides with lipid 
membranes. In particular, to investigate phase separation in lipid membranes induced by 
antimicrobial peptides.28,29,52  We examined the interaction of the two peptides with DPPG 
using this technique. The thermograms are shown in Figure 3.9 and the determined transition 
temperatures and enthalpies are listed in Table 3.1.  Lipid DPPG alone shows a pre-transition 
to the Pβ phase at 37.2 
oC and a main chain melting temperature to the Lα phase at 40.4
oC in 
the second heating scan. This is in agreement with published data.28,29 First heat scans of 
peptide and DPPG differ from subsequent scans due to non-equilibrium effects. Figure 3.9 
shows the DSC thermograms from the second heating scans of DPPG with 0.08 wt% R3F3 
and R4F4. The data show that upon addition of R3F3 a shouldered peak is observed, with a 
main transition at 38 oC and a shoulder at 40 oC. On the other hand, R4F4 shows a double 
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peak with maxima at 37 oC and at 44 oC. The presence of double peaks/shoulder peaks 
suggests phase separation of the peptide-rich and peptide-depleted regions in the sample. If 
there is electrostatic binding to the PG head group, an increase in Tm would be expected.
28 
However, if the peptide is interacting with the hydrophobic region of the membranes, this 
can lead to perturbation of the lipid chain packing and a reduction in transition temperature.28 
Therefore, the data suggests that R3F3 interacts with the hydrophobic region of DPPG due to 
the decrease in Tm of 1.5 
oC. In contrast, R4F4 causes enhanced coexistence of Lα and Pβ 
phases, possibly indicating the formation of phase separated domains (rafts).  
 
Figure 3.9 Differential scanning calorimetry thermograms of DPPG with and without 
peptides. Scans displayed are second heat scans.  
 
Table 3.3. Transition peaks, energy of transition and HWHM calculated from Figure 3.9. 
DSC data, of 0.5 wt% DPPG with and without peptide.  
 
Sample T1 / 
oC T2   / 
oC ΔH / kJ mol
-1 HWHM 
0.5 wt% DPPG 37.2 40.4 29.8 28.0 
0.5 wt% DPPG, 0.08 wt% R3F3 38.5 40.9 37.8 48.5 
0.5 wt% DPPG, 0.08 wt% R4F4 37.8 44.4 25.3 15.1 
 
T1 = Transition temperature 1, T2 = Transition temperature 2, ΔH = change in enthalpy across 
the peaks and HWHM = half width half maximum of the overall peak 
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In the mixture of 1:3 DPPG/DPPE with R4F4, there is a small increase in the transition 
temperature compared with lipid alone by 2.17 oC. The transition temperature of 62.94 oC is 
similar to the transition temperature of DPPE which is 63 oC, showing evidence of DPPE-
rich regions, which shows de-mixing may be occurring. There is also a decrease in the ΔH, 
showing that the peptide is destabilising the Lβ phase, enabling transition to the liquid phase 
with a lower energy requirement.  
 
 
Figure 3.10. DSC thermograms for 1:3 DPPG/DPPE with R4F4. 
 
Table 3.2. Transition peaks, energy of transition and HWHM calculated from Figure 3.10. 
DSC data, of 0.5 wt% 1:3 DPPG/DPPE with and without peptide. 
  
Sample T1 / 
oC ΔH / kJ mol-1 HWHM 
0.5 wt% 1:3 DPPG/DPPE 60.77 37.5 52.03 
0.5 wt% 1:3 DPPG, 0.08 wt% 
R4F4 
62.94 34.1 25 
 
T1 = Transition temperature 1, T2 = Transition temperature 2, ΔH = change in enthalpy across 
the peaks and HWHM = half width half maximum of the overall peak 




3.2.5 Biofilm disruption and interactions with ci-d-GMP 
 
P. aeruginosa has the ability to form biofilms, which is a major problem in infections, in 
particular those of the respiratory tract. An important regulator of biofilm formation in P. 
aeruginosa is the second messenger signalling molecule cyclic di-GMP (c-di-GMP).53–55 
High levels of c-di-GMP in P. aeruginosa are associated with the formation of biofilms, 
which leads to virulence and persistence of bacteria in hosts.54,56 Compounds that can reduce 
and prevent biofilm formation by targeting c-di-GMP are therefore attracting attention. We 
first examined whether R3F3 and R4F4 inhibit biofilm growth formation and then examined 
interactions of these peptides with c-di-GMP. Crystal violet was used to assay biofilm 
formation, this cationic dye binding to anionic polysaccharides in the biofilm.57,58 The assay 
shows that R4F4 causes a reduction of biofilm formation in two strains of P. aeruginosa, 
PA01 and ATCC-12600. At a concentration 0.05 wt% of R3F3, we observe 84% survivability 
of the PA01 biofilm (Figure 3.11a) whereas R4F4 significantly reduces biofilm viability to 
37% of P. aeruginosa strain PA01 and 33% for strain ATCC-12600 (Figure 3.11b)  
A series of biophysical techniques to observe the interaction of both peptides with ci-d-GMP 
were used, which included SAXS, CD and TEM. At concentrations of 100 μM or more, c-
di-GMP exists in equilibrium with its homodimer.48 Interestingly, the CD spectra of R4F4 
and R3F3 show that c-di-GMP causes a strong increase in molar ellipticity (Figure 3.12a) at 
a 255 nm maximum for R3F3 and a slight red shifted maximum of R4F4 of 259 nm. There is 
also an increase in negative ellipticity at the minimum at 281 nm for R3F3 and 284 nm for 
R4F4, which corresponds to the stacking of the four guanine rings present in dimers of c-di-
GMP. This shows that the addition of the peptides stabilises the homodimer.48 The red-
shifted peak positions for R4F4 are evidence of altered π-stacking in the complex between c-
di-GMP and R4F4, which is not observed for the c-di-GMP complex with R3F3. 
TEM images for c-di-GMP with R3F3 show the formation of nanosheets (Figure 3.12c). In 
contrast, the TEM image for c-di-GMP with R4F4 shows the formation of a fibrous network 
structure (Figure 3.12e). Differences in structure also change the slope of the SAXS profiles 
in the low q region (Figure 12.b), I ~ q-n. The slope of the low q intensity for c-di-GMP alone 
is n = 0.8 consistent with locally extended structures. Upon addition of R3F3, the slope 
changes to n = 1.8 which suggests the formation of layered structure, such as bilayers as seen 
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in the TEM images. The peptide alone shows n = 3.5. For R4F4 (Figure 3.12d), the slope 
changes to n = 4.2, suggesting the presence of compact globular structures.   
 
 
Figure 3.11. Biofilm viability of P.aeruginosa determined through crystal violet assays 
when exposed to a) R3F3 and b) R4F4. where error bars = standard deviation, n= 3.  




Figure 3.12. Interactions of R3F3 and R4F4 with ci-d-GMP, a) Circular Dichroism, b) and 
d) are SAXS profiles c) TEM of R3F3 with ci-d-GMP and e) TEM of R4F4 with ci-d-GMP.  
 
 





 Figure 3.13. Indirect measurements of ci-d-GMP a) Congo red assay measuring amount of 
polysaccharide produced by bacteria, at the peptide concentrations indicated and b) Congo 
red staining vials showing flocculation of the bacteria to the bottom of the tube as opposed 
to the sides where there is growth. Where, n=3, error bars = standard deviation, *= p<0.05, 
**=p<0.01 and ***= p<0.001. 
 
Congo red staining can be used to quantify the amount of polysaccharides produced by 
bacteria.59  Congo red binds to fibrous material, and bacteria produce polysaccharides in 
response to either stress or high levels of c-di-GMP, which lead to biofilm formation. This 
has been used as an indirect measurement of c-di-GMP levels since these are correlated to 
polysaccharide expression.59  Congo red binds to polysaccharides resulting in a decreased 
optical density (OD) when polysaccharide matrices are formed by the bacteria.59 When 
adding R4F4 to P. aeruginosa, we observe a decrease in optical density of the supernatant 
(Figure 3.13b). This indicates enhanced biofilm growth. However, it was observed that from 
0.0625 mg/mL to 0.25 mg/mL there was a precipitate at the bottom of the tube, and some 
film growth occurred at the interface of the tube between the air and the solution. P. 
aeruginosa is a motile organism, therefore is expected to form a biofilm at the interface.60 
At 0.5 mg/mL (0.05 wt%), a concentration that is the above the MIC in water, and for which 
37% biofilm viability is observed (Figure 3.12b), there is no biomass on the side of the tube, 
but a deposit on the bottom of the tube. P. aeruginosa has a mucoidal phenotype, which 
means it can form a polysaccharide capsule around itself in response to stressed conditions.61 
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Therefore we conclude that the reduction in the OD is due to stressed bacteria producing 
polysaccharides as part of the stress response.  
3.3 Conclusions  
 
The two SLP peptides R3F3 and R4F4 both self-assemble above a critical aggregation 
concentration obtained by fluorescence probe assays. Overall, their propensity for 
aggregation is weak, displayed by the higher cac values obtained compared to many other 
SLP’s, SAXS intensity profiles above the cac which suggest significant amounts of 
monomer still present, and CD and FTIR analysis of secondary structure which is not well 
defined.  
Moreover, the “blocky” nature of R4F4 and R3F3 leads to changes in morphology of self-
assembly compared to their homologues. In comparison to previously studied alternate 
hydrophilic-hydrophobic peptides, [RF]3 forming globules, compared to R3F3 forming 
twisted nanotapes, and [RF]4 forming nanofibers, compared to R4F4 which forms nanosheets.  
 
 
Scheme 3.2. Overall Self-assembly of a) R3F3 and b) R4F4   




Both R3F3 and R4F4 have strong antimicrobial activity against the pseudomonas species, 
within the range of human cell viability.  The latter is particularly active against 
pseudomonas species, including, P.aeruginosa in the planktonic form, as well as plant 
pathogen P.syringae.  Activity in this planktonic form may be in part due to the interactions 
with the bacterial lipid membrane, which in pseudomonas contains ca. 21 % PG and 60% 
PE. The ratio of 1:3 DPPG/DPPE best represents this composition, which when measured 
by SAXS and cryo-TEM with peptide mixtures shows disruption of the membranes.   
Further to this, the activity of R3F3 and R4F4 against P.aeruginosa in biofilms was examined. 
The former displayed small activity against biofilm formation, whereas for the latter there 
was a significant reduction in biofilm formation at 0.05 wt% to 37%, although not complete 
death which was observed in the planktonic form. Since c-di-GMP is known to be an 
important signalling molecule involved in pseudomonas biofilm formation, the interactions 
between the two peptides and ci-d-GMP was examined. CD confirmed that there was an 
interaction with the peptides which stabilised the homodimer form of c-di-GMP. In the case 
of R4F4, modification of the π-stacking interactions was observed. This points to a potential 
mechanism for the inhibition of biofilm formation. The  guanidinium group in the arginine 
is known to bind c-di-GMP through H-bonding and electrostatic interactions.48,62  To further 
examine this, Congo red staining of polysaccharides, which were overexpressed by bacteria 
exposed to the antimicrobial activity of R4F4. 
 
3.4 Experimental Section  
 
3.4.1 Materials  
 
 R3F3 and R4F4 were synthesised by Peptide Synthetics (Fareham, UK). Purity was 
determined by HPLC, and for R3F3 was found to be 97.83%, the molar mass from ESI-MS 
was Mw = 928.089 g mol
-1. The purity of R4F4 was 97.98%, and the molar mass from ESI-
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3.4.2 Sample Preparation 
 
Samples of R3F3 and R4F4 were dissolved in water. The native pH was found to be 2.22 and 
2.28 respectively. Adjustment of pH to pH 7.0 was done using 0.5 M NaOH.  
 
3.4.3 Fluorescence assays 
 
The critical aggregation concentrations (cac) of R3F3 and R4F4 were determined using 
fluorescence spectroscopy. Fluorescence spectra were recorded with a Varian Cary Eclipse 
fluorescence spectrometer with samples in 4 mm inner width quartz cuvettes. ANS (8-
anilinonaphthalene-1-sulfonic acid) was used to probe the aggregation as a probe that is 
sensitive to hydrophobic environments making it suitable to locate the cac.44,63–66 ANS 
assays were performed using a 66.8 µM ANS solution to solubilise R3F3 and R4F4. 
Fluorescence spectra were recorded between 400-650 nm (λex = 356nm). Additionally, ThT 
was used to determine the cac of R3F3, as it is sensitive to the formation of amyloid fibrils 
at the cac.33,34,65,67,68 ThT assays were performed using 5.0 x 10-3 wt% solution to solubilise 
the peptide. Spectra were recorded between 460-600 nm (λex = 440 nm). 
 
3.4.4 Circular Dichroism (CD) 
 
CD spectra were recorded using a Chirascan spectropolarimeter (Applied Photophysics, UK) 
in the wavelength range 180 – 260 nm. Samples 1 wt% of R3F3 and R4F4 in pure H2O at 
native pH and pH 7 were pipetted into a quartz plate cell with 0.1 mm path length. Data with 
absorbance less than 2 only are reported. Measurements were recorded with a 0.5 nm 
bandwidth, 1 mm step and 1 second collection time per point. The CD signal for the 
background solution was subtracted from the CD signal of the sample, and molar ellipticity 
was calculated.  
 
3.4.5 Fourier Transform Infrared Spectroscopy (FTIR) 
 
Spectra were recorded using a Thermo Scientific Nicolet iS5 equipped with a DTGS 
detector, with a Specac Pearl liquid cell (sample contained between fixed CaF2 plates). 
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Aliquots 80 µl of 1 wt% R3F3 and R4F4 at native and pH 12 dissolved in D2O were prepared 
and added into the liquid cell. Spectra were scanned 128 times over the range 900 − 4000 
cm-1  
 
3.4.6 Transmission Electron Microscopy (TEM) 
 
TEM imaging was performed using a JEOL 2100 Plus TEM microscope operated at 200 kV. 
Droplets of sample were placed on Cu grids coated with a carbon film (Agar Scientific, UK), 
stained with uranyl acetate (0.5 wt %) (Sigma-Aldrich, UK) and dried. Specimens were then 




Cryo-TEM was kindly done by Jani Seitsonen, Aalto University, Finland. Vitrified 
specimens were prepared using an automated FEI Vitrobot device using Quantifoil 3.5/1 
holey carbon copper grids with a hole size of 3.5 μm. Prior to use, grids were plasma cleaned 
using a Gatan Solarus 9500 plasma cleaner and then transferred into the environmental 
chamber of a FEI Vitrobot at room temperature and 100% humidity. Thereafter sample 
solution was applied onto the grid, and it was blotted twice for 5 s and then vitrified in a 1/1 
mixture of liquid ethane and propane at a temperature of −180 °C. The grids with vitrified 
sample solution were maintained at liquid nitrogen temperature and then cryo-transferred to 
the microscope. Imaging was carried out using a field emission cryo-electron microscope 
(JEOL JEM-3200FSC) operating at 200 kV. Images were taken in bright field mode and 
using zero loss energy filtering (Ω type) with a slit width of 20 eV. Micrographs were 
recorded using a Gatan Ultrascan 4000 CCD camera. Specimen temperature was maintained 
at −187 °C during the imaging.  
 
3.4.8 Liposome preparation  
 
Liposomes were prepared using the thin-layer hydration method. Weighed quantities of 
DPPG and DPPE were prepared by dissolution in chloroform, and thin lipid films were 
prepared by drying the lipids under a stream of nitrogen gas. Films were then placed under 
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vacuum for 2 hours to remove any remaining organic solvent. After this, lipids were 
resuspended in water to a final concentration of 0.5 wt% lipid, heated above their Tm and 
vortexed for 5 minutes. Liposome mixtures were then left to equilibrate before experiments.  
DPPG/DPPE vesicles were prepared using this method at different molar ratios of 1:3, 1:1, 
3:1 and 1:0 DPPG:DPPE. To obtain peptide/ lipid mixtures, resuspended lipids were added 
to peptide powders to make up a 0.08 wt% concentration of peptide, heated above the Tm 
and vortexed for 5 minutes, then left to equilibrate.  Dynamic light scattering (DLS) was 
measured to check the size of the liposomes using a Zetasizer instrument (data not shown). 
 
3.4.9 Small-angle X-ray scattering  
 
Solution small-angle X-ray scattering (SAXS) data was collected on the bioSAXS beamline 
B21, at Diamond Light Source, Harwell, United Kingdom and beamline ID02 of the 
European Synchrotron Radiation Facility (ESRF), Grenoble France. On beamline B21, 
samples of 1 wt% R3F3 and 1 wt% R4F4 were loaded into PCR tubes in an automated sample 
changer. The samples were then delivered into a temperature-controlled quartz capillary and 
exposed for 1s, acquiring 30 frames at 20 oC. Data was collected using a Pilatus Dectris 2M 
detector with a 3.9 m sample-detector distance and X-ray wavelength λ = 1.0 Å. Background 
was manually subtracted using ScÅtter. Form factor modelling was done using SASfit.  
At ID02, samples were loaded into a glass capillary (internal radius = 2 mm) using a syringe. 
The beamline operated with an X-ray wavelength λ = 1.0 Å. 2D data was collected using a 
Rayonix MX170 detector, with a 1.474 m sample-detector distance. 
 
3.4.10 Differential Scanning Calorimetry  
 
Differential scanning calorimetry measurements were carried out using a nanoDSC, DSC 
TA-Q200 instrument. Aliquots 600 μL of lipid mixtures at 0.5 wt% with and without 0.08 
wt% peptide were degassed for 10 minutes before being 600 μL pipetted into the DSC. Data 
were acquired from 20 oC to 60 oC. The scan rate was 1 oC per minute at a pressure of 3 bar. 
Solvent background, Enthalpy (ΔH) and specific heat capacity was calculated in 
NanoAnalyze.  
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3.4.11 Cell Viability assays  
 
The cytotoxicity of both R3F3 and R4F4 was examined. In vitro cell culture was conducted 
using 161Br (European Collection of Authenticated Cell Cultures, ECACC) cells, a human 
skin fibroblast cell line. Cells were cultured in EMEM (Eagle’s minimum essential medium), 
with 2 mM glutamine, enriched with 15% fetal bovine serum (FBS) and 1% non-essential 
amino acids (NEAA). Cells were maintained in a humidified atmosphere of 37 oC, 5% CO2.  
Potential cytotoxicity effects were examined using the MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) assay. The peptides were dissolved in complete media. 
Cells were seeded into a 96-well plate at 4x104 cells/mL and allowed to adhere for 24 hours 
in 100 µL complete medium. After this, 100 µL of either complete media and/or peptide 
solution was added, to give either control solution, or solutions of peptide between the 
concentrations of 
 0.0625 mg/mL to 4 mg/mL.   
Cells were incubated for 67 hours. After this, 20 µL MTT (5 mg/ mL, in PBS) was added to 
each well plate and allowed to incubate for 5 hours. After a further 5 hours (72 hours total) 
the solution was removed from the wells and replaced with 100 µL DMSO per well, which 
dissolves the formazan crystals. Plates were incubated for 30 minutes, and then analysed 
using a UV microplate reader (λ=570 nm). Results are reported as a percentage cell viability 
compared to control (untreated) values, and fitted to a sigmoidal function using Origin Lab 
as a guide to the eye. 
 
3.4.12 Antimicrobial Studies   
 
The antimicrobial assays were performed with three types of bacteria which cause disease 
in humans, two being Gram-negative Escherichia coli (K12),69 and Pseudomonas 
aeruginosa  (PA01) ,70 and one being Gram-positive Staphylococcus aureus (8325-4).71 
Plant bacterial strains P.syringae, P.putida, P.agarici and P.fluorescens were also used to 
examine specificity against pseudomonas.  Stock cultures were stored in -80 oC in 7% (v/v) 
DMSO.  Prior to experiments, samples of all human bacteria were streaked out onto LB 
(Lysogeny Broth) agar and grown overnight at 37oC, whereas the plant bacteria were grown 
overnight at 27oC 




3.4.12.1 Bacterial survival assays  
 
 In order to examine whether the peptides were bacteriocidal, one colony from streaked 
plates was transferred into 7 mL sterile lysogeny broth (LB), and grown overnight at 37 oC 
under agitation at 150 rev / min, on an orbital shaker, and these cultures were used for 
ongoing experiments. Cultures were then transferred into a 15 ml Falcon tube and cells were 
harvested by centrifugation at 9000 rpm at 4 oC for 10 minutes. The supernatant was 
discarded and the pellet was resuspended in 1.5 mL ice-chilled PBS (phosphate buffered 
saline).  
After this, 30 μL of this solution was transferred into 300 μL of 0.5 mg/mL (or 0.05 wt%) of 
R3F3 or R4F4, in sterile water, or control solutions of 300 μL of sterile water. Solutions were 
then vortexed for 5 seconds and 3 x 20μL were taken at times 0, 120 and 1440 minutes. 
These samples were then serially diluted in PBS, and 10 μL of each dilution was platted onto 
LB agar and incubated at 37 oC overnight before colony counting.  
 
3.4.13.2 Biofilm assays  
 
To form a biofilm, Pseudomonas aeruginosa PA01 and ATCC2363 strains were grown 
overnight in LB media. Following this, the culture was diluted 1:100 in M63 minimal 
medium supplemented with arginine and magnesium sulphate, with and without R3F3 or 
R4F4, with four technical replicates. After this the plate was incubated for 4-24 hrs.  
Following incubation, the supernatant was discarded and then gently washed in water several 
times to decrease background staining. After this, 125 µL of 0.1 wt% Crystal violet solution 
was added to each well of the microtiter plate and incubated for 10 minutes. Following this, 
the plate was washed several times and left to dry overnight.  
After this, 125 µL of 30% acetic acid in water was added, to solubilise the biofilm, and the 
plate was incubated for further 10 minutes to allow solubilisation. Absorbance was measured 
using a plate reader at 550 nm. Anova and Tukey were used to assess statistical significance.  
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3.4.14.3 Indirect measurements of c-di-GMP using Congo Red  
 
Pseudomonas aeruginosa PA01 was grown overnight in LB media. After this, the culture 
was diluted 1:100 in 1 ml of M63 minimal medium supplemented with 0.4 % L-arginine and 
1 mM magnesium sulphate, with 40 μg/mL Congo red with and without R4F4. Control 
solutions were also prepared using the described medium above with no bacterial cells 
present. Congo red provides an indirect measure of c-di-GMP levels as it binds to the matrix 
of the biofilm, production of which is correlated to c-di-GMP levels.59 Samples were shaken 
at 200 RPM overnight in a shaking incubator. After this, 200 uL of supernatant was added 
in triplicate to a 96 well place, and measured using a plate reader at 490 nm. Results are 
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4.1 Introduction  
 
An established method for developing novel peptide-based biomaterials is to conjugate them to 
other molecules. Conjugation of peptides with other materials can enhance amphiphilicity, 
biocompatibility and functionality by increasing stability and half-life. Peptide conjugation to 
polymers is particular interest, especially with polymers that can be synthesised inexpensively, 
and this can lead to biomaterials with a diverse range of applications.1–8  This can change the 
behaviour of the polymers, which is influenced by the size and nature of the incorporated 
peptide, and the positioning of attachment. Therefore, it is possible to generate a large range of 
novel materials, which include peptide-functionalized polymer hydrogels,9–14 which have 
important applications including but not limited to, slow release drug delivery systems15–20 and 
supports and matrices for cells with applications in tissue engineering.21–32   
Capping polymers that are hydrophilic with hydrophobic end groups creates telechelic 
polymers. Telechelic polymers exhibit useful rheological behaviours due to their noncovalent 
end group associations, which is exploited in associative polymers, 33,34 which are used as 
thickeners. Additionally, this is exploited in polyethylene glycol (PEG)-based polymers. 
Examples are Pluronics, which are polymeric surfactants, with the ability to form hydrogels at 
high concentrations in aqueous solution. Pluronics have a linear triblock polymer architecture. 
Tetronics are analogous to pluronics but with a four-arm architecture. 35 PEG or PEO-(poly 
ethylene oxide) based polymers have been previously reported to have low toxicity and high 
biocompatibility.  They have been proposed act as inert spacers within peptide sequences to 
improve stability and circulation time of actives, for applications such as cell signalling, 36 drug 
delivery20  and gene delivery. 37    
There have been few studies on the self-assembling properties of telechelic peptide-polymer 
conjugates. Heise and co-workers reported that PEG-oligotyrosine diblock copolymers 
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examining a range of different molecular weights of PEG conjugated to varying length of 
oligotyrosine repeating units. 38  They observed an optimum composition of PEG2000-Tyr6 
(where Tyr6 denotes 6 tyrosine residues) which was found to undergo thermo-responsive 
gelation at 0.25 – 0.3 wt % between 25 oC and 50 oC. These conjugates form β-sheet fibrils, 
which had better packing upon increased temperature, confirmed by circular dichroism. 
Moreover, this hydrogel was found to be cytocompatibile and biodegradable.  
Hamley and co-workers reported on the gel-sol transition of PEO conjugates with hydrophobic 
dipeptides, including dityrosine and diphenylalanine.11 These conjugates were synthesised by 
coupling dipeptides to bis-aminopropyl PEO with a molar mass of 1500 g mol-1. The Fmoc 
protecting group, which was used in synthesis, was retained in some of the prepared conjugates, 
at either one or both termini. This influenced the hydrophile-lipophile balance, resulting in a 
significant impact on self-assembling behaviour. One conjugate with a di-tyrosine cap and a C-
terminal Fmoc protecting group was found to undergo a gel-sol transition period near body 
temperature, driven by loss of β-sheet structure associated with extended fibril formation.11 The 
self-assembly of three conjugates, Tyr5-PEO2K-Tyr5, Tyr5-PEO6K-Tyr5 and  Tyr3-PAla-
Tyr3 [PAla = poly(L-alanine), PEO2K and PEO6K are PEO with Mw = 2000 g mol
-1 and 6000 
mg mol-1 respectively],  was examined.39 These polymers were synthesised by living NCA (N-
carboxy anhydride) polymerization techniques which allows control of polymer chain length. 
Tyr5-PEO2K-Tyr5 and Tyr3-PAla-Tyr3 were shown to have poor solubility in water until 
adjusted to pH 12, whereas Tyr5-PEO6K-Tyr5 showed good solubility. All three polymer 
conjugates were shown to assemble into β-sheet fibrillar structures probed by cryo-TEM. 
Interestingly, hydrogel formation was not observed for any samples up to 20 wt%.39  
The Lendlein group also worked with similar telechelic conjugates of DAT (desaminotyrosine) 
or DATT (desaminotyrosyl-tyrosine), with a linear PEG (3000 g mol-1) midblock and also four 
arm-PEG conjugates, which were shown to self-assemble at high concentration.40 The same 
group investigated star-shaped and linear oligo-ethylene glycol/ DATT conjugates.40 Moreover, 
the structure, self-assembled conformation and rheological properties of gelatine (which has 
collagen-based helical structure) functionalised with either DAT or DATT at lysine residues 
was examined41,42. Fibrillar hydrogels have also been reported for PAla-PGlu-PAla, [PGlu: 
poly(L-glutamic acid)] in aqueous buffer.43  
This chapter examines the self-assembly in aqueous solution of telechelic PEO star-shaped 
polymers capped with short tyrosine sequences synthesised by Dimitrios Skoulas and Hermis 
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Iatrou.44 The creation of tyrosine-functionalised conjugates is of interest in the development of 
biomaterials. The central core PEO star molecular mass is either 10 kg mol-1 or 20 kg mol-1. 
Tyrosine is considered to be hydrophobic according to the majority of hydrophobicity scales45,46 
(excluding the Kyte-Doolittle scale47), and is capable of undergoing π-π stacking (aromatic) 
interactions. Tyrosine is involved in biological interactions including cell signalling, where it 
is responsive to a large number of tyrosine kinase and phosphatase enzymes, which have the 
ability to phosphorylate or dephosphorylate tyrosine residues. These interactions are vital for a 
large number of signalling cascades, and are of clinical interest because dysregulation is highly 
linked to a number of cancers.48,49 Therefore, this material could be of interest for development 
of enzyme responsive materials. The self-assembly is examined using a number of 
spectroscopic techniques including fluorescence, FTIR, CD, SAXS, Cryo-TEM and finally cell 
viability assays to assess cytocompatibility.  
 
 
Scheme 4.1. The peptide-polymer conjugates, on the left is [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 
and on the right hand side is [poly(L-tyrosine3-4)-b-(PEO 5k)]4 
 
4.2 Results and Discussions  
 
To examine whether there is a critical concentration for aggregation of the telechelic polymers, 
a fluorescence assay using 8-anilinonaphthalene-1-sulfonic acid (ANS) was performed.  ANS 
is sensitive to hydrophobic environments50–54 which gives  information on copolymer 
aggregation. Figure 4.1 shows fluorescence intensity against concentration. The cac for 
[poly(L-tyrosine4-5)-b-(PEO 2.5k)]4   was found to be 0.0035 wt% and for [poly(L-tyrosine3-4)-
b-(PEO 5k)]4   it was found to be considerably higher at 0.019 wt%. This could be explained by 
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[poly(L-tyrosine4-5)-b-(PEO 2.5k)]4   having a higher ratio of hydrophobic segments to 
hydrophilic units compared to [poly(L-tyrosine3-4)-b-(PEO 5k)]4   as the PEO chain is shorter.  
 
Figure 4.1. Critical aggregation concentrations measured using ANS fluorescence 
measurements 
 
The secondary structure of the peptide end blocks was examined at a concentration above the 
cac using a combination of circular dichroism (CD), FTIR and XRD. Figure 4.2a and b shows 
the CD spectra for the conjugates. For [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4, at native pH (pH 
7.88), the spectra (Figure 4.2) show minima at 195 nm and 218 nm, which may be evidence of 
some β-sheet structure, and a maximum at 228 nm. When adjusted to pH 12 (Figure 4.2b), there 
is reduced molar ellipticity indicating a loss of structure, although there is similarity in shape 
of those measured at native pH. For [poly(L-tyrosine3-4)-b-(PEO 5k)]4 at native pH, the spectra 
have maxima at 205 nm. Both conjugates at native pH show a 228 nm peak, which is due to 
tyrosine absorbance.11,39 Similar features having been observed for Tyr5-PEO6k-Tyr5 and Tyr2-
PEO1.5k-Tyr2.
39 When adjusted to pH 12 (Figure 4.2b), [poly(L-tyrosine3-4)-b-(PEO 5k)]4 
shows reduced molar ellipticity implying loss of secondary structure.  The temperature 
dependence of the CD data was examined in the range of 10-70 oC (Figure 4.3) and there were 
no significant changes in molar ellipticity upon heating for either [poly(L-tyrosine4-5)-b-(PEO 
2.5k)]4 or [poly(L-tyrosine3-4)-b-(PEO 5k)]4 at native and pH 12. 
In order to confirm that pH adjustment does not cause irreversible change and peptide 
degradation, CD spectra were measured. The conjugate solutions were measured at native pH, 
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adjusted to pH 12 using NaOH and measured, and then adjusted back to native pH using HCl 
and remeasured. The data is shown in Figure 4.4. The reversibility of the CD spectra shows that 
the peptide does not decompose at high pH but rather unfolds and refolds. 
 
Figure 4.2. CD spectra for both conjugates at 1 wt% 
 
 
The FTIR spectra measured for the two polymers at native pH (but not pH 12), shown in figure 
4.5 shows a strong peak at 1515 cm-1 which is assigned to the Tyr-OH side chain residue.55 The 
amide I’ region provides information about C=O deformation modes, meaning secondary 
structure can be determined. Due to complexities in the spectra, the FTIR spectra of the 
precursor molecules, (PEO 2.5k)4 and (PEO 5k)4 star polymers were also collected. The spectra 
for [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 at native pH shows a peak at 1626 cm
-1, indicating the 
presence of β-sheet structure.55,56 This peak is less defined for [poly(L-tyrosine3-4)-b-(PEO 
5k)]4. There is also a small peak at 1612 cm
-1 which can be associated with tyrosine.57 At pH 
12, [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 has a slight shifted peak value of 1630 cm
-1. The FTIR 
spectra measured for [poly(L-tyrosine3-4)-b-(PEO 5k)]4 has no defined peak across the amide I’ 
region. At pH 12, [poly(L-tyrosine3-4)-b-(PEO 5k)]4 shows a small peak at 1653 cm
-1 indicating 
it is disordered.58 Both samples at native pH show a peak near 3400 cm-1 which is consistent 
with –OH stretch deformations of hydrogen bonded carbonyl groups in PEO.59,60 All samples 
show peaks around 1455 cm-1 and 1474 cm-1 which are assigned to backbone –CH2 deformation 
PEO modes.59,60 
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Figure 4.3. Temperature-dependent CD spectra. a) 0.025% [poly(L-tyrosine4-5)-b-(PEO 
2.5k)]4, native pH 7.8, b) 0.025% [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4, pH 12, c) 0.025% 
[poly(L-tyrosine3-4)-b-(PEO 5k)]4, native pH 6.9, d) 0.025% [poly(L-tyrosine3-4)-b-(PEO 5k)]4. 
1 mm pathlength.  
 
Figure 4.4 CD spectra showing the reversibility of pH-induced conformational transitions




Figure 4.5. FTIR spectra for 1 wt % samples. Spectra are normalised to the absorbance at 
1900 cm-1. 
 
X-ray fibre diffraction was used to investigate the structure (Figure 4.6). The fibre X-ray 
diffraction patterns were isotropic and were reduced to one-dimensional form. All the samples 
show broad peaks at around 4.6 and 3.8 Å consistent with a high degree of PEO crystallinity.39 
These peaks overlap with those from β-sheet structures and it is therefore not possible to 
deconvolute PEO crystallinity and β-sheet formation in these samples.11,39  The assignment of 
these peaks to PEO crystallinity was confirmed through measurement of the PEO star precursor 
molecules. Previously, tyrosine end groups have been shown to affect PEO unit cell dimensions 
for example, in the case of  Tyr5-PEO6K-Tyr5.
39 For the star polymers there is a decrease in 
crystallinity between [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 at native pH and pH 12. A slight 
decrease in crystallinity is observed in the X-ray diffraction patterns obtained for [poly(L-
tyrosine3-4)-b-(PEO 5k)]4 comparing data at pH 12 and native pH. 
 




Figure 4.6.  X-ray fibre diffraction.  Data obtained from dried stalks made from 3 wt% solutions 
of, a) [poly(L-tyrosine4-5)-b-(PEO 2.5K)]4 and precursor molecule (PEO 2.5K)4, and, b)  
[poly(L-tyrosine3-4)-b-(PEO 5k)]4 and precursor molecule (PEO 5k)4 
 
In order to observe the possibility of dityrosine formation under alkaline condition at pH 12, 
fluorescence spectroscopy was performed. Dityrosine links can be a means of stabilising self-
assembled structures, and this has previously been reported to play a role in the nucleation of 
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fibril formation.61 Figure 4.7a,b shows the emission spectra obtained at λex = 320 nm. A peak 
close to 400 nm is associated with dityrosine formation.61–63 At pH 12, spectra for both [poly(L-
tyrosine4-5)-b-(PEO 2.5k)]4 and for [poly(L-tyrosine3-4)-b-(PEO 5k)]4 show a peak at 
approximately 400 nm. At native pH of 7.8 and 6.9 respectively, this peak is absent. This is 
expected due to the fact that the tyrosine hydroxyl unit is present at native pH as opposed to the 
phenolate form present at high pH.61–63   
The excitation spectra (Figure 4.7c,d) for both poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 and for 
[poly(L-tyrosine3-4)-b-(PEO 5k)]4  show a red shift of the 280 nm peak at native pH to 320 nm 
at pH 12, also consistent with dityrosine formation.61,63 Contrary to other reports, the intensity 
in the excitation spectrum is lower at pH 12 than at the native pH.61 
 
 
Figure 4.7. a and b) Fluorescence emission spectra of 0.1 wt% Conjugates (λex=320) and c) 
and d) Fluorescence excitation spectrum of 0.1 wtp% conjugates (λem=410).  
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Cryo-TEM (Figure 4.8) was used to image the self-assembled nanostructures. The ANS 
fluorescence assays confirm that aggregation occurs above a critical concentration for the 
conjugates. For comparison, Cryo-TEM images for the precursor molecules (PEO 2.5k)4 and 
(PEO 5k)4 were also examined. For [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 at native pH (Figure 
4.8a), there was a mixture of large spherical nanostructures of an average size of 31 nm and 
short clusters of fibres. Interestingly, cryo-TEM for the same conjugate in a pH 12 solution 
(Figure 4.8b) shows very little assembly, showing that adjusting the pH disrupts the self-
assembly of [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4.  There are occasional spherical structures. The 
cryo-TEM images for the precursor molecule (PEO 2.5k)4 show very little self-assembly with 
occasional aggregates (Figure 4.8c).. The [poly(L-tyrosine3-4)-b-(PEO 5k)]4 sample at native pH 
(Figure 4.8d) shows a mixture of fibrillar structures and small spherical structures. At pH 12 
(Figure 4.8e) the self-assembled nanostructure is a mixture of long straight fibrils and smaller 
spherical nanostructures with an average diameter of 15 nm. Straight fibres have been 
previously observed with linear conjugates of aromatic peptides with linear PEG (PEO), for 
example, Phe4-PEO5k
64 and Tyr5-PEO6K-Tyr5.
39  The precursor molecule (PEO 5k)4 show very 
little self-assembly (Figure 4.8f). Figure 4.9 shows additional cryo-TEM images from other 
areas of the TEM grids, with less frequently observed assembles.   
To further probe the self-assembled structures of the PEO conjugates, small-angle X-ray 
scattering measurements were performed. The measured data and corresponding fits are shown 
in Figure 4.10. Both the pH adjusted, and native pH polymers were fitted to a general mass 
fractal Gaussian model to describe the aggregated structures and a Gaussian coil form factor, 
to account for the presence of monomers in solution. This model describes the data very well. 
The SAXS data for the precursor polymers was fitted to a general Gaussian coil model.  The 
parameters of the fits are listed in Table 1 and 2. 
 




Figure 4.8. Cryo-TEM images of 1 wt % conjugates. (a) [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 
(native pH). (b) [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 (pH 12) (c) (PEO 2.5k)4 (d) [poly(L-
tyrosine3-4)-b-(PEO 5k)]4 (native pH) (e) [poly(L-tyrosine3-4)-b-(PEO 5k)]4 (pH 12), (f) (PEO 
5k)4  
 




Figure 4.9. Rare self-assembled structures observed by Cryo-TEM for the conjugates. (a) 
[poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 pH 12 shows occasional spherical structures. (b) (PEO 
2.5k)4 shows occasional spherical clusters. (c) [poly(L-tyrosine4)-b-(PEO 5k)]4 pH 7 shows 
occasional short straight fibres and longer fibres. (d) [poly(L-tyrosine4)-b-(PEO 5k)]4 shows 
occasional very long fibers, (e) (PE0 5k)4 shows occasional large clusters.  
 





Figure 4.10. SAXS Profiles for 1 wt% conjugates dissolved in water. a) SAXS profiles for 
[poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 and b) SAXS profiles for [poly(L-tyrosine3-4)-b-(PEO 5k)]4. 
Scattering profiled are multiplied by factors of 10 and only every third data point is shown. 
 
 
Table 4.1. Parameters of SAXS fits for [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 and [poly(L-
tyrosine3-4)-b-(PEO 5K)]4 at native and adjusted pH. Fitting to a generalised Gaussian coil and 
mass fractal Gaussian model using SASFIT. Here Rg is the radius of gyration, D is the 
dimension fractal, I(0) is the forward scattering, v is the Flory exponent, N is the scaling factor 











Generalised Gaussian coil 
BG 
Rg / nm v I(0) N 
(PEO 2.5)4 3.25 0.40 5.60 5.07 0.56 
(PEO 5K)4 5.80 0.47 13.2 5.43 0.54 
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Table 4.2.  Parameters of SAXS fits for [poly(L-tyrosine4-5)-b-(PEO 2.5K)]4 and [poly(L-
tyrosine3-4)-b-(PEO 5k)]4 at pH 12. Fitting to a generalised Gaussian coil model using SASFIT.  
Where Rg is the radius of gyration, nu is the flory exponent, I0 is forward scattering, N is the 




The radius of gyration (Rg) of the star polymers was calculated using the equation
65:  









The Rg for (PEO 2.5k)4 and (PEO 5k)4 was calculated to be 1.36 and 1.93 nm respectively.  The 
fits show a radius of gyration of 3.25 nm and 5.80 nm respectively which indicates significant 
swelling. Interestingly, only the pH adjusted [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 shows the 
signature of monomers with a component of scattering from Gaussian coils with Rg=5.59 nm. 
Kratky plots (figure 4.11) were used to further visualize the data for the precursor molecules. It 
can be seen that the precursor molecules have a typical shape of unfolded molecules having 
branched conformations. The Kratky plots for the conjugates behaviour are not consistent with 
 Mass fractal 
Gaussian 
Generalised Gaussian Coil 
BG 
Rg / nm D I(0) Rg / nm v I(0) N 
[poly(L-tyrosine4-5)-b-
(PEO 2.5k)]4 pH 7.89 
(native) 
28.3 2.4 26.1 13.9 0.23 3.70 1.3 3.54x10-4 
[poly(L-tyrosine4-5)-b-
(PEO 2.5k)]4 pH 12 
26.4 2.2 9.34 11.5 0.34 1.7 0.7 6.56x10-4 
[poly(L-tyrosine3-4)-b-
(PEO 5k)]4 pH 6.93 
(native) 
29.2 1.9 4.7 15.8 0.29 0.5 0.4 3.00x10-5 
[poly(L-tyrosine3-4)-b-
(PEO 5k)]4 pH 12 
34.4 2.5 2.8 5.59 0.54 0.5 0.1 1.15x10-3 
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this, this probably due to the fact that the Kratky approximation assumes globular like 
structures.  
 
Figure 4.11. Kratky plots  to show unfolded conformation of precursor molecules. Kratky plots 
of the SAXS data for precursor molecules, consistent with branched conformation.  
 
In order to examine the cytocompatibility of the conjugates, the viability of [poly(L-tyrosine4-
5)-b-(PEO 2.5k)]4 and [poly(L-tyrosine3-4)-b-(PEO 5k)]4 was tested using 161Br skin fibroblast 
cells using an 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay 
(Figure 4.12). [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 and [poly(L-tyrosine3-4)-b-(PEO 5k)]4 were 
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shown to be tolerated by the cells up to a concentration of 0.05 wt% (above >83% viability, 
with no statistical significant difference between the concentrations and the negative control.) 
Above this concentration there is significant decrease in cell proliferation. The cell viability in 
solution containing the precursor molecules was examined. It was found that there was 
decreased cell viability at high concentrations for (PEO 5K)4, which displayed a significant 
reduction in viability at 0.5 wt% whereas (PEO 2.5K)4 showed a slight decrease in viability. 
This indicates that the decreased viability could be due to the PEO molar mass, as (PEO 5k)4 
has a greater effect on cell viability than the (PEO 2.5k)4. This is in agreement with previous 
work, where high molecular mass PEG at high concentrations have been shown to display some 
toxicity.66  The precursor molecules have less effect on viability than the [poly(L-tyrosine4-5)-
b-(PEO 2.5k)]4 and [poly(L-tyrosine3-4)-b-(PEO 5k)]4 , showing that the presence of the tyrosine 
does slightly reduce viability at higher concentrations. The concentrations tolerated by the cells 
are significantly higher than the critical aggregation point.    
The cell viability of tyrosine alone was measured. Concentrations were chosen based on the 
tyrosine content in each of the precursor molecules. The highest concentration of tyrosine, 
present in  0.5 wt% of the [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 could not be tested with the MTT 
assay due to tyrosine solubility, the limit of which is 0.045 wt% in water.  Interestingly, the 
concentrations of tyrosine alone present in the precursor molecules (Figure 4.12) does not show 
to have an effect on viability, suggesting that is due to the oligo-tyrosine block.   
We examined possible gel formation for the telechelic star polymers. Gel formation in water 
was not observed up to concentrations where the conjugates became insoluble. This is in 
agreement with previous work based on linear Tyr5-PEO6k-Tyr5 previously investigated by our 
group, in which gelation was not observed even with 20 wt% polymer in aqueous solution.11 
As an alternative means to produce gels, we used the widely available and readily gelled 
polysaccharide sodium alginate. Therefore, peptide functionalized gels (Figure 4.13) were 
made using 1 wt % sodium alginate, 0.1 wt% CaCl2, and either 0.1, 1 or 5 wt% of conjugate 
(apart from [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 which is not soluble at 5 wt% concentration). 
CaCl2 at 0.1 wt% and sodium alginate have previously been shown to be non-toxic, and indeed 
are shown to be able to support and encapsulate cells.67 
 




Figure 4.12. Cell Viability profile for [poly(L-tyrosine4-5)-b-(PEO 2.5K)]4 and [poly(L-




Figure 4.13. Image of formed hydrogels. a)  0.1 wt% CaCl2, 1 wt% NaAlg, b) 1 wt% [poly(L-
tyrosine4-5)-b-(PEO 2.5k)]4 , 0.1 wt% CaCl2, 1 wt% NaAlg. c) 0.1 wt% [poly(L-tyrosine4-5)-b-
(PEO 2.5k)]4 , 0.1 wt% CaCl2, 1 wt% NaAlg d) 5 wt% [poly(L-tyrosine3-4)-b-(PEO 5k)]4, , 0.1 
wt% CaCl2, 1 wt% NaAlg e) 1 wt% [poly(L-tyrosine3-4)-b-(PEO 5k)]4, , 0.1 wt% CaCl2, 1 wt% 
NaAlg f) 0.1 wt% [poly(L-tyrosine3-4)-b-(PEO 5k)]4, , 0.1 wt% CaCl2, 1 wt% NaAlg.  




To probe the structure of the gels and to examine whether the peptide caused structural changes, 
SAXS measurements were performed. SAXS measurements were performed on hydrogels 
comprising of 0.1 wt% and 1 wt% of [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 and 0.1 wt%, 1 wt% 
and 5 wt% of [poly(L-tyrosine3-4)-b-(PEO 5k)]4 with 0.1 wt% CaCl2 and 1 wt% sodium alginate 
was conducted. The measured fits and corresponding data are shown in Figures 4.14. SAXS 
profiles were also measured on the unfunctionalized alginate gel. This was fitted to a broad 
peak fit model. The parameters of the fit are listed in table 4.3. From the SAXS data it can be 
seen that the gel structure is not significantly influenced by addition of 0.1 wt% star polymer, 
but there is a significant change with addition of 1 wt% polymer. This is manifested by a 
significant change in scattering at low q (development of a broad peak) and a change in slope 
at high q. 
 
Figure 4.14. SAXS of peptide functionalized gels. a) [poly(L-tyrosine4-5)-b-(PEO 2.5K)]4   
functionalized gels. b) [poly(L-tyrosine3-4)-b-(PEO 5k)]4 functionalized gels. Scattering profiles 
is multiplied by multiples of 10 and only every third data point is shown for clarity. 










Table 4.3. Parameters of SAXS fits for [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 and [poly(L-
tyrosine3-4)-b-(PEO 5k)]4 functionalised hydrogels. Fitting to a broad peak model with a 
sloping background using SASFIT.  Where I(0) is the forward scattering, ξ is the correlation 
length, q0 is the peak position which is related to d-spacing (q0= 2π/d). m and p are 





Broad Peak Background 
I(0) ξ q0 m p c_0 c_4 α 
0.1 wt% CaCl2 , 1 wt% 
NaAlg 
0.32 14.3 0.01 1.37 1.70 0.02 4.79x10-5 2.09 
0.1 wt% [poly(L-tyrosine4-
5)-b-(PEO 2.5k)]4 
0.1 wt% CaCl2 , 1 wt% 
NaAlg 
0.20 12.96 0.02 1.35 1.96 0.02 1.93x10-6 2.88 
1 wt% [poly(L-tyrosine4-
5)-b-(PEO 2.5k)]4 
0.1 wt% CaCl2 , 1 wt% 
NaAlg 
0.04 8.98 0.08 1.15 1.80 0.01 4.98x10-4 1.85 
0.1 wt% [poly(L-tyrosine3-
4)-b-(PEO 5k)]4 
0.1 wt% CaCl2 , 1 wt% 
NaAlg 
0.20 16.2 0.01 1.65 1.22 0.02 2.08x10-5 2.21 
1 wt% [poly(L-tyrosine3-
4)-b-(PEO 5k)]4 
0.1 wt% CaCl2 , 1 wt% 
NaAlg 
0.08 10.1 0.01 1.32 2.49 0.004 3.40x10-5 2.10 
5 wt% [poly(L-tyrosine3-
4)-b-(PEO 5k)]4 
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4.3 Summary and Conclusions 
The novel conjugates [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 and [poly(L-tyrosine3-4)-b-(PEO 
5k)]4 have been shown to self-assemble with a disordered conformation, forming highly 
polydisperse mixtures of globules and fibres through a combination of microscopy, scattering 
and spectroscopic techniques. 
 
Scheme 4.2. Schematic of proposed aggregation of the PEO conjugates.  
 
  Adjustment of pH of [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 to pH 12 causes a loss in secondary 
structure, and disruption of self-assembly, whereas [poly(L-tyrosine3-4)-b-(PEO 5k)]4 shows 
change in self-assembly from fibrillar worm-like globules to long very straight fibres and small 
globules. This straight fibre formation is consistent with other work,39 where pH adjusted 
tyrosine end capped linear telechelic PEO was examined. The increased polydispersity of self-
assembly comparative to linear PEO molecules previously studied may be due to the star-shape 
of the PEO which gives conformational restrictions, leading to irregular packing and 
interactions.  The XRD patterns show that PEO crystallinity occurs through drying.  
  Interestingly, [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 and [poly(L-tyrosine3-4)-b-(PEO 5k)]4   
cause decreased cell viability at higher concentrations (above 0.05 wt%). From the precursor 
molecules, it can be seen that this in part may be due to the branched nature of the PEO 
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molecules, where size is clearly causing decreased cell proliferation in this case.  Tyrosine is 
an important amino acid in many cell signalling cascades, being the site of phosphorylation 
targeted by a specific set of protein kinases named tyrosine-kinases. The presence of several 
tyrosine residues enhances the lack of proliferation. Self-assembly occurs well below the 
concentrations of some of the tolerated concentrations showing that self-assembly itself is not 
linked to or causative of cytotoxicity. Future work could focus on the bioactivity of these 
conjugates, such as tyrosine phosphorylation using kinases. 
 




The two conjugates, of [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 and [poly(L-tyrosine3-4)-b-(PEO 
5k)]4  were custom synthesized by Dmitros Skulous and Hermis Iatrou, using NCA-
polymerization techniques reported elsewhere.68  
4.4.2 Sample Preparation  
 
The conjugate [poly(L-tyrosine3-4)-b-(PEO 5k)]4 was found to have greater solubility than 
[poly(L-tyrosine4-5)-b-(PEO 2.5k)]4.in water and in D2O. Samples were studied at native pH and 
pH 12. The native pH values of [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 and [poly(L-tyrosine3-4)-b-
(PEO 5k)]4 were 7.74 and 6.90 respectively. For the alkaline solutions, pH was adjusted to 12 
using 1M NaOH solution. 
4.4.3 Fluorescence assays 
 
Fluorescence spectroscopy was used to determine the critical aggregation concentrations (cac) 
of [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 and [poly(L-tyrosine3-4)-b-(PEO 5k)]4. Fluorescence 
spectra were recorded with a Varian Cary Eclipse fluorescence spectrometer with samples in 4 
mm inner width quartz cuvettes. 8-anilinonaphthalene-1-sulfonic acid (ANS) was used to probe 
the aggregation as probe that is sensitive to hydrophobic environments making it suitable to 
locate the cac.50–54  ANS assays were performed using 66.8µM ANS (0.002 wt%) solution to 
solubilise the telechelic conjugates. Fluorescence spectra were recorded between 400-650 nm 
(λex = 356 nm). 
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 The possibility of dityrosine formation for [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 and [poly(L-
tyrosine3-4)-b-(PEO 5k)]4  at native and alkaline pH was measured using a Varian Cary Eclipse 
fluorescence spectrophotometer. The fluorescence was measured for water and for 0.1 wt% of 
[poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 and [poly(L-tyrosine3-4)-b-(PEO 5k)]4 at native pH and pH 
12. Samples were measured in 4 mm inner width quartz cuvettes, and the slit width was 5 nm. 
Emission spectra were recorded at λex=320 nm from 340 to 600 nm. A total of 5 averages were 
taken, and the background was subtracted. Excitation spectra were also measured at λex=410 
nm, from 250 nm to 410 nm. A total of 5 averages were taken, and the background was 
subtracted.  
4.4.4 Circular Dichroism (CD) 
 
CD spectra were recorded using a Chirascan spectropolarimeter (Applied Photophysics, UK) 
in the wavelength range 180 – 260 nm. The samples, 0.025 wt% in D2O were pipetted into a 1 
mm path length bottle, with absorbance less than 2 at any point being reported. Measurements 
were recorded with a 0.5 nm bandwidth, 1 mm step and 1 second collection time per point. Data 
was collected at 10oC intervals between 10-70 oC were measured, with samples being allowed 
to adjust at each temperature for 5 minutes. The CD signal for the background was subtracted 
from the CD signal of the sample, and molar ellipticity was calculated.  
 
4.4.5 Fourier Transform Infrared Spectroscopy (FTIR) Studies of Self-Assembly 
 
Spectra were recorded using a Thermo Scientific Nicolet IS5 equipped with a DTGS detector, 
with a PEARL liquid cell (sample was contained between fixed CaF2 plates). 80 µl of 1 wt% 
sample dissolved in D2O were prepared and added to a PEARL liquid cell. Spectra were 
scanned 128 times over the range of 900 − 4000 cm-1  
 
 4.4.6 Cryogenic Transmission Electronic Microscopy (Cryo-TEM) 
 
 Cryo-TEM was performed by M.Reza at Aalto University, Finland. Vitrified specimens were 
prepared using an automated FEI Vitrobot device using Quantifoil 3.5/1 holey carbon copper 
grids with a hole size of 3.5 μm. Prior to use, grids were plasma cleaned using a Gatan Solarus 
9500 plasma cleaner and then transferred into an environmental chamber of a FEI Vitrobot at 
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room temperature and 100% humidity. Thereafter sample solution was applied onto the grid, 
and it was blotted twice for 5 s and then vitrified in a 1/1 mixture of liquid ethane and propane 
at a temperature of −180 °C. The grids with vitrified sample solution were maintained at liquid 
nitrogen temperature and then cryotransferred to the microscope. Imaging was carried out using 
a field emission cryo-electron microscope (JEOL JEM-3200FSC) operating at 200 kV. Images 
were taken in bright field mode and using zero loss energy filtering (Ω type) with a slit width 
of 20 eV. Micrographs were recorded using a Gatan Ultrascan 4000 CCD camera. Specimen 
temperature was maintained at −187 °C during the imaging.  
 
4.4.7 X-ray diffraction (XRD) 
 
Measurements were performed on a stalk prepared by suspending a 3 wt% solution of conjugate 
between two wax coated capillaries. After drying, wax capillaries were separated leaving the 
stalk on the end of one capillary. Diffraction was measured using the Oxford Diffraction Gemini 
Ultra instrument at the University of Reading. Stalks were mounted vertically onto the four axis 
goniometer. The sample-detector distance was 44 mm, and the X-ray wavelength was λ=1.5418 
Å. The wavenumber scale (q = 4π sin θ/λ where 2θ is the scattering angle) was geometrically 
calculated. The detector was a Sapphire CCD. 
 
4.4.8 Small-angle X-ray scattering  
 
Collection of solution small-angle X-ray scattering (SAXS) data was performed on the 
bioSAXS beamline B21, at Diamond Light Source, United Kingdom and BM29, ESRF, 
Grenoble, France. Solutions of 1 wt% [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 and [poly(L-
tyrosine3-4)-b-(PEO 5K)]4 at native pH and pH 12 were loaded in PCR tubes in an automated 
sample changer. Samples (30 µl) were then delivered into a temperature controlled quartz cell 
capillary and exposed for 15 s, collecting 18 frames at 20 oC. Data was collected using a Pilatus 
Dectris 2M detector. Background was manually subtracted using ScÅtter.69 Form factor 
modelling was done using SASfit.70  
 At the ESRF, solutions of (PEO 2.5k)4 and (PEO 5k)4 at native pH were loaded into PCR tubes 
in an automated sample changer. Samples of 30 ul were then delivered in a temperature 
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controlled quartz cell capillary and exposed for 3 s, collecting 10 frames at 20 oC. Data was 
collected using a Pilatus Dectris 1M detector. The sample detector distance was 2.89 m. Form 
factor modelling was done using SASfit.70 
SAXS for Gels was also performed on Diamond beamline B21, with a custom-designed gel cell 
with kapton windows. Samples were manually loaded, and exposed for 3 s, collecting 18 frames 
at 20 oC. Data was collected using a Pilatus Dectris 2M detector.  Background was manually 
subtracted using ScÅtter.69 Form factor modelling was done using SASfit.70 
 
4.4.9 Cytotoxicity Studies  
 
The cytotoxicity of both the [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 and [poly(L-tyrosine3-4)-b-
(PEO 5k)]4 was examined. In vitro cell culture was conducted using 161Br (ECACC), a human 
skin fibroblast cell line. Cells were cultured in EMEM, with 2 mM glutamine, enriched with 
15% fetal bovine serum (FBS) and 1% non-essential amino acids (NEAA). Cells were 
maintained in a humidified atmosphere of 37 oC, 5% CO2.  
 Potential cytotoxic effects were examined using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay. The polymers [poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 and 
[poly(L-tyrosine3-4)-b-(PEO 5k)]4 were dissolved in complete medium and 2% DMSO, and 
sterile filtered. Cells were seeded into a 96-well plate at 4x104 cells/mL and allowed to adhere 
for 24 hours in 100 µL complete medium. After this, 100 µL of either complete media and/or 
peptide solution was added, to give either control solution (complete media, 1% DMSO), and 
solutions containing 5 mg/mL, 1 mg/mL, 0.5 mg/mL, 0.1 mg/mL and 0.05 mg/mL peptide (1% 
DMSO).  
 Cells were incubated for 67 hours. After this, 20 µL MTT (5 mg/ mL, in PBS) was added to 
each well plate and allowed to incubate for 5 hours. After a further 5 hours of MTT addition 
(72 hours total) the solution was removed from the wells and replaced with 100 µL DMSO per 
well, which dissolves the formazan crystals. Plates were incubated for 30 minutes, and then 
analysed using the UV microplate reader (λ=570 nm). Results are reported as a % cell viability 
compared to control (untreated) values.  
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4.4.10 Peptide-functionalised Gels  
 
Peptide conjugate decorated gels were prepared by adding poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 
and [poly(L-tyrosine3-4)-b-(PEO 5k)]4 to a solution of 1 wt% sodium alginate, in the final 
concentrations of 0.1 wt%, 1 wt% and 5 wt% (excluding poly(L-tyrosine4-5)-b-(PEO 2.5k)]4 as 
it was not soluble at this concentration). To each solution, CaCl2 was added up to a 
concentration of 0.1 wt%. The solutions were vortexed for 3 minutes, and left at room 
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5.1 Introduction  
 
Self-assembly is the ability of molecules to organise into ordered structures from a bottom up 
approach. This process is fundamentally important for life, and has a range of applications 
including material science and biotechnology.1–5 Self-assembling peptides which form 
nanotube structures are of high interest due to their many applications including antimicrobials, 
biomineralization, photosystem models, biosensors and biomaterials.6,7  
The ability of short sequenced cyclised peptides consisting of alternating -L and -D amino acids 
has been extensively examined. Ghandiri and co-workers demonstrated controlled nanotube 
formation of cyclo(L-Gln-D-Ala-L-Glu-D-Ala) based on pH variation, characterised by a range 
of biophysical techniques and modelling.8–10 Lambert and co-workers confirmed pH variation 
as a method to control nanotube formation of an -L,-D-alternating octapeptide containing two 
Asp units.11 Cyclic peptides containing β-amino acids have also been shown to form nanotubes 
with a similar stacking interaction to -L, -D-alternating nanotubes12 that can form ion channels 
in bilayers. These may act as affinity sites for different proteins.13 Another class of cyclic 
peptide that forms nanotubes are those consisting of D-amino acids and γ-aminocyclo-
hexanecarboxylic acid, which gives the core of the nanotubes hydrophobic cavities, providing 
potential functionalisation capabilities.14–18  
Lanreotide, (NH3-(D)Nap-Cys-Tyr-(D)Trp-Lys-Val-Cys-Thr-CONH2), is a synthetic peptide 
and a growth hormone inhibitor, used to treat acromegaly. It forms a hydrogel which is 
administered as a long acting implant in patients. The self-assembly of Lanreotide has been 
extensively examined.19,20 The pathway of assembly is β-hairpin structures, which dimerise to 
form open ribbons, followed by the formation of helical ribbons, which later close to form 
nanotubes.21,22 The self-assembly is driven by amphiphilicity, and the segregation of the 
aromatic side chains which leads to β-sheet associations. A series of mutational studies found 
that D(Napj) and Tyr were the drives of the self-assembly into nanotubes.23 At 10 wt%, these 
nanotubes are monodisperse.,19 with higher concentrations having polydispersity and embedded 
tubes.19,20 Double walled Lanreotide nanotubes have been observed when combined with 




silica24 and divalent counterions, the latter of which was shown to affect the diameter.25,26 These 
can have applications in biomineralization.  
Recently the self-assembly of the peptide hormone oxyntomodulin, a 37 long amino acid, was 
examined.27 Oxyntomodulin is an agonist to glucagon and GLP-1 receptors, with promise to be 
a treatment for obesity, as it suppresses appetite and increases energy expenditure.28–31 
Oxyntomodulin was found to form nanofibers of ~10 nm diameter and up to 1 µm length in 
water at 1 wt%, forming a gel-like structure. These fibres were shown to be stable at 0.1 wt%, 
and were shown to release oxyntomodulin slowly in rat models, prolonging exposure compared 
to free oxyntomodulin from 4 hours to 5 days.27 
Oxytocin (CYIQNCPLG) is a nine amino-acid neuropeptide which has been well characterised 
biologically.32,33  Oxytocin has both physiological actions as well as psychological actions in 
many species, and is a critical hormone in the central and peripheral nervous systems. This 
includes childbirth and lactation in mammals, bonding, modulation of anxiety and roles in 
autism development.32,33 Oxytocin has a disulphide salt bridge between the two cysteine 
residues which cause cyclisation.  
Oxytocin is also administered to mothers who have just given birth to prevent the loss of blood 
postpartum.34 Although oxytocin is effective for this, it is unstable at higher temperatures, due 
to the disulphide and amide bonding within its structure. This is an issue in countries where 
Oxytocin cannot be stored at lower temperatures. To overcome this, an analogue of oxytocin, 
carbetocin,  (Butyryl-Tyr(Me)-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2) which does not have these 
heat stable regions, has been shown to be as effective as oxytocin for preventing excessive 
bleeding during childbirth.35,36  
This chapter focuses on the self-assembly behaviour of oxytocin and carbetocin at native pH 
and pH 12 in aqueous conditions. The peptides are examined using an array of biophysical 
characterisation techniques to include: Fluorescence CD, SAXS, FTIR, Cryo-TEM and TEM. 
Finally, the behaviour of a lipidated variant of oxytocin (named LOT-1) is examined in ethanol 
(as it is insoluble in water) and compared to the self-assembly of oxytocin in ethanol.  
















5.2.1 Self-assembly of carbetocin and oxytocin in water. 
 
The self-assembly of both oxytocin and carbetocin at native and pH 12 was examined. To 
ensure that the peptides did not lyse at pH 12, mass spectroscopy was used. No distinguishable 
changes were found between native pH and pH 12 (Appendix Figure 3 and 4). 
The critical aggregation concentration for oxytocin and carbetocin in water was determined 
using ANS. ANS binds to the hydrophobic environment, indicating hydrophobic collapse.37,38 
Oxytocin has a cac of 0.04 wt%, and carbetocin was found to have a cac of 0.09 wt%. The 
increase in ANS intensity was much more distinguishable with oxytocin than with carbetocin 
which could mean that carbetocin has a less defined aggregation concentration. This implies 
that the loss of the S-S disulphide bridge, and the methylation of the tyrosine reduce the 
aggregation propensity. Methylation of the tyrosine may affect the ability of the ring to have 
strong π-π stacking interactions.  
 
Figure 5.1. cac values determined by ANS of a) and b) Oxytocin and c) and d) Carbetocin.  





To assess the secondary structure, circular dichroism (CD) and Fourier transform infrared 
spectroscopy (FTIR) were used. Samples of 1 wt% oxytocin or carbetocin samples were 
measured. At native pH, oxytocin has a minimum of 205 nm, indicating a disordered secondary 
structure. The 230 nm peak corresponds to tyrosine. Adjustment to pH 12 causes a shift and 
broadening of the 230 nm peak present in the native pH to 240 nm, and an increased molar 
ellipticity of the negative 200 nm peak, indicating disordered secondary structure.39–41 
Temperature CD for oxytocin at native pH showed irreversibility, as the minimum did not 
return to the original shape. When adjusted to pH 12, oxytocin was temperature reversible. 
carbetocin at native pH has a minimum peak at 210 nm, with no positive β-sheet band, 
indicating that carbetocin is disordered.39–41 The negative molar ellipticity at 210 nm is slightly 
reduced when adjusted to pH 12, however at pH 12 there is an increase in the 230 nm tyrosine 
band.42–44 Both carbetocin at native pH and pH 12 showed reversibility to the original molar 
ellipticity after heating, unlike oxytocin at native pH. This is expected as oxytocin is reported 
to be heat sensitive.35 
At 2 wt% pH 12 oxytocin forms a self-standing gel. Figure 5.3 shows the CD spectrum of 
oxytocin gel, which shows a minimum peak at 218 nm, indicating that there is a shift from 
disordered structure to β-sheet secondary structure when adjusting pH.39–41 Moreover, the 
shifted tyrosine peak has a significant increase in molar ellipticity indicating the tyrosine rings 
are stacking together strongly, which could imply that π-stacking is important in the 
hydrogelation process. 





Figure 5.2. CD spectrum of a) 1 wt% oxytocin, pH native, b) 1 wt% oxytocin pH 12, c) 1wt% 
carbetocin pH native, d) 1 wt% carbetocin pH 12.  
FTIR was measured for oxytocin and carbetocin at native pH. The 1458 cm-1 peak corresponds 
to the proline C-N bond vibration.45 The 1516 cm-1 peak corresponds to tyrosine bond vibrations 
in the C-C and C-H bonds.45 The third peak at 1559 cm-1 corresponds to asparagine side 
chains.45 The amide I’ region for both carbetocin and oxytocin is dominated by a large peak 
around 1643 cm-1 at native pH which corresponds to disordered secondary structure, confirming 
the circular dichroism.45,46  




























 2 wt% Oxytocin pH 12 gel
 
Figure 5.3. CD spectrum for 2 wt% oxytocin gel. 
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Figure 5.4. FTIR spectra of 1 wt% oxytocin and 1 wt% carbetocin at native pH  
To examine the self-assembled morphology, SAXS, TEM and cryo-TEM were used for both 
oxytocin and carbetocin. Cryo-TEM for 1 wt% oxytocin at native pH showed small globular 
structures with a radius of 21 nm (± 5 nm); these are potentially vesicles. For a 2 wt% sample, 
TEM revealed that there was a large polydispersity in globular size, ranging from 19 nm to 152 
nm. SAXS data for 1 and 2 wt% oxytocin was fitted to a model for monomers, using a 
generalised Gaussian coil form factor which accounts for clusters of monomers. This fits the 
data very well. The radius of gyration was found to be 6.8 nm for a 1 wt% sample and 5.8 nm 




for 2 wt%, with a v of 0.55 for 1 wt%, and 0.19 for the 2wt% sample, showing that at 1 wt% 
the structure is swollen and 2wt% the structure is more folded.  
Cryo-TEM for 1 wt% oxytocin at pH 12 (Figure 5.5), shows a change in the tertiary structure 
to polydisperse fibrils. These fibrils have a radius of 17 nm ± 6.3, with lengths ranging from 
150 nm - 800 nm. Thus, adjustment to pH 12 promotes fibril formation. SAXS data shown in 
Figure 5.6, did not agree with the cryo-TEM data, showing monomers at 1 wt% pH 12 which 
was fitted to a Gaussian coil form factor.47 The discrepancy between native pH and pH 12 
oxytocin by cryo-TEM and SAXS requires further investigation, but potentially can be 
explained by radiation damage, as oxytocin is known to degrade at high temperatures35 and may 
be sensitive to X-ray radiation.   
The oxytocin hydrogel (2 wt% oxytocin, pH 12) is formed of large fibrils, visualised by TEM 
(Figure 5.6) and cryo-SEM (Figure 5.7). In TEM these fibrils range from 2.7 μm to 5.3 μm, 
with radius of 72  nm ± 16 nm. SAXS data shows a low intensity scaling of I ~ -2.7, implying 
that the aggregated particle is larger than the resolution limit, and the data should be remeasured 
with an increased q range. At high q, there is a Bragg peak at d = 21.2 Å which corresponds 
approximately to the size of an oxytocin molecule.  
For solutions of 1 wt% and 2wt% Carbetocin at native pH and 1 wt% Carbetocin pH 12, no 
self-assembly at native pH was observed through cryo-TEM, SAXS or TEM. However, as 
shown in Figure 5.6, 2 wt% Carbetocin shows large spherical structures at low magnification 
which could also be visualised via light microscope. These aggregates appear to be crystalline 
in TEM.  
When stained with Congo red dye, a dye commonly used to detect amyloid like fibres, both 
Carbetocin and Oxytocin at 2 wt% adjusted to pH 12 show birefringence through polarised light 
microscopy (Figure 5.7). As Carbetocin is slightly crystalline at this pH it could imply that the 
crystal structures are non-cubic. 





Figure 5.5. Cryo-TEM images of a) 1 wt% oxytocin, native pH, b) 1 wt% oxytocin, pH 12, c) 1 
wt% carbetocin, pH native, d) 1 wt% carbetocin pH 12 
Figure 5.6. SAXS data for oxytocin and carbetocin.  

























Rg 6.8 6.9 5.8 6.5 7.3 5.4 
ν 0.20 0.24 0.19 0.60 0.27 0.31 
I(0) 0.03 0.01 0.03 0.01 0.10 0.01 
N 0.15 0.27 0.27 0.52 0.10 0.50 
BG 9.28x10-4 1.20x10-3 1.74x10-3 7.513x10-4 2.85x10-3 6.84x10-4 
Where  ν = Flory exponent, Rg is the radius of gyration and I(0) is the forward scattering.  





Figure 5.6. TEM images of a) and b) 2 wt% oxytocin at native pH and c and d) 2 wt% oxytocin 
at pH 12. e) 2 wt% carbetocin native pH and f) and g) 2 wt% carbetocin pH 12    





Figure 5.7. cryo-SEM images of 2wt% Oxytocin pH 12 hydrogel showing fibres.  
 
 
Figure 5.8. Polarised optical microscopy images of peptides stained with Congo red a) 2 wt% 
oxytocin pH 12 hydrogel and b) 2 wt% carbetocin pH 12 solution.   
 
5.2.2 Self-assembly of Oxytocin and LOT-1 in Ethanol  
 
LOT-1 is a lipidated version of oxytocin (Scheme 5.1) which has been modified with two C16 
palmitoyl chains C16-CY(C16)IQNCPLG-NH2. Due to this lipidation, LOT-1 is not soluble in 
H2O, or combinations of H2O/Ethanol at 0.1 wt%. Therefore, self-assembly was examined in 
ethanol, and oxytocin was re-examined in ethanol solvent to compare the change in assembly.  
Circular dichroism was used to characterise secondary structure. Oxytocin was found to form 
a poly-proline helix characterised by a double minimum (Figure 5.9a), in the CD spectra, at 220 
nm and 205 nm.48–50 This differs from the secondary structure observed in H2O which was 




disordered.  Oxytocin in ethanol has a tyrosine peak at 230 nm like that observed in water, 
however LOT-1 has lost this peak perhaps due to the lipidation of the tyrosine, which may 
affect the polarity of the ring.  LOT-1 had a disordered structure at low temperature 
characterised by a peak at 205 nm (Figure 5.9b). When the temperature was raised above 30oC, 
there was an irreversible change in structure, indicating a loss of secondary structure.  
 
Figure 5.9. Circular Dichroism of a) 0.5 wt% oxytocin and b) 0.5 wt% LOT-1  
 
Cryo-TEM and SAXS were used to probe the tertiary structure of LOT-1 and oxytocin in 
ethanol. Interestingly, the cryo-TEM of Oxytocin in ethanol revealed a mixture of long fibres 
with a diameter of 6.2 ± 2.5 nm, and spherical globular structures with an average diameter of 
17 ± 4.5 nm. The lipidated peptide shows a preference to irregular shaped clusters, with an 
average diameter of 26.5 ± 4.7 nm. These clusters were seen to aggregate into large fibrillar 
particles as show in Figure 5.10b.  
SAXS for oxytocin was fitted to a long cylindrical shell model. 47 Intensity profiles for Oxytocin 
fibrils were fitted with a length of 50 nm, compared to LOT-1 which was fitted with a smaller 
fixed length based on the cryo-TEM showing different fibril morphologies. The radius for these 
fibres were all roughly around 3 nm, with a shell thickness between 2.0 nm and 2.5 nm. The fit 
parameters are listed in Table 5.2. 





Figure 5.10. a) Cryo-TEM of 0.5 wt% oxytocin in ethanol b) cryo-TEM of 0.5 wt% LOT-1, and 
c) and d) SAXS profiles.  
Table 5.2. SAXS fits parameters for oxytocin and LOT-1 in ethanol fitted using long cylindrical 




0.5 wt% Oxytocin 0.1 wt% LOT-1 0.5 wt% LOT-1 
N 0.02 1 0.11 0.19 
R ±  R (Å) 30 ±15 33 ± 15 34 ± 15 30 ± 15 
Dr (Å) 2.5 2.5 2.0 2.0 
L 500 500 100 100 
ηcore (a.u.) 9.10x10-4 2.58x10-3 6.00x10-4 6.18x10-4 
ηshell (a.u.) 4.97x10-3 1.54x10-3 2.60x10-3 4.20x10-3 
ηsolv (a.u.) 5.79x10-5 2.95x10-5 3.0x10-5 3.12x10-5 
BG 0.014 0.037 0.032 0.15 
Here N denotes scaling parameter, R denotes core radius, Dr denotes shell thickness,  and ηcore, 
ηshell and ηcore denote the scattering length density of the core, shell and solvent, and BG denotes 
background. 




5.3 Conclusions  
 
Overall the self-assembly of oxytocin and carbetocin in aqueous solution, and the self-assembly 
of LOT-1 and oxytocin in ethanol was examined. Oxytocin at 1 wt% native pH and pH 12 
showed conflicting results with cryo-TEM and SAXS, requiring further experiments to 
understand reasons for the observed discrepancy. Oxytocin is known to degrade at higher 
temperatures, which limits the current clinical use. This could mean that oxytocin is also 
radiation sensitive. Thus, other techniques, for example atomic force microscopy (AFM) could 
be used to examine self-assembly, to complement the cryo-TEM or SAXS studies. 
Interestingly, Oxytocin forms a β-sheet hydrogel at 2 wt% and pH 12. This hydrogel exhibits 
anisotropic SAXS patterns and has birefringent properties. 
Carbetocin has very weak self-assembly, remaining as a monomer (confirmed by cryo-TEM 
and SAXS) until adjusted to pH 12 for a 2 wt% solution, for which large birefringent crystalline 
structures are seen with TEM and polarised light microscopy. This is confirmed by SAXS 
through a low q intensity scaling with n = -3 decay indicating large particle structures.  
Interestingly, in ethanol oxytocin forms poly-proline helical long fibril structures, as confirmed 
by SAXS and TEM. Lipidation of oxytocin (LOT-1) has poor water solubility and assembles 
irregularly into clustered fibrils. 
 




Oxytocin, CYIQNCPLG-NH2, Mw=1007.2 cyclised with a disulphide bridge was purchased as 
an acetate salt from CS Bio at >98% purity. Carbetocin, N(4-Mercapto-1-oxobutyl)-O-methyl-
YIQNCPLG-thioester acetate Mw = 988  LOT-1, Mw=1484.02, C16-CY(C16)IQNCPLG-NH2 
was synthesised at Hokkaido University, and received as a acetate salt, as a gift. Mixtures were 
made by adding 0.5 wt%, 1 wt% 2 wt% in nano-pure water or EtOH. Adjustment of pH was 
done using 0.5M NaOH solutions.  
 




5.4.2 Fluorescence Assays 
 
 The presence of any critical aggregation concentration (cac) was assayed using fluorescence 
probes, measuring spectra for a series of peptide concentrations. Fluorescence spectra were 
recorded with a Varian Cary Eclipse fluorescence spectrometer with samples in 4 mm inner 
width quartz cuvettes. ANS (8-anilinonaphthalene-1-sulfonic acid) was further used to examine 
whether there is a cac for oxytocin and carbetocin in water. 
 
5.4.3. Circular Dichroism (CD) Spectroscopy  
 
CD spectra were recorded using a Chirascan spectropolarimeter (Applied Photophysics, UK) 
in the wavelength range 180 – 260 nm. Samples containing 1 wt% Carbetocin and Oxytocin in 
pure H2O or oxytocin or 0.5 wt% LOT-1 in ethanol at were pipetted into 0.1 mm pathlength 
quartz cuvettes. Data with absorbance less than 2 at any point only are reported. Measurements 
were recorded with a 0.5 nm bandwidth, 1 nm step and 1 s collection time per point. The CD 
signal for the background solution was subtracted from the CD signal of the sample, and molar 
ellipticity was calculated.  
 
5.4.4. Fourier Transform Infrared (FTIR) Spectroscopy 
 
 Spectra were recorded using a Thermo Scientific Nicolet IS5 instrument equipped with a 
DTGS detector, with a PEARL liquid cell (sample contained between fixed CaF2 plates). 
Aliquots containing 80 µL of 1 wt% oxytocin or carbetocin in D2O were prepared and added to 
a PEARL liquid cell. Spectra were scanned 128 times over the range of 900 − 4000 cm-1. The 
peptide signal was background corrected with the FTIR spectra of D2O.  
 
5.4.5. Cryogenic Transmission Electron Microscopy (cryo-TEM)  
 
Cryo-TEM measurements were performed by Mehedi Reza and Jani Seitsanen at Aalto 
University, Finland. Vitrified specimens were prepared using an automated FEI Vitrobot device 




using Quantifoil 3.5/1 holey carbon copper grids with a hole size of 3.5 μm. Prior to use, grids 
were plasma cleaned using a Gatan Solarus 9500 plasma cleaner and then transferred into the 
environmental chamber of a FEI Vitrobot at room temperature and 100% humidity. After this, 
sample solutions were applied onto a grid, and were blotted twice for 5 s and then vitrified in a 
1/1 mixture of liquid ethane and propane at a temperature of −180 °C. The grids with vitrified 
sample solution were maintained at liquid nitrogen temperature and then cryo-transferred to the 
microscope. Imaging was carried out using a field emission cryo-electron microscope (JEOL 
JEM-3200FSC) operating at 200 kV. Images were taken in bright field mode and using zero 
loss energy filtering (Ω type) with a slit width of 20 eV. Micrographs were recorded using a 
Gatan Ultrascan 4000 CCD camera. The specimen temperature was maintained at −187 °C 
during the imaging.  
 
5.4.6. Cryo-SEM  
 
Cryo-SEM was performed using an FEI Quanta 600F instrument in the EM CAF laboratory at 
Reading University. The oxytocin gel was mounted onto aluminium stubs and frozen in a 
liquid-nitrogen slush at −210°C. Once frozen, the sample was transferred under vacuum to a 
sample preparation chamber and allowed to equilibrate to the appropriate temperature prior to 
fracturing. The gel was fractured at −140°C and allowed to sublime at−90°C for approximately 
5 minutes. The sample was cooled to −140°C and then coated with platinum and imaged at 5 
keV 
  
5.4.7 Transmission Electron Microscopy (TEM) 
 
TEM imaging was performed in the EM CAF laboratory at Reading University, using a JEOL 
2100Plus TEM microscope operated at 200 kV. Droplets of sample were placed on Cu grids 
coated with a carbon film (Agar Scientific, UK), stained with uranyl acetate (1 wt %) (Sigma-








5.4.8 Optical polarised Microscopy (POM) 
 
Congo Red Staining and Birefringence Monitored by Polarized Optical Microscopy (POM). A 
filtered solution of 0.5 wt % Congo red solution was pipetted onto a glass microscope slide with 
oxytocin hydrogel or carbetocin solution, and stained for approximately 2 min. Images of the 
sample placed between crossed polarizers were obtained with an Olympus CX-41 microscope 
 
5.4.9. Small-angle X-ray scattering (SAXS) 
 
Data from solutions was collected on the bioSAXS beamlines B21 (Diamond Light Source, 
UK).  Peptide solutions were loaded into PCR tubes in an automated sample changer, then 30 
μL was delivered into a temperature-controlled quartz capillary and 28 frames (1 s each) of 
SAXS data were acquired at 20 oC. For hydrogels, samples were loaded into a custom designed 
gel cell holder at B21, and measured at ambient temperature. The camera length was 3.9 m, and 
the X-ray wavelength was λ= 1.02 Å. Data was collected using a Dectris PILATUS 2M detector 
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Conclusions and Future Work 
 
 6.1 Conclusions  
 
This thesis extensively examines the self-assembling behaviour, membrane interactions and 
biological activity of different peptides for therapeutic use including antimicrobials, enzyme 
responsive materials and peptide hormones.  
Chapter 2 focuses on the self-assembly and bioactivity of arginine and alanine rich surfactant 
like peptides (SLP’s) and bola-amphiphiles, with constructs AnR and RAnR. Bola-amphiphiles 
with longer alanine chains were shown to have greater aggregation propensity, where RA3R 
and RA6R do not self-assemble into regular structures, whereas RA9R and RA12R assembled 
into fibres, and form hydrogels at concentrations at or above 5 wt%. The SLPs self-assembled 
to form fibres. The cytocompatibility of the bola-amphiphiles did not depend on molecular 
weight, and can be classified in order of most toxic to least: RA9R, RA3R, RA12R and RA6R, 
where RA6R is the most tolerated. The SLPs were generally more cytocompatibile, with all the 
SLPs having IC50 concentrations above 0.5 wt%, apart from A12R2. These peptides were 
screened against several strains of bacteria at concentrations below the IC50, and displayed 
strong activity against P.aeruginosa. Interactions with lipid membrane models based on 
DPPG/DPPE examined through DSC, SAXS and Cryo-TEM showed evidence of peptide de-
mixing and ordering of bilayers, which was assumed to be the origin of their antimicrobial 
properties.  
Chapter 3 focuses on the self-assembling behaviour of two symmetrical short peptides, rich in 
arginine and phenylalanine. These peptides, R3F3 and R4F4, have disordered secondary structure 
with SAXS measurements revealing monomers. TEM shows the occasional large aggregated 
structure of long tapes for R3F3 and sheets for R4F4. These peptides were screened with several 
strains of bacteria at cytocompatible concentrations and displayed selective activity to the 
Pseudomonas species. R4F4 was particularly active, displaying activity against a range of plant 
Pseudomonas as well as clinically relevant Pseudomonas aeruginosa. Peptide interaction with 
lipid membranes revealed reordering of lipid DPPG/DPPE membrane models. Interesting R4F4 
completely disrupted the formation of DPPG/DPPE liposomes, when the PG/PE ratio was most 
similar to the P.aeruginosa membrane composition. Finally, the effect of R3F3 and R4F4 on 
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biofilm formation of P.aeruginosa was measured using a crystal violet assay. The peptide R4F4 
was found to reduce biofilm formation by 70%. Both peptides showed interactions with c-di-
GMP, visualised through TEM and SAXS. Attempts to indirectly measure c-di-GMP in bacteria 
using Congo red stain showed flocculation of the bacteria. The RNFN peptides showed 
interesting antimicrobial properties.  
Chapter 4 focuses on the self-assembly of telechelic PEO-star conjugates functionalised with 
tyrosine. These conjugates showed changes in self-assembly upon pH adjustment. The  [poly(L-
tyrosine4-5)-b-(PEO 2.5k)]4 conjugate showed clustered structures at native pH, and disrupted 
self-assembly visualised through cryo-TEM at pH 12.  The larger conjugate, [poly(L-tyrosine3-
4)-b-(PEO 5k)]4 showed changes in self-assembly, from fibril worm-like globules, to long 
straight fibres and small globules. The self-assembly of these branched conjugates were 
polydisperse, which may be due to the star architecture. These conjugates were found to be 
cytocompatible at sufficiently high concentration.  
Finally, Chapter 5 focuses on the self-assembly of peptide hormones oxytocin, analogue 
Carbetocin and lipidated oxytocin (LOT-1). Oxytocin in aqueous solution had conflicting 
results. SAXS measurements showed monomers at 1 wt% Oxytocin at native pH and pH 12. 
However, cryo-TEM and TEM, revealed vesicle formation at native pH and fibril formation at 
pH 12. This may be due to Oxytocin being heat sensitive, which may also mean it is radiation 
sensitive. At 2 wt% pH 12, oxytocin forms a β-sheet hydrogel, visualised by SAXS, TEM, cryo-
SEM which is birefringent. Carbetocin had a very weak aggregation, at native pH and pH 12, 
consistently displayed by cryo-TEM, SAXS and TEM. At 2 wt% peptide solution, the peptide 
formed large birefringent crystalline structures. LOT-1 was insoluble in water, due to increased 
hydrophobicity of the lipid chain, thus LOT-1 and Oxytocin were studied in ethanol. LOT-1 
formed irregular clusters of fibrils, visualised by cryo-TEM and SAXS. Oxytocin in ethanol 
formed poly-proline II helical secondary structure and assembled into fibrils.  
The work carried out in this thesis has demonstrated the capabilities of peptides for a range of 
therapeutic applications. The results demonstrate the promise of small synthetic oligopeptides 
for antimicrobial applications, the properties of telechelic star polymers for enzyme responsive 
material development, and the characterisation of peptide hormone oxytocin and analogues, 




6.2. Future work  
 
Considering the antimicrobial peptides discussed in chapters 2 and 3, with structures RANR, 
ANR, and FNRN, future work should focus firstly understanding in greater detail the mechanism 
of action, and secondly improving constructs to enhance activity. To understand further the 
mechanism of interactions, SEM and TEM could be undertaken on bacteria to see visually 
whether there are any changes to the bacterial membrane at a range of concentrations below the 
MIC concentration. This could give information on whether the peptide is membrane disruptive 
or whether it interacts with downstream intracellular targets. A further method to be considered 
is to fluorescently label the peptide and use a technique such as confocal microscopy to trace 
the peptide’s movement within the cell. Further to this, to explore the effect on peptides on gene 
expression (if the peptides do interact with intracellular targets), techniques like bioarray or 
qPCR could be used to examine whether the peptides lead to up or down regulation of specific 
genes. This could provide us with further useful information on interactions between peptides 
and intracellular targets. This may then lead to informed modification of the sequence, 
increasing the specificity of the peptides to any targets. 
A factor that was noticeable during the antimicrobial screening was that the peptides reduced 
the CFU of the bacteria within the first 2 hours of exposure. A method to track whether the 
peptide has been degraded by the bacteria within this time could be mass spec analysis, or NMR 
if a part-deuterium labelled version of the peptide was used. Further to this, the peptides could 
then be modified with D-amino acids, lipids or PEG chains to improve stability. Particularly for 
R4F4, the strongest AMP examined, assaying R5F5, or changing the sequence to examine the 
effects of alternating [RF] units or bola-amphiphile like units (RFNR) have on antimicrobial 
activity and cell viability could prove to beneficial for therapeutic development. Additionally, 
incorporating other amino acid residues which are important to antimicrobial activity, such as 
K, W, C, H, or P, could be of interest to see whether this creates a broader range of activity.   
Moreover, examining the peptides in a more physiologically relevant buffers such as PBS, and 
screening them against different cell lines including blood platelet cell lines, could be important 
in determining their suitability as a proposed candidate for clinical use.  
Considering the tyrosine functionalised telechelic PEO-star conjugates, increasing the number 
of arms may be of interest, with potential to function as a more dendrimer like material could 
be interesting for applications as a delivery vehicle. Moreover, examining whether tyrosine 
kinases phosphorylates the conjugate and if these conjugates could have anticancer applications 
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could be of interest, as many tyrosine kinases are upregulated in many types of cancer. It is 
possible that cancer cell lines with high tyrosine kinase activity may be affected by this 
conjugate.   
Finally, in the instance of peptide hormone oxytocin, more analytical methods to resolve the 
self-assembly, such as AFM, could be used. Although the hydrogel forms at pH 12, it would be 
interesting to see whether this could be ‘seeded’ into a solution at a physiological pH to establish 
whether this could promote fibre formation. This may be of interest as self-assembled oxytocin 



























Figure A1. Seeding density of a) 161BR cells and b) HDFa cells. The seeding density selected 





































































Figure A5. Mass Specta of Carbetocin, pH 12, 0.01 wt%.   
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